Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.
Excerpt | Reference |
"Reperfusion injury is a limiting factor in lung transplantation." | ( Conte, JV; Foegh, ML; Katz, NM; Ramwell, PW; Wallace, RB, 1991) |
"In conclusion, reperfusion injury is caused not only by the increase of oxygen free radicals but by the destruction of scavenging systems." | ( Okajima, S, 1990) |
"Intestinal ischemia-reperfusion injury is a common and important clinical event associated with the activation of an endogenous inflammatory response." | ( Caty, MG; Guice, KS; Hinshaw, DB; Oldham, KT; Schmeling, DJ, 1989) |
"Reducing reperfusion injury is effective in reducing flap loss after prolonged ischemia." | ( Arena, S; Dolan, RW; Kerr, D; Schneiderman, T, 1995) |
"The severity of "reperfusion injury" is dependent on the extent to which the involved pathways are activated and on the degree of tissue susceptibility to them." | ( Burkhart, KM; Gmur, DJ; Zager, RA, 1995) |
"Reperfusion injury is a pathophysiological entity distinct from the primary ischaemic injury; the oxygen arriving with blood recirculation, although necessary for alleviating the ischaemic status, may be harmful and provoke additional injury in the already damaged tissue." | ( Albariño, AR; Carceller, F; Díez-Tejedor, E; Gutiérrez-Molina, M; López-Pajares, R; Roda, JM, 1993) |
"Because ischemia-reperfusion injury is associated with decreased endothelial synthesis of prostacyclin and nitric oxide, we tested whether the addition of prostacyclin or the nitric oxide precursor L-arginine to WA would improve preservation." | ( Chapelier, AR; Dartevelle, PG; Hervé, P; Mazmanian, M; Reignier, J; Weiss, M; Xiong, L, 1994) |
"Ischaemia-reperfusion injury is a complex phenomenon often encountered in surgical practice." | ( Grace, PA, 1994) |
"Postischaemic reperfusion injury is often attributed to the generation of oxygenated free radicals which may subsequently promote lipid peroxidation in cell membranes." | ( Deby, C; Defechereux, T; Defraigne, JO; Franssen, C; Lamy, M; Limet, R; Meurisse, M; Philippart, C; Pincemail, J; Serteyn, D, 1993) |
"Hypoxia/reperfusion injury is a major clinical problem." | ( Gogvadze, V; Richter, C, 1993) |
"Reperfusion injury is a large problem in the early stage after lung transplantation." | ( Harada, Y; Horiguchi, T, 1993) |
"Lung ischemia-reperfusion injury is associated with increased vascular permeability, which may be due in part to oxygen (O2) free radicals." | ( Cooper, JD; Dresler, CM; Haniuda, M; Mizuta, T; Patterson, GA, 1995) |
"Reperfusion injury is a phenomenon complicating microvascular reconstruction." | ( Huang, L; Klitzman, B; Panza, W; Serafin, D; Zavitsanos, G, 1996) |
"Ischemia-reperfusion injury is one of the major problems in reconstructive microsurgery." | ( Balling, E; Hartmund, T; Hauge, EM; Hjortdal, VE, 1997) |
"Ischemia reperfusion injury is manifested by oedema and increased microvascular permeability." | ( Aras, N; Bayraktaroğlu, G; Bengisun, J; Bengisun, JS; Camur, A; Köksoy, C, 1997) |
"Reperfusion injury is the major cause of early respiratory morbidity after single-lung transplantation." | ( Boujoukos, AJ; Griffith, BP; Keenan, RJ; Martich, GD; Vega, JD, 1997) |
"Postischemic reperfusion injury is caused by microcirculatory disturbances, including both nutritive perfusion failure (no reflow) and leukocyte activation (reflow paradox)." | ( Menger, MD; Müller, JM; Vollmar, B, 1997) |
"Liver ischemia and reperfusion injury is mediated by oxygen free radicals, cytokines, and prostanoids produced by Kupffer cells and infiltrating neutrophils." | ( Garcia, R; Helton, S; Lo, CJ; Terasaki, M, 1997) |
"Liver ischemia and reperfusion injury is associated with activation of multiple inflammatory pathways, including free radicals, cytokines, and neutrophil-mediated tissue damage among others." | ( Garcia-Criado, FJ; Gomez-Alonso, A; Misawa, K; Palma-Vargas, JM; Toledo, AH; Toledo-Pereyra, LH; Valdunciel-Garcia, JJ, 1997) |
"Ischemia-reperfusion injury is one of the major problems in organ transplantation." | ( Ansley, DM; Duncan, S; English, JE; Fradet, G; Nikbakht-Sangari, M; Pearson, B; Qayumi, AK; Sammartino, C, 1997) |
"Ischemia-reperfusion injury is one of the significant problems in clinical lung transplantation." | ( Dienemann, H; Hoffmann, H; Messmer, K; Müller, C; Sakamaki, F; Schildberg, FW, 1997) |
"Ischemia reperfusion injury is still a leading cause of early graft dysfunction after transplantation." | ( Baumert, H; Caritez, JC; Carretier, M; Eugene, M; Germonville, T; Hauet, T; Journe, F; Mothes, D; Tillement, JP, 1998) |
"Initial ischemia-reperfusion injury is associated with organ retrieval, storage, and transplantation adversely affects early graft function and influences the development of chronic graft dysfunction." | ( Baumert, H; Carretier, M; Eugene, M; Goujon, JM; Hauet, T; Lacoste, L; Richer, JP; Tillement, JP, 1999) |
"Ischemia/reperfusion injury is a commonly occurring event with severe pathologic consequences." | ( Eppinger, M; Lemmon, G; Miller, S; Nolan, D; Peoples, J; Prem, JT, 1999) |
"Hepatic ischemia/reperfusion injury is initiated by the activation of Kupffer cells and their subsequent release of proinflammatory mediators, including tumor necrosis factor-alpha (TNFalpha)." | ( Edwards, MJ; Kato, A; Lentsch, AB; Miyazaki, M; Yoshidome, H, 1999) |
"Ischemia-reperfusion injury is encountered frequently in conditions that diminish intestinal blood flow." | ( Akyol, O; Aydin, E; Aydinç, M; Gültek, A; Gürsoy, MH; Karaman, A; Koltuksuz, U; Ozen, S; Uz, E, 1999) |
"Reperfusion injury is a serious problem after clinical liver transplantation, often leading to dys- or even non-function of grafts." | ( Broelsch, CE; Hertl, M; Hertl, MC; Kluth, D; Kunkel, P; Malagó, M; Prevot, B; Schilling, S, 1999) |
"Ischemia/reperfusion injury is increasingly recognized as a common and important mechanism in the pathogenesis of acute pancreatitis and especially in the progression from mild edematous to severe necrotizing form." | ( Sakorafas, GH; Tsiotou, AG, 2000) |
"Reperfusion injury is one of the factors that unfavorably affects stroke outcome and shortens the window of opportunity for thrombolysis." | ( Bolay, H; Dalkara, T; Gürsoy-Ozdemir, Y; Saribaş, O, 2000) |
"Ischemia/reperfusion injury is often the final and irreversible factor causing flap failure in microvascular surgery for head and neck defects." | ( Carroll, WR; Esclamado, RM, 2000) |
"Reperfusion injury is the leading cause of early graft dysfunction after lung transplantation." | ( Demertzis, S; Dwenger, A; Hausen, B; Langer, F; Schäfers, HJ; Scherer, M, 2000) |
"Ischemia-reperfusion injury is considered a risk factor for the development of chronic transplant nephropathy (CTN) although the mechanisms that mediate its effects have not been completely established." | ( Alsina, J; Condom, E; Cruzado, JM; Grinyó, JM; Herrero-Fresneda, I; Lloberas, N; Merlos, M; Riera, M; Torras, J, 2000) |
"Reperfusion injury is a perplexing cause of early graft failure after lung transplantation." | ( Fiser, SM; Kaza, AK; Kern, JA; Kron, IL; Long, SM; Tribble, CG, 2001) |
"Reperfusion injury is propagated by an inflammatory-mediated tissue edema and damage after reestablishment of vascular flow following an initial ischemic insult." | ( Ghavami, A; Mowlavi, A; Neumeister, M; Song, YH, 2001) |
"Cerebral ischemia-reperfusion injury is associated with a developing inflammatory response with pathologic contributions from vascular leukocytes and endogenous microglia." | ( Beech, JS; Grainger, DJ; Menon, DK; Mosedale, DE; Reckless, J; Williams, SC, 2001) |
"Ischemia/reperfusion injury is a major cause of transplanted heart dysfunction." | ( Fukumoto, Y; Moriyama, Y; Nakamura, K; Sakasegawa, K; Sakata, R; Toda, R; Ueno, M; Yamamoto, H; Yotsumoto, G, 2001) |
"Ischemia/ reperfusion injury is one risk factor for atherosclerosis." | ( Morita, I; Murota, SI; Zhang, YW, 2001) |
"Hepatic ischemia-reperfusion injury is an important cause of graft dysfunction after liver transplantation." | ( Lou, J; Majno, P; Mentha, G; Morel, P; Oberholzer, J; Toso, C; Triponez, F; Yang, H, 2002) |
"Reperfusion injury is believed to contribute to the pathophysiology of ischemic cell death, but the precipitating factors have yet to be completely elucidated." | ( Lust, WD; Pundik, S; Ratcheson, RA; Selman, WR; Taylor, C, 2002) |
"Mesenteric ischemia-reperfusion injury is a serious complication of shock." | ( Attuwaybi, B; Kone, BC; Zou, L, 2003) |
"Ischemia-reperfusion injury is a major cause of early graft dysfunction after liver transplantation." | ( Almada, LL; Furno, G; Guibert, EE; Rodriguez, JV; Scandizzi, AL, 2003) |
"Liver ischemia-reperfusion injury is a serious problem during liver resection and transplantation." | ( Kawachi, S; Kitajima, M; Matsumoto, K; Morisue, A; Mukai, M; Shimazu, M; Tanabe, M; Wakabayashi, G; Yamamoto, S; Yoshida, M, 2003) |
"Ischemia-reperfusion injury is a significant problem in lung transplantation." | ( Ishikawa, N; Kawaguchi, M; Oda, M; Tsunezuka, Y; Watanabe, G, 2003) |
"Cerebral ischaemia-reperfusion injury is associated with the generation of reactive oxygen species during the early phases of reoxygenation." | ( Hirayama, A; Kato, N; Nagase, S; Nose, T; Yanaka, K, 2003) |
"Ischemia-reperfusion injury is a major complication occurring in acute myocardial infarction, cardiopulmonary bypass surgery, and heart transplantation." | ( Ishikawa, H; Kanaoka, M; Kojima, S; Sakai, J; Satoh, H; Yamamoto, S, 2003) |
"Hepatic ischemia-reperfusion injury is characterized by an intense acute inflammatory response that is dependent on a number of proinflammatory mediators." | ( Lentsch, AB; Okaya, T, 2004) |
"Reperfusion injury is a common clinical problem that lacks effective therapy." | ( Carroll, M; Chan, RK; Hechtman, HB; Ibrahim, SI; Moore, FD; Verna, N, 2003) |
"Ischemia-reperfusion injury is a microvascular event documented in numerous in vivo animal models." | ( Al-Badawi, H; Patton, GM; Peterson, B; Russo, AL; Soler, H; Watkins, MT, 2004) |
"Ischaemia-reperfusion injury is a well established if paradoxical phenomenon whereby ischaemic tissue, doomed to necrosis if it is not reperfused, is actually further damaged by oxidative attack when perfusion is restored." | ( Kelly, CJ; Kingston, R; Murray, P, 2004) |
"Ischemia/reperfusion injury is associated with the proliferation and hypertrophy of astrocytes and with inflammatory responses." | ( Kaminska, B; Zawadzka, M, 2005) |
"Organ ischemia-reperfusion injury is caused by two consecutive steps, microcirculatory disturbance and neutrophil-endothelial cell interactions, which are caused by inflammatory cytokines." | ( Hakamada, K; Murata, A; Nara, M; Narumi, S; Nishimura, A; Nozaki, T; Ono, H; Sasaki, M; Seino, K; Takahashi, K; Takiguchi, M; Totsuka, E; Umehara, M; Wajima, N, 2004) |
"Ischemia-reperfusion injury is a dominant factor limiting tissue survival in any microsurgical tissue transplantation, a fact that also applies to allogeneic hand transplantation." | ( Baumeister, S; Gebhard, MM; Germann, G; Heitmann, C; Kleist, C; Ofer, N; Opelz, G; Terne, P, 2004) |
"Hepatic ischemia-reperfusion injury is an inevitable consequence during liver surgery." | ( Fan, ST; Ho, JW; Lee, TK; Li, XL; Lo, CM; Man, K; Ng, KT; Sun, CK; Zhao, Y, 2005) |
"Ischemia-reperfusion injury is an unavoidable problem for organ transplantation including small bowel transplantation, and causes a large intra-individual variation of tacrolimus (FK506) pharmacokinetics." | ( Goto, M; Inui, K; Ito, K; Masuda, S; Okuda, M; Omae, T; Shimomura, M, 2005) |
"Reperfusion injury is a consequence of inadequate energy supply and acidosis in ischemic tissues and a chain of events triggered by oxygen-derived free radicals released in response to exposure of oxygen." | ( Akbas, MH; Berki, KT; Bulbul, S; Kanko, M; Maral, H; Omay, O; Ozden, M; Yavuz, S, 2005) |
"Secondary or reperfusion injury is potentially amenable to neuroprotective strategies." | ( Perlman, JM, 2004) |
"However, severe reperfusion injury is still a major cause for postoperative morbidity and mortality." | ( Bertolotti, A; Cuniberti, L; del Valle, HF; Favaloro, RR; Gómez, CB; Laguens, RP; Martínez, V; Negroni, JA; Ossés, J, 2005) |
"Reperfusion injury is a problem in organ transplantation." | ( Armbruster, FP; Boehnert, MU; Hilbig, H, 2005) |
"Ischemia/reperfusion injury is a leading cause of renal damage and antisense gene therapy has been shown to ameliorate its effects." | ( Copeland, D; Funk, J; Lai, LW; Lien, YH; Phull, H; Purves, T; Ramakumar, S; Ulreich, JB, 2005) |
"Ischemia-reperfusion injury is a major factor in the early phase of lung transplantation." | ( Akamatsu, H; Arai, H; Kojima, K; Shimoyama, T; Sunamori, M; Tabuchi, N; Tanaka, H, 2005) |
"Ischemia-reperfusion injury is often responsible for delayed graft function after transplantation." | ( Chlubek, D; Ciechanowski, K; Domanski, L; Olszewska, M; Pawlik, A; Safranow, K; Sulikowski, T; Urasinska, E, 2006) |
"Reperfusion injury is characterized by free radical production and endothelial inflammation." | ( Corcoran, TB; Engel, A; O'Shea, A; Shorten, GD, 2006) |
"Ischemia/reperfusion injury is an inherent consequence of solid organ transplantation that increases tissue inflammation and negatively impacts organ transplant function and survival." | ( Araki, M; Fahmy, N; Fairchild, RL; Flechner, S; Goldfarb, D; Krishnamurthi, V; Kumon, H; Modlin, C; Novick, AC; Zhou, L, 2006) |
"Such reperfusion injury is a major problem during cardiac surgery and in the treatment of coronary thrombosis and stroke." | ( Halestrap, AP, 2006) |
"Cerebral ischaemia-reperfusion injury is associated with an inflammatory response, with contributions from leucocytes and microglia." | ( Heusch, G; Schulz, R, 2006) |
"Hepatic ischemia-reperfusion injury is one of the major problems in liver transplantation." | ( Shen, F; Sun, HW; Zhou, YM, 2006) |
"Ischemia-reperfusion injury is of major clinical relevance during liver transplantation." | ( Jiang, H; Li, J; Meng, F; Qiao, H; Sun, X; Tong, L, 2006) |
"Ischemia and reperfusion injury is a pathologic process with serious consequences, arising due to interruption of arterial blood flow." | ( Acil, C; Kanko, M; Maral, H; Ozden, M, 2006) |
"Ischemia-reperfusion injury is a serious clinical situation which can cause serious morbidity and mortality." | ( Akyol, H; Bingul, S; Colak, E; Gul, AE; Kaptanoglu, L; Kucuk, HF; Kurt, N; Ozalp, F; Torlak, OA, 2006) |
"Renal ischemia reperfusion injury is known to shorten telomeres and upregulate stress-induced genes, such as the cyclin-dependent kinase (CDK) inhibitor p21." | ( Heininger, D; Hochegger, K; Huber, JM; Koppelstaetter, C; Mayer, G; Rosenkranz, AR; Tagwerker, A, 2007) |
"Ischemia-reperfusion injury is a determinant in liver injury occurring during surgical procedures, ischemic states, and multiple organ failure." | ( Boogaerts, JG; Nuyens, V; Stadler, M, 2007) |
"Reperfusion injury is a perplexing cause of early graft failure after lung transplantation and today we know that reperfusion may be more harmful to tissues than the preceding ischemia." | ( Demirel, R; Dilek, FH; Esme, H; Fidan, H; Solak, O; Unlu, M, 2006) |
"Ischemia-reperfusion injury is caused by the activation of inflammatory and cytoprotective genes, such as macrophage chemoattractant protein-1 and heme oxygenase-1, respectively." | ( Câmara, NO; Cenedeze, MA; Pacheco-Silva, A; Pesquero, JB; Wang, PH, 2006) |
"Ischemia/reperfusion injury is regarded as the main cause of failure in revascularization of limbs and transfer of free flaps in the so called nonreflow phenomenon." | ( Bertani, A; Bertani, C; Campodonico, A; Carboni, A; Marchesini, A; Mazzanti, L; Pangrazi, PP; Riccio, M; Scalise, A; Talevi, D, 2007) |
"1." | ( Arab, HA; Cheung, K; Hickman, PE; Kadkhodaee, M; Potter, JM; Roberts, MS, 2007) |
"Reperfusion injury is a phenomenon that occurs when tissues are subjected to ischaemia for a variable period of time, after which they are reperfused." | ( Acet, A; Askar, I; Aydogan, H; Aydogan, N; Bay-Karabulut, A; Fariz, A; Gurlek, A; Parlakpinar, H, 2007) |
"Lung reperfusion injury is a significant problem in cardiothoracic surgery." | ( Ellman, PI; Gazoni, LM; Kron, IL; Laubach, VE; Law, MG; Linden, J; Reece, TB; Singh, R; Tribble, CG, 2008) |
"Ischemia-reperfusion injury is a common early event in kidney transplantation and contributes to a delay in organ function." | ( Bueno, V; Cury, PM; da Silva, LB; Palma, PV, 2007) |
"Hypoxia-reperfusion injury is an important determinant of secondary brain injury." | ( Ghori, K; Harmon, D; Lan, W; Seigne, P; Shorten, GD; Walsh, F, 2008) |
"Reperfusion injury is a complication of recanalization therapies after focal cerebral ischemia." | ( Gardner, H; Heiland, S; Horstmann, S; Koziol, J; Martinez-Torres, FJ; Nagel, S; Su, Y; Wagner, S, 2008) |
"Ischemia/reperfusion injury is a major problem in clinical transplantation (Tx)." | ( Büchler, MW; Dei-Anane, G; Gross, ML; Guan, X; Kern, M; Liang, R; Ludwig, J; Nickkholgh, A; Schemmer, P; Schmidt, J; Zeier, M, 2008) |
"Ischaemia-reperfusion injury is still a major problem after lung transplantation." | ( Guth, S; Kramm, T; Mayer, E; Prüfer, D, 2007) |
"Ischemia-reperfusion injury is a leading cause of acute renal failure and a major determinant in the outcome of kidney transplantation." | ( de Zeeuw, D; Deelman, LE; Helfrich, W; Henning, RH; Sandovici, M; van Goor, H, 2008) |
"Ischemia-reperfusion injury is one of the central nonimmunologic processes involved in renal allograft dysfunction." | ( Desurmont, T; Doucet, C; Eugene, M; Favreau, F; Goujon, JM; Hauet, T; Hébrard, W; Manguy, E; Mauco, G; Milin, S; Papadopoulos, V; Yamamoto, Y, 2008) |
"Reperfusion injury is a significant complication of the management of ST-elevation MI (STEMI)." | ( Baran, K; Brickman, CM; Dauerman, H; Grip, L; Krakover, R; Kumar, S; McCabe, CH; Morrow, DA; Murphy, SA; Salzman, AL; Slomowitz, N, 2009) |
"Renal ischemia/reperfusion injury is a major complication of kidney transplantation." | ( Choi, AM; Faleo, G; Kohmoto, J; McCurry, KR; Murase, N; Nakahira, K; Nakao, A; Shimizu, H; Sugimoto, R; Takahashi, T, 2008) |
"Hepatic ischaemia-reperfusion injury is a serious problem that occurs during various surgical operations such as liver transplantation, surgical revascularization, and partial organ resection." | ( Altinkaynak, K; Atamanalp, SS; Demirci, N; Keles, MS; Yildirim, A, 2008) |
"Ischemia-reperfusion injury is a common pathological occurrence causing tissue damage in heart attack and stroke." | ( Arreola, J; Kaba, NK; Kim, M; Knauf, PA; Law, FY; Lefort, CT; Martel-Gallegos, G; Schultz, J; Waugh, RE, 2008) |
"Ischemia/reperfusion injury is thought to play an important role in postoperative liver dysfunction and morbidity following major liver surgery." | ( Cassidy, D; Dixon, E; McKay, A; Sutherland, F, 2008) |
"Ischemia-reperfusion injury is an important cause of graft failure." | ( Abbate, M; Arduini, A; Azzollini, N; Cassis, P; Cugini, D; Gagliardini, E; Noris, M; Peschechera, A; Pezzotta, A; Remuzzi, G, 2008) |
"Ischaemia-reperfusion injury is the mechanism underlying (partial) flap loss." | ( Bast, A; Buurman, WA; van den Heuvel, MG; van der Hulst, RR, 2009) |
"Lung ischemia-reperfusion injury is associated with impaired gas exchange from increased edema formation and surfactant inactivation." | ( Cobelens, PM; Heijnen, CJ; Kavelaars, A; Kesecioglu, J; Lachmann, B; van der Kaaij, N; van Putte, BP, 2009) |
"Cerebral ischemia/reperfusion injury is characterized by the development of inflammatory response, in which vascular macrophages and endogenous microglia are involved." | ( Eguchi, N; Hattori, N; Liu, M; Urabe, T; Urade, Y; Yamasaki, Y, 2009) |
"Some mechanisms of reperfusion injury are now recognized; they include oxygen free radical (OFR), white blood cells activation, changes in calcium influx, alteration of microvascular blood flow, and sympathetic activation." | ( Albertini, JP; Artigou, JY; Bonnefont-Rousselot, D; Charniot, JC; DeLattre, J; Dever, S; Monsuez, JJ; Nataf, P; Pavie, A; Vignat, N, 2010) |
"Ischemia/reperfusion injury is mediated by various mechanisms." | ( Backhaus, J; Büchler, MW; Flechtenmacher, C; Gebhard, MM; Kincius, M; Liang, R; Schemmer, P; Schindler, G; Zorn, M, 2009) |
"Ischemia/reperfusion injury is an unavoidable complication in liver surgery and transplantation." | ( Bode, A; Gebhard, MM; Golling, M; Lorenz, MW; Zapletal, C, 2009) |
"Renal ischemia and reperfusion injury is the major cause of acute renal failure and may also be involved in the development and progression of some forms of chronic kidney disease." | ( Erkasap, N; Isikli, B; Kabadere, S; Kinaci, MK; Koken, T; Kucuk, A; Tosun, M, 2009) |
"Renal ischemia/reperfusion injury is a major cause of acute renal failure." | ( Badavi, M; Ghaffari, MA; Hosseini, F; Naseri, MK; Rashidi, I; Shahbazian, H, 2009) |
"Ischemia-reperfusion injury is induced by recovery of blood flow after ischemia." | ( Asai, T; Ishii, T; Oku, N; Urakami, T, 2010) |
"Ischemia-reperfusion injury is a major concern with portal triad clamping (PTC) in liver surgery." | ( Björnstedt, M; D'souza, MA; Isaksson, B; Jersenius, U; Lundell, L; Nowak, G; Permert, J; Ungerstedt, J, 2011) |
"Ischemia-reperfusion injury is the propagation of injury following reintroduction of oxygen to previously ischemic tissue." | ( Henderson, PW; Nagineni, V; Singh, SP; Spector, JA; Sung, J; Weinstein, AL, 2010) |
"Ischaemia-reperfusion injury is a life-threatening complication of lung transplantation." | ( Calderone, A; Jayaweera, S; Lim, HK; Marasco, SF; Pepe, S; Rosenfeldt, FL, 2010) |
"Cerebral ischemia/reperfusion injury is a common secondary effect of cardiac arrest which is largely responsible for postresuscitative mortality." | ( Martijn, C; Wiklund, L, 2010) |
"Ischemia-reperfusion injury is believed to be a major cause of transferred skin flap failure." | ( Cherri, J; Freitas, FA; Marchesan, WG; Piccinato, CE, 2010) |
"Ischemia/reperfusion injury is a major problem in renal transplantation." | ( Assa, S; Daneshmand, A; Dehpour, AR; Deroee, AF; Elmi, A; Emami, H; Nezami, BG; Talab, SS; Tavangar, SM, 2010) |
"Hepatic ischemia-reperfusion injury is a common phenomenon in hepatic surgical procedures and can result in further severe damage." | ( Bao, L; Meng, HY; Wang, CC; Yin, W; Zhang, L; Zhang, WX; Zhou, LF, 2011) |
"Kidney ischemic reperfusion injury is the leading cause of acute renal failure and dysfunction of transplanted kidneys." | ( Soleimani, M; Zahedi, K, 2011) |
"Renal reperfusion injury is associated with increased mortality and morbidity due to acute kidney failure." | ( Bagheri, F; Dabiri, S; Gol, A; Javadi, A, 2011) |
"Ischemia-reperfusion injury is a concern for almost every clinical specialty and minocycline seems to be an attractive cytoprotective agent that can ameliorate the damage due to these properties." | ( Barry, SP; Chen-Scarabelli, C; Faggian, G; Field, MG; Knight, RA; Latchman, DS; Mazzucco, A; Qureshi, W; Saravolatz, L; Scarabelli, GM; Scarabelli, TM; Stephanou, A; Ulgen, BO; Vasquez, D, 2011) |
"Reperfusion injury is characterized by significant oxidative stress." | ( Barden, AE; Corcoran, TB; Grape, S; Koren, V; Mas, E; Mori, TA; Phillips, M; Roberts, LJ, 2011) |
"Ischemia/reperfusion injury is a complex cascade of interconnected events involving cell damage, apoptosis, vigorous inflammatory responses, microcirculation disturbance, and thrombogenesis." | ( Kimura, S; Murase, N; Ozaki, KS, 2012) |
"Cerebral ischemia-reperfusion injury is the main reason for the loss of neurons in the ischemic cerebrovascular disease." | ( Cui, W; Ge, GL; Huang, QF; Jiang, YF; Wang, Y, 2010) |
"Ischemia/reperfusion injury is a leading cause of acute renal failure triggering an inflammatory response associated with infiltrating macrophages, which determine disease outcome." | ( Hotter, G; Hughes, J; Jung, M; Kluth, DC; Pérez-Ladaga, A; Sola, A; Viñas, JL; Vinuesa, E, 2012) |
"Ischemia-reperfusion injury is a common complication after lung transplantation." | ( Arnaoutakis, GJ; Beaty, CA; Berkowitz, DE; George, TJ; Jandu, SK; Santhanam, L; Shah, AS, 2012) |
"Renal ischemia-reperfusion injury is a major cause of acute kidney injury." | ( Brown, KM; D'Agati, VD; Haase, VH; Kim, JY; Kim, M; Lee, HT; Park, SW, 2012) |
"Ischemia-reperfusion injury is associated with a high rate of primary organ dysfunction and thereby contributes substantially to morbidity and mortality in the course of liver transplantation." | ( Lehne, K; Nobiling, R, 2013) |
"Ischaemia-reperfusion injury is associated with reduced bioavailability of nitric oxide (NO) and microvascular dysfunction." | ( Berkowitz, D; Grönros, J; Jung, C; Kiss, A; Palmér, M; Pernow, J, 2013) |
"Ischaemia/reperfusion injury is a common problem in hepatic surgery." | ( Jiang, P; Liu, H; Liu, L; Zhou, SP, 2013) |
"Ischemia/reperfusion injury is the leading cause of acute tubular necrosis." | ( Ando, R; Fukami, K; Iwatani, R; Kaida, Y; Kaifu, K; Kusumoto, T; Nakayama, Y; Obara, N; Okuda, S; Taguchi, K; Toyonaga, M; Ueda, S; Yamagishi, S; Yokoro, M, 2014) |
"Ischemia-reperfusion injury is a common complication in liver surgery with oxidative stress related graft failure as a potential complication." | ( Burczynski, FJ; Crawford, D; Fletcher, LM; Liu, X; Roberts, MS; Thorling, CA, 2014) |
"Intestinal ischemia-reperfusion injury is one of the main factors leading to multiple organ failure after resuscitation of prolonged hemorrhagic shock; however, the current conventional fluid resuscitation still cannot effectively reduce intestinal injury caused by prolonged hemorrhagic shock." | ( Chen, J; Jia, W; Luo, L; Xiao, J; Xiao, Y; Zhao, L, 2014) |
"Intestinal ischemia-reperfusion injury is associated with mucosal damage and has a high rate of mortality." | ( Celik, HT; Kılıc, M; Onal, CO; Onal, O; Sarer, AE; Sirma, A; Yetisir, F; Yurekli, B; Zeybek, ND, 2015) |
"Reperfusion injury is a complex pathophysiological process that involves multiple factors and pathways." | ( Liu, FC; Tsai, HI; Yu, HP, 2015) |
"Ischemia-reperfusion injury is unavoidable during organ transplantation." | ( Carter, D; Davison, M; Gunaratnam, L; Haig, A; Liu, W; Lobb, I; Sener, A, 2015) |
"Hepatic ischemia-reperfusion injury is a disease pattern that is associated with an acute inflammatory reaction." | ( Eckle, VS; Granja, T; Köhler, D; König, K; Mirakaj, V; Rosenberger, P; Schlegel, M, 2016) |
"Renal ischemia-reperfusion injury is a leading cause of acute kidney injury; the pathogenesis of which remains poorly understood and effective therapies are still lacking." | ( Dong, Z; Hao, J; Li, L; Mei, C; Mei, S; Su, Y; Wei, Q, 2017) |
"Ischemia-reperfusion injury is one of the leading causes of acute renal failure which is a common clinical event leading to development of chronic kidney disease and a high mortality; especially in elderly people." | ( Aydin, MS; Esrefoglu, M; Iraz, M; Ozer, OF; Selek, S; Tok, OE, 2016) |
"Ischemia-reperfusion injury is the major complication of abdominal aortic surgery, and it mainly affects the lower extremities and remote organs." | ( Burat, I; Dalkilic, N; Tuncer, S, 2017) |
"Ischaemia-reperfusion injury is a necessary part of organ transplantation and a key determinant of both acute and chronic graft failure." | ( Briedé, JJ; Cos, P; Gielis, JF; Quirynen, L; Roelant, E; Van Schil, PEY, 2017) |
"Ischemia-reperfusion injury is the main obstacle for ovarian tissue transplantation." | ( Koçkaya, EA; Kolusari, A; Okyay, AG, 2018) |
"Reperfusion injury is largely attributed to excess mitochondrial production of reactive oxygen species (ROS)." | ( Bollen Pinto, B; Bromage, DI; Dal-Pizzol, F; Dos Santos Cardoso, J; Dyson, A; Feelisch, M; Galfo, F; Hargreaves, I; Lach, AB; Martin, JF; Moore, KP; Pescador Mendonça, B; Sabbatini, G; Singer, M, 2017) |
"Ischemia/reperfusion injury is still a major cause of morbidity and mortality during liver surgery and transplantation." | ( Gligorijevic, J; Ilic, I; Radojkovic, D; Radojkovic, M; Stanojevic, G; Stojanovic, M; Stojanovic, N, 2017) |
"Ischemia-reperfusion injury is characterized by an increase in oxidative stress and leads to significant morbidity and death." | ( Berkowitz, DE; Bush, EL; Crawford, TC; Damarla, M; Damico, RL; Grimm, JC; Hassoun, PM; Johnston, L; Kim, BS; Magruder, JT; Santhanam, L; Shah, AS; Stephens, RS, 2018) |
"Renal ischemia/reperfusion injury is the most common cause of acute kidney injury, which frequent occurrence in critically ill patients." | ( Cetinkaya, A; Duzcu, SE; Ozturk, H; Tekce, BK, 2018) |
"Lung ischaemia-reperfusion injury is a complex pathophysiological process due to the production of reactive oxygen species and the generation of inflammatory reaction." | ( Wang, JJ; Wang, JS; Wang, ML; Wang, WD; Wei, CH; Zhang, J, 2018) |
"Hind limb ischemia-reperfusion injury is an important pathology in vascular surgery." | ( Cai, J; Jiang, Y; Li, H; Li, K; Qiao, T; Zhang, M; Zhang, X; Zhao, H, 2018) |
"Ischaemia-reperfusion injury is inevitable during renal transplantation and can lead to delayed graft function and primary non-function." | ( De Deken, J; Jochmans, I; Lerut, E; Martinet, W; Monbaliu, D; Pirenne, J; Rex, S, 2018) |
"Ischemia-reperfusion injury is associated with serious clinical manifestations, including myocardial hibernation, acute heart failure, cerebral dysfunction, gastrointestinal dysfunction, systemic inflammatory response syndrome, and multiple organ dysfunction syndrome." | ( Cheng, PW; Cheng, YL; Li, CJ; Li, CY; Liao, WT; Tsai, AP; Wu, MY; Yiang, GT, 2018) |
"Ischemia/reperfusion injury is characterized by excess generation of reactive oxygen species (ROS)." | ( Chung, HJ; Hwang, JE; Jo, YH; Kim, K; Lee, JH; Yang, C, 2018) |
"Ischemia/reperfusion injury is a tissue injury occurring post-reperfusion of tissues with pre-existing ischemia." | ( Alidadiani, N; Baradaran, B; Dilaver, N; Ghaderi, S; Heidari, HR; Heim, C; Ramsperger-Gleixner, M; SoleimaniRad, J; Weyand, M, 2018) |
"Cerebral ischemia-reperfusion injury is the tissue damage caused when blood supply begins to the tissue after a period of ischemia or poor oxygen supply." | ( Jung, GB; Kang, SW; Kim, D; Lee, GJ, 2018) |
"Ischemia-reperfusion injury is the most important part in the progress of ischemic stroke." | ( Chen, NH; Song, XY; Yang, PF, 2016) |
"Cold ischemia-reperfusion injury is unavoidable during organ transplantation, and prolonged preservation is associated with poorer function recovery." | ( Blanco-Gozalo, V; García-Cenador, B; López-Hernández, FJ; López-Montañés, D; López-Novoa, JM; Sanz Giménez-Rico, JR, 2018) |
"Lung ischemia-reperfusion injury is among the complications seen after lung transplantation, resulting in morbidity and mortality." | ( Chen-Yoshikawa, TF; Date, H; Masuda, S; Okabe, R; Saito, M; Suetsugu, K; Takahagi, A, 2019) |
"Ischemia-reperfusion injury is caused by a period of ischemia followed by massive blood flow into a tissue that had experienced restricted blood flow." | ( Wenke, JC; Wetzel, MD, 2019) |
"Ischemia/reperfusion injury is the most common cause of acute kidney injury." | ( Hayashi, K; Miura, T; Nishinaka, T; Shimokawa, T; Takama, M; Terada, T; Tsutsui, H; Yamagata, M; Yoneda, K; Yukimura, T, 2019) |
"Lung ischemia-reperfusion injury is a complex pathophysiologic process associated with high morbidity and mortality." | ( Cui, X; Ding, W; Jiang, T; Liu, T; Liu, Y; Lv, X; Meng, Q; Yue, Z, 2019) |
"Ischemia reperfusion injury is unavoidable in the setting of transplantation and may lead to primary dysfunction of the transplanted organ." | ( Akbaba, S; Bostancı, T; Cimen, S; Ersoy, PE; Sayin, T; Yildirim, Z, 2020) |
"Ischemia-reperfusion injury is one of the leading causes of tissue damage and dysfunction, in particular, free tissue transfer, traumatically amputated extremity, and prolonged tourniquet application during extremity surgery." | ( Iuchi, K; Kamimura, N; Nishimaki, K; Ogawa, R; Ohta, S; Watanabe, M; Yokota, T, 2017) |
"Ischemia-reperfusion injury is an organ failure caused by hypoxia and reperfusion, which is closely associated with oxidative stress and inflammation." | ( Cellat, M; Gokcek, İ; Güvenç, M; İsler, CT; Özkan, H; Uyar, A; Yakan, A, 2020) |
"Renal ischemia/reperfusion injury is a common cause of acute kidney injury (AKI) and hypertension might contribute to the increased incidence of AKI." | ( Brkic, P; Ivanov, M; Jeremic, R; Jovovic, D; Karanovic, D; Kovacevic, S; Mihailovic-Stanojevic, N; Miloradovic, Z; Nesovic-Ostojic, J; Vajic, UJ; Zivotic, M, 2020) |
"Ischemia and reperfusion injury is a complex hemodynamic pathological phenomenon that engages the metabolic to inflammatory machinery in development of disease conditions like heart failure, stroke and acute kidney failure." | ( Naureen, Z; Raza, Z; Saleem, U, 2020) |
"Ischemia-reperfusion injury is encountered in numerous processes such as cardiovascular diseases or kidney transplantation; however, the latter involves cold ischemia, different from the warm ischemia found in vascular surgery by arterial clamping." | ( Alechinsky, L; Barrou, B; Cechova, P; Favreau, F; Faye, PA; Guillard, J; Hauet, T; Inal, S; Ory, C; Thuillier, R; Trouillas, P, 2020) |
"Ischemia-reperfusion injury is inevitable during intestinal transplantation (ITx) and executes a key role in the evolution towards rejection." | ( Brown, RM; Canovai, E; Ceulemans, LJ; Corcos, O; De Hertogh, G; Dejong, CHC; Gupte, G; Hartog, H; Hundscheid, IHR; Joly, F; Kip, AM; Lenaerts, K; Mirza, D; Olde Damink, SWM; Pirenne, J, 2020) |
"Ischemia/reperfusion injury is a complex molecular cascade that causes deleterious cellular damage and organ dysfunction." | ( Alam, HB; Hsu, CH; Pickell, Z; Williams, AM, 2020) |
"Cerebral ischemia-reperfusion injury is pivotal in the development of multiple-subcellular organelle and tissue injury after acute ischemic stroke." | ( Hu, Z; Li, L; Lu, T; Mo, X; Peng, W, 2020) |
"Kidney ischemia-reperfusion injury is a common pathophysiological phenomenon in the clinic." | ( Bai, L; Bai, X; Guo, Z; Luo, D; Ren, X; Wang, D; Wang, Q; Yang, J; Zhang, E; Zhao, X, 2020) |
"Cerebral ischemia-reperfusion injury is a common complication that occurs during stroke treatment." | ( Feng, Y; He, J; Luo, Q; Qu, Y; Sun, X; Sun, Z; Wang, D; Wang, Y; Yang, T; Yang, Y; Yu, G; Zhu, Y, 2020) |
"Ischemia-reperfusion injury is the second most common injury of the spinal cord and has the risk of neurological dysfunction and paralysis, which can seriously affect patient quality of life." | ( Chen, J; Gao, P; Gu, C; Huang, Y; Kong, F; Li, L; Liu, H; Liu, W; Luo, Y; Qian, D; Yin, G; Zhang, C; Zhao, X; Zhou, Z, 2020) |
"Liver ischemia reperfusion injury is associated with coagulation and inflammatory responses." | ( Arnold, K; Cooley, BC; Liao, YE; Liu, J; Pawlinski, R; Xu, Y, 2020) |
"Cerebral ischemia/reperfusion injury is a severe problem in patients with brain ischemia." | ( Fan, L; Zhou, L, 2021) |
"Ischemia-reperfusion injury is correlated with a substantial inflammatory response." | ( Beiras-Fernandez, A; Chun, FKH; Haffer, H; Kornberger, A; Richter, M; Wang, P; Wenzel, M, 2021) |
"Ischemia-reperfusion injury is an important contributor to acute kidney injury and a major factor affecting early functional recovery after kidney transplantation." | ( Cai, XM; Li, ZA; Lin, QK; Pan, XH; Pang, RQ; Ruan, GP; Yao, X, 2020) |
"Cerebral ischemia-reperfusion injury is caused by a blood reperfusion injury in the ischemic brain and usually occurs in the treatment stage of ischemic disease, which can aggravate brain tissue injury." | ( Hua, L; Huang, L; Li, X; Liang, X; Liu, Y; Yang, C; Ye, H; Zhang, X, 2021) |
"Ischemia-reperfusion injury is one of the most critical phenomena in lung transplantation and causes primary graft failure." | ( Carricondo, F; Cebollero, M; García-Aldao, U; Garutti, I; Martín-Albo, L; Ortega, J; Romera, A; Romero-Gómez, B; Simón, C; Vara, E; Zapatero, S, 2021) |
"Reperfusion injury is still a major challenge that impedes neuronal survival in ischemic stroke." | ( Chen, H; Chen, Q; Chu, Y; Guo, Q; Jiang, C; Li, C; Li, X; Liu, P; Luo, Y; Ning, T; Song, H; Su, B; Sun, T; Wang, Y; You, H; Zhang, T; Zhang, Y; Zhao, Z; Zhou, W; Zhou, Z, 2021) |
"Ischemia-reperfusion injury is the commonest form of acute kidney injury (AKI)." | ( Eleftheriadis, T; Filippidis, G; Liakopoulos, V; Pissas, G; Stefanidis, I, 2021) |
"Ischemia-reperfusion injury is related to kidney dysfunction due to bilateral lower limb ischemia." | ( Mubarak, HA; Othman, MA; Sayed, MM, 2022) |
"Even ischemia-reperfusion injury is temporarily attenuated in the penumbra by medications; insults of detrimental factors from the core still erode the penumbra continuously along with drug metabolism and clearance." | ( Chen, J; Chen, Y; Gao, X; Li, F; Liang, K; Liu, S; Liu, Y; Lu, H; Mei, N; Tang, Z; Tong, S; Wang, X; Xie, L; Xu, J; You, Y; Zhou, S, 2022) |
"Ischemia-reperfusion injury is a histopathological event and is an important cause of morbidity and mortality after hepatobiliary surgery." | ( Dogan, HO; Erdogan, MM; Karatas, O; Koc, S; Polat, V, 2022) |
"Ischemia-reperfusion injury is the leading cause of acute kidney injury." | ( Efthymiadi, M; Eleftheriadis, T; Golfinopoulos, S; Liakopoulos, V; Pissas, G; Stefanidis, I, 2022) |
"Ischemia-reperfusion injury is a critical liver condition during hepatic transplantation, trauma, or shock." | ( Bauer, M; Clemens, MG; Dahmen, U; Figge, MT; Kan, C; Lupp, A; Medyukhina, A; Nietzsche, S; Pennington, SA; Press, AT; Settmacher, U; Ungelenk, L; Wang, R; Wetzker, R, 2023) |
"Ischemia-reperfusion injury is thought to be the most important factor affecting the success of liver surgery." | ( Goksoy, E; Kepil, N; Umman, V; Uzun, H, 2023) |
"Renal ischemia-reperfusion injury is caused by a temporary reduction in oxygen-carrying blood flow to the kidney, followed by reperfusion." | ( Ali, RAH; Altimimi, M; Hadi, NR, 2023) |
Drug | Indicated | Relationship Strength | Studies | Trials |
acetylcarnitine | 0 | low | 6 | 0 |
dinitrochlorobenzene | 0 | low | 1 | 0 |
2,3-dihydroxybenzoic acid | 0 | low | 24 | 0 |
provitamin c | 0 | low | 2 | 0 |
2-keto-4-methylvalerate | 0 | low | 1 | 0 |
protocatechuic acid | 0 | medium | 8 | 1 |
3-aminopropionaldehyde | 0 | low | 1 | 0 |
acetoacetic acid | 0 | low | 1 | 0 |
phosphoserine | 0 | low | 1 | 0 |
gamma-aminobutyric acid | 0 | low | 54 | 0 |
4-hydroxybenzyl alcohol | 0 | low | 3 | 0 |
4-hydroxybenzaldehyde | 0 | low | 1 | 0 |
4-hydroxybenzoic acid | 0 | low | 1 | 0 |
aminolevulinic acid | 0 | low | 4 | 0 |
ethylene glycol | 0 | medium | 1 | 1 |
acetic acid | 0 | low | 5 | 0 |
adenine | 0 | medium | 67 | 1 |
agmatine | 0 | low | 9 | 0 |
allantoin | 0 | low | 1 | 0 |
ammonium hydroxide | 0 | medium | 11 | 1 |
quinacrine | 0 | low | 10 | 0 |
beta-alanine | 0 | low | 3 | 0 |
benzene | 0 | medium | 2 | 2 |
benzoic acid | 0 | low | 2 | 0 |
benzyl alcohol | 0 | low | 3 | 0 |
betaine | 0 | medium | 7 | 2 |
1-butanol | 0 | low | 4 | 0 |
butyric acid | 0 | low | 5 | 0 |
carbamates | 0 | low | 8 | 0 |
carbon monoxide | 0 | low | 133 | 0 |
carnitine | 0 | medium | 43 | 1 |
methane | 0 | medium | 21 | 2 |
choline | 0 | medium | 10 | 2 |
aconitic acid | 0 | low | 1 | 0 |
citric acid, anhydrous | 0 | medium | 14 | 1 |
chlorine | 0 | medium | 22 | 2 |
hydrochloric acid | 0 | low | 6 | 0 |
coumarin | 0 | low | 1 | 0 |
salicylic acid | 0 | low | 20 | 0 |
aminoethylphosphonic acid | 0 | low | 1 | 0 |
phloroglucinol | 0 | low | 2 | 0 |
gallic acid | 0 | low | 12 | 0 |
octanoic acid | 0 | low | 2 | 0 |
hydrogen sulfide | 0 | medium | 142 | 2 |
dihydrolipoic acid | 0 | low | 2 | 0 |
3-hydroxybutyric acid | 0 | low | 7 | 0 |
n(1)-methylnicotinamide | 0 | low | 1 | 0 |
guaiacol | 0 | low | 6 | 0 |
n(1)-acetylspermidine | 0 | low | 1 | 0 |
n(g),n(g')-dimethyl-l-arginine | 0 | low | 15 | 0 |
malic acid | 0 | low | 6 | 0 |
3,4-dihydroxyphenylacetic acid | 0 | low | 11 | 0 |
dibenzofuran | 0 | medium | 2 | 2 |
creatine | 0 | low | 38 | 0 |
cytosine | 0 | low | 4 | 0 |
lactic acid | 0 | medium | 203 | 10 |
dimethylamine | 0 | low | 2 | 0 |
dimethyl sulfoxide | 0 | medium | 50 | 2 |
formaldehyde | 0 | low | 2 | 0 |
glycine | 0 | medium | 139 | 2 |
glycerol | 0 | medium | 30 | 3 |
glycolic acid | 0 | low | 1 | 0 |
carbonic acid | 0 | low | 1 | 0 |
hydrogen carbonate | 0 | medium | 26 | 1 |
dalteparin | 0 | medium | 14 | 2 |
histamine | 0 | medium | 52 | 2 |
hydrogen | 0 | medium | 96 | 2 |
hydroquinone | 0 | low | 1 | 0 |
imidazole | 0 | low | 3 | 0 |
indoleacetic acid | 0 | low | 1 | 0 |
itaconic acid | 0 | low | 4 | 0 |
dihydroxyphenylalanine | 0 | low | 1 | 0 |
kynurenine | 0 | low | 7 | 0 |
thioctic acid | 0 | medium | 64 | 4 |
malonic acid | 0 | low | 2 | 0 |
pyruvaldehyde | 0 | low | 4 | 0 |
methanol | 0 | low | 6 | 0 |
phytic acid | 0 | low | 3 | 0 |
inositol | 0 | low | 8 | 0 |
n-acetylserotonin | 0 | low | 4 | 0 |
nickel | 0 | medium | 3 | 3 |
niacinamide | 0 | low | 34 | 0 |
niacin | 0 | low | 2 | 0 |
nitrates | 0 | medium | 162 | 5 |
nitroxyl | 0 | medium | 12 | 2 |
nitrites | 0 | medium | 173 | 5 |
nitrous oxide | 0 | low | 3 | 0 |
hydroxide ion | 0 | low | 2 | 0 |
orotic acid | 0 | low | 1 | 0 |
oxaloacetic acid | 0 | low | 3 | 0 |
oxalic acid | 0 | low | 1 | 0 |
oxamic acid | 0 | low | 3 | 0 |
4-hydroxyphenylpyruvic acid | 0 | low | 1 | 0 |
palmitic acid | 0 | low | 4 | 0 |
phenol | 0 | low | 1 | 0 |
phosphoenolpyruvate | 0 | low | 7 | 0 |
phosphorylcholine | 0 | low | 6 | 0 |
phosphorylethanolamine | 0 | low | 3 | 0 |
propylene glycol | 0 | medium | 3 | 1 |
propionic acid | 0 | low | 2 | 0 |
pteridines | 0 | low | 1 | 0 |
purine | 0 | low | 3 | 0 |
putrescine | 0 | low | 5 | 0 |
pyridoxal phosphate | 0 | low | 4 | 0 |
pyruvic acid | 0 | medium | 51 | 1 |
quinolinic acid | 0 | low | 1 | 0 |
thiosulfates | 0 | low | 4 | 0 |
dithionite | 0 | low | 1 | 0 |
sulfites | 0 | medium | 5 | 1 |
spermidine | 0 | low | 10 | 0 |
spermine | 0 | low | 11 | 0 |
succinic acid | 0 | medium | 30 | 2 |
sulfur dioxide | 0 | medium | 6 | 1 |
taurine | 0 | medium | 73 | 1 |
thiamine | 0 | low | 2 | 0 |
thymine | 0 | low | 1 | 0 |
toluene | 0 | medium | 14 | 2 |
trimethyloxamine | 0 | low | 5 | 0 |
trimethylamine | 0 | low | 2 | 0 |
tryptamine | 0 | low | 1 | 0 |
uracil | 0 | medium | 2 | 1 |
uric acid | 0 | medium | 69 | 3 |
urea | 0 | medium | 104 | 3 |
vanillin | 0 | low | 1 | 0 |
xanthine | 0 | low | 34 | 0 |
2-amino-5-phosphonovalerate | 0 | low | 6 | 0 |
8-hydroxy-2-(di-n-propylamino)tetralin | 0 | low | 1 | 0 |
alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid | 0 | low | 4 | 0 |
2,3-piperidinedicarboxylic acid | 0 | low | 1 | 0 |
4-iodo-2,5-dimethoxyphenylisopropylamine | 0 | low | 2 | 0 |
sk&f-38393 | 0 | low | 1 | 0 |
huperzine a | 0 | low | 2 | 0 |
1,10-phenanthroline | 0 | low | 1 | 0 |
1,2-dioctanoylglycerol | 0 | low | 2 | 0 |
1,3-dipropyl-8-cyclopentylxanthine | 0 | low | 23 | 0 |
s,s'-1,4-phenylene-bis(1,2-ethanediyl)bis-isothiourea | 0 | low | 1 | 0 |
1,5-dihydroxyisoquinoline | 0 | low | 2 | 0 |
pk 11195 | 0 | low | 3 | 0 |
1-(2-trifluoromethylphenyl)imidazole | 0 | low | 2 | 0 |
1-anilino-8-naphthalenesulfonate | 0 | low | 34 | 0 |
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 0 | low | 1 | 0 |
14,15-epoxy-5,8,11-eicosatrienoic acid | 0 | low | 8 | 0 |
n-(3-(aminomethyl)benzyl)acetamidine | 0 | low | 18 | 0 |
1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one | 0 | low | 4 | 0 |
2,2'-dipyridyl | 0 | low | 3 | 0 |
2,4-dinitrophenol | 0 | low | 1 | 0 |
2-amino-5,6-dihydro-6-methyl-4h-1,3-thiazine | 0 | low | 1 | 0 |
mercaptoethanol | 0 | low | 1 | 0 |
2-aminoethoxydiphenyl borate | 0 | low | 9 | 0 |
zopolrestat | 0 | low | 1 | 0 |
3,4-methylenedioxyamphetamine | 0 | low | 5 | 0 |
amitrole | 0 | low | 8 | 0 |
3-aminobenzamide | 0 | medium | 32 | 1 |
3-bromo-7-nitroindazole | 0 | low | 1 | 0 |
3-nitropropionic acid | 0 | low | 7 | 0 |
ro 5-4864 | 0 | low | 1 | 0 |
4-amino-1,8-naphthalimide | 0 | low | 2 | 0 |
4-aminopyridine | 0 | low | 3 | 0 |
4-diphenylacetoxy-1,1-dimethylpiperidinium | 0 | low | 2 | 0 |
homovanillic acid | 0 | low | 8 | 0 |
5,5-dimethyl-1-pyrroline-1-oxide | 0 | low | 8 | 0 |
phenytoin | 0 | low | 4 | 0 |
5,7-dichlorokynurenic acid | 0 | low | 1 | 0 |
5,8,11,14-eicosatetraynoic acid | 0 | low | 2 | 0 |
5-dimethylamiloride | 0 | low | 4 | 0 |
5-(n,n-hexamethylene)amiloride | 0 | low | 1 | 0 |
ethylisopropylamiloride | 0 | low | 6 | 0 |
5-hydroxydecanoate | 0 | low | 41 | 0 |
hydroxyindoleacetic acid | 0 | low | 2 | 0 |
5-methoxytryptamine | 0 | low | 1 | 0 |
7-nitroindazole | 0 | low | 19 | 0 |
8-(4-sulfophenyl)theophylline | 0 | low | 5 | 0 |
8-phenyltheophylline | 0 | low | 6 | 0 |
oxyquinoline | 0 | medium | 2 | 1 |
tacrine | 0 | low | 1 | 0 |
aa 861 | 0 | low | 2 | 0 |
2,2'-azobis(2-amidinopropane) | 0 | low | 4 | 0 |
abt 702 | 0 | low | 1 | 0 |
acetaminophen | 0 | medium | 17 | 1 |
acetazolamide | 0 | medium | 7 | 1 |
n-acetyltryptophan | 0 | low | 2 | 0 |
6-acetylaminocaproic acid | 0 | low | 1 | 0 |
beta-aminoethyl isothiourea | 0 | low | 1 | 0 |
ag 127 | 0 | low | 1 | 0 |
5-aminoisoquinolinone | 0 | low | 7 | 0 |
albendazole | 0 | medium | 4 | 2 |
albuterol | 0 | low | 1 | 0 |
alosetron | 0 | low | 1 | 0 |
alpha-cyano-4-hydroxycinnamate | 0 | low | 1 | 0 |
alprazolam | 0 | low | 1 | 0 |
am 251 | 0 | low | 4 | 0 |
amantadine | 0 | low | 1 | 0 |
ambroxol | 0 | low | 2 | 0 |
amifostine anhydrous | 0 | low | 5 | 0 |
pimagedine | 0 | low | 46 | 0 |
p-aminohippuric acid | 0 | low | 11 | 0 |
theophylline | 0 | low | 22 | 0 |
amiodarone | 0 | low | 6 | 0 |
amitriptyline | 0 | low | 2 | 0 |
amlodipine | 0 | low | 8 | 0 |
amobarbital | 0 | low | 2 | 0 |
anastrozole | 0 | low | 2 | 0 |
aniracetam | 0 | low | 2 | 0 |
antipyrine | 0 | low | 83 | 0 |
acetovanillone | 0 | low | 43 | 0 |
apraclonidine | 0 | low | 1 | 0 |
aristolochic acid i | 0 | low | 3 | 0 |
aspirin | 0 | medium | 51 | 2 |
atenolol | 0 | low | 8 | 0 |
alpha-amino-3-hydroxy-5-tert-butyl-4-isoxazolepropionate | 0 | low | 1 | 0 |
aurintricarboxylic acid | 0 | low | 2 | 0 |
azathioprine | 0 | low | 8 | 0 |
baclofen | 0 | low | 7 | 0 |
2,2-bis(4-glycidyloxyphenyl)propane | 0 | low | 4 | 0 |
bay-k-8644 | 0 | low | 4 | 0 |
bencyclane | 0 | low | 1 | 0 |
benphothiamine | 0 | low | 1 | 0 |
benzamide | 0 | low | 4 | 0 |
benzo(a)pyrene | 0 | medium | 2 | 2 |
benzothiazide | 0 | medium | 1 | 1 |
bepridil | 0 | low | 3 | 0 |
berberine | 0 | low | 25 | 0 |
diminazene | 0 | low | 3 | 0 |
betaxolol | 0 | low | 7 | 0 |
bethanechol | 0 | low | 3 | 0 |
bifemelane | 0 | low | 2 | 0 |
bisbenzimidazole | 0 | low | 4 | 0 |
bisindolylmaleimide i | 0 | low | 2 | 0 |
bisoprolol | 0 | low | 4 | 0 |
bretylium | 0 | low | 1 | 0 |
seratrodast | 0 | low | 1 | 0 |
buflomedil | 0 | low | 2 | 0 |
bumetanide | 0 | low | 7 | 0 |
bupivacaine | 0 | medium | 6 | 2 |
buspirone | 0 | low | 1 | 0 |
busulfan | 0 | low | 1 | 0 |
caffeine | 0 | medium | 19 | 2 |
verapamil | 0 | medium | 72 | 3 |
beta-glycerophosphoric acid | 0 | low | 3 | 0 |
pantogab | 0 | low | 1 | 0 |
candesartan cilexetil | 0 | low | 4 | 0 |
candesartan | 0 | low | 17 | 0 |
carbamazepine | 0 | low | 1 | 0 |
carmustine | 0 | low | 1 | 0 |
carvedilol | 0 | low | 23 | 0 |
carbonyl cyanide m-chlorophenyl hydrazone | 0 | low | 3 | 0 |
celecoxib | 0 | medium | 19 | 2 |
celiprolol | 0 | low | 1 | 0 |
cetirizine | 0 | low | 1 | 0 |
chelerythrine | 0 | low | 19 | 0 |
chloral hydrate | 0 | low | 1 | 0 |
chlordiazepoxide | 0 | low | 1 | 0 |
chloroquine | 0 | medium | 17 | 2 |
chlorpheniramine | 0 | medium | 6 | 1 |
chlorpromazine | 0 | low | 5 | 0 |
chlorzoxazone | 0 | low | 2 | 0 |
ciclopirox | 0 | low | 1 | 0 |
cilostazol | 0 | medium | 33 | 1 |
cimetidine | 0 | low | 15 | 0 |
ciprofibrate | 0 | low | 1 | 0 |
clenbuterol | 0 | low | 3 | 0 |
clofibrate | 0 | low | 5 | 0 |
clofibric acid | 0 | low | 1 | 0 |
clonidine | 0 | medium | 8 | 1 |
clotrimazole | 0 | low | 6 | 0 |
cyclocreatine | 0 | low | 2 | 0 |
cycloleucine | 0 | low | 1 | 0 |
cystamine | 0 | low | 2 | 0 |
dimethyl 2,3,5,6-tetrachloroterephthalate | 0 | low | 1 | 0 |
dantrolene | 0 | low | 11 | 0 |
dapi | 0 | low | 3 | 0 |
dapsone | 0 | low | 5 | 0 |
decanoic acid | 0 | low | 2 | 0 |
2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone | 0 | low | 1 | 0 |
deferiprone | 0 | low | 3 | 0 |
deferoxamine | 0 | medium | 109 | 3 |
desipramine | 0 | low | 3 | 0 |
amphetamine | 0 | low | 1 | 0 |
eflornithine | 0 | low | 6 | 0 |
diazepam | 0 | low | 4 | 0 |
diazoxide | 0 | low | 40 | 0 |
diclofenac | 0 | medium | 14 | 2 |
dichlorphenamide | 0 | low | 1 | 0 |
diethylcarbamazine | 0 | low | 4 | 0 |
pentetic acid | 0 | low | 5 | 0 |
dilazep | 0 | low | 5 | 0 |
dimaprit | 0 | low | 2 | 0 |
diphenhydramine | 0 | low | 1 | 0 |
diphenyleneiodonium | 0 | low | 9 | 0 |
dipyridamole | 0 | medium | 18 | 1 |
disopyramide | 0 | low | 2 | 0 |
disulfiram | 0 | medium | 2 | 1 |
valproic acid | 0 | low | 18 | 0 |
racemetirosine | 0 | low | 2 | 0 |
thiorphan | 0 | low | 1 | 0 |
2,3-dimethoxy-1,4-naphthoquinone | 0 | low | 1 | 0 |
donepezil | 0 | low | 5 | 0 |
doxazosin | 0 | low | 1 | 0 |
droperidol | 0 | low | 1 | 0 |
dsp 4 | 0 | low | 4 | 0 |
e 4031 | 0 | low | 1 | 0 |
ebselen | 0 | low | 18 | 0 |
econazole | 0 | low | 2 | 0 |
9-(2-hydroxy-3-nonyl)adenine | 0 | low | 6 | 0 |
embelin | 0 | low | 1 | 0 |
emodin | 0 | medium | 10 | 2 |
enflurane | 0 | low | 1 | 0 |
erythrosine | 0 | medium | 38 | 1 |
ethacrynic acid | 0 | low | 2 | 0 |
ether | 0 | low | 2 | 0 |
eicosapentaenoic acid ethyl ester | 0 | low | 1 | 0 |
ethylenediamine | 0 | low | 1 | 0 |
etodolac | 0 | low | 1 | 0 |
famotidine | 0 | low | 8 | 0 |
carbonyl cyanide p-trifluoromethoxyphenylhydrazone | 0 | low | 1 | 0 |
felodipine | 0 | low | 1 | 0 |
fendiline | 0 | low | 2 | 0 |
fenofibrate | 0 | low | 12 | 0 |
fenoldopam | 0 | medium | 5 | 1 |
fentanyl | 0 | medium | 7 | 1 |
flufenamic acid | 0 | low | 1 | 0 |
flumazenil | 0 | low | 5 | 0 |
fluorouracil | 0 | low | 2 | 0 |
fluoxetine | 0 | low | 6 | 0 |
flurbiprofen | 0 | low | 6 | 0 |
fp 83 | 0 | low | 2 | 0 |
flutamide | 0 | low | 2 | 0 |
furegrelate | 0 | low | 1 | 0 |
furosemide | 0 | low | 7 | 0 |
gabapentin | 0 | low | 3 | 0 |
gabexate | 0 | medium | 14 | 2 |
gemfibrozil | 0 | low | 2 | 0 |
gentamicin | 0 | low | 11 | 0 |
2,5-dihydroxybenzoic acid | 0 | low | 14 | 0 |
gliclazide | 0 | low | 2 | 0 |
glimepiride | 0 | low | 2 | 0 |
glutaral | 0 | low | 2 | 0 |
glyburide | 0 | medium | 54 | 1 |
go 6976 | 0 | low | 2 | 0 |
gossypol | 0 | low | 1 | 0 |
guaifenesin | 0 | low | 19 | 0 |
guanethidine | 0 | low | 1 | 0 |
guanidine | 0 | low | 1 | 0 |
gyki 52466 | 0 | low | 1 | 0 |
1-(5-isoquinolinesulfonyl)-2-methylpiperazine | 0 | low | 19 | 0 |
fasudil | 0 | low | 18 | 0 |
haloperidol | 0 | low | 4 | 0 |
halothane | 0 | medium | 15 | 2 |
hexamethonium | 0 | low | 2 | 0 |
ethidium | 0 | low | 9 | 0 |
hydralazine | 0 | low | 5 | 0 |
hydroxychloroquine | 0 | low | 5 | 0 |
hydroxyurea | 0 | low | 7 | 0 |
hypericin | 0 | low | 1 | 0 |
ibudilast | 0 | low | 1 | 0 |
ibuprofen | 0 | low | 12 | 0 |
phenelzine | 0 | low | 1 | 0 |
lidocaine | 0 | medium | 46 | 3 |
idebenone | 0 | low | 7 | 0 |
ifenprodil | 0 | low | 2 | 0 |
imipramine | 0 | low | 1 | 0 |
amrinone | 0 | medium | 9 | 1 |
indapamide | 0 | low | 2 | 0 |
indirubin-3'-monoxime | 0 | low | 4 | 0 |
indole-3-carbinol | 0 | low | 2 | 0 |
indomethacin | 0 | low | 75 | 0 |
iodixanol | 0 | low | 1 | 0 |
iohexol | 0 | low | 7 | 0 |
iomeprol | 0 | low | 1 | 0 |
iopromide | 0 | low | 3 | 0 |
iothalamic acid | 0 | low | 1 | 0 |
indolepropionic acid | 0 | low | 2 | 0 |
avapro | 0 | medium | 2 | 1 |
irsogladine | 0 | low | 2 | 0 |
1-methyl-3-isobutylxanthine | 0 | low | 1 | 0 |
isoflurane | 0 | medium | 115 | 4 |
isoproterenol | 0 | low | 26 | 0 |
isradipine | 0 | low | 2 | 0 |
juglone | 0 | low | 2 | 0 |
ketamine | 0 | medium | 46 | 4 |
ketanserin | 0 | low | 1 | 0 |
ketoconazole | 0 | low | 1 | 0 |
ketoprofen | 0 | medium | 3 | 2 |
ketorolac | 0 | low | 2 | 0 |
ketotifen | 0 | low | 8 | 0 |
khellin | 0 | low | 2 | 0 |
kinetin | 0 | low | 1 | 0 |
kynurenic acid | 0 | low | 5 | 0 |
mimosine | 0 | low | 2 | 0 |
labetalol | 0 | low | 1 | 0 |
lamotrigine | 0 | low | 6 | 0 |
beta-lapachone | 0 | low | 2 | 0 |
leflunomide | 0 | low | 5 | 0 |
letrozole | 0 | low | 1 | 0 |
lidoflazine | 0 | low | 2 | 0 |
linopirdine | 0 | low | 1 | 0 |
lomerizine | 0 | low | 1 | 0 |
loratadine | 0 | low | 1 | 0 |
losartan | 0 | medium | 38 | 2 |
loxoprofen | 0 | low | 1 | 0 |
ly 171883 | 0 | low | 1 | 0 |
2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one | 0 | low | 55 | 0 |
manidipine | 0 | low | 1 | 0 |
edaravone | 0 | medium | 95 | 3 |
mecamylamine | 0 | low | 2 | 0 |
mechlorethamine | 0 | low | 1 | 0 |
meclizine | 0 | low | 2 | 0 |
meclofenamic acid | 0 | low | 3 | 0 |
memantine | 0 | medium | 14 | 1 |
meperidine | 0 | low | 1 | 0 |
mephenytoin | 0 | medium | 2 | 2 |
2-mercaptoethylguanidine | 0 | low | 1 | 0 |
mesalamine | 0 | low | 3 | 0 |
metformin | 0 | medium | 48 | 3 |
methadone | 0 | medium | 1 | 1 |
methoxsalen | 0 | low | 1 | 0 |
methoxyflurane | 0 | low | 1 | 0 |
methyl parathion | 0 | low | 1 | 0 |
methyl salicylate | 0 | medium | 1 | 1 |
metoclopramide | 0 | low | 1 | 0 |
metoprolol | 0 | medium | 9 | 1 |
metyrapone | 0 | low | 6 | 0 |
mexiletine | 0 | low | 6 | 0 |
mianserin | 0 | low | 1 | 0 |
miconazole | 0 | low | 1 | 0 |
midazolam | 0 | medium | 14 | 1 |
midodrine | 0 | low | 1 | 0 |
minoxidil | 0 | low | 1 | 0 |
mirtazapine | 0 | low | 1 | 0 |
ml 7 | 0 | low | 2 | 0 |
moclobemide | 0 | low | 1 | 0 |
modafinil | 0 | low | 1 | 0 |
molsidomine | 0 | low | 27 | 0 |
muscimol | 0 | low | 7 | 0 |
apnea | 0 | low | 1 | 0 |
nafamostat | 0 | medium | 12 | 1 |
nafronyl | 0 | low | 1 | 0 |
activins | 0 | low | 8 | 0 |
nicardipine | 0 | low | 8 | 0 |
niclosamide | 0 | low | 1 | 0 |
nifedipine | 0 | low | 31 | 0 |
nimesulide | 0 | low | 6 | 0 |
nimodipine | 0 | low | 36 | 0 |
nisoldipine | 0 | low | 2 | 0 |
nitrendipine | 0 | low | 3 | 0 |
nizofenone | 0 | low | 3 | 0 |
nomifensine | 0 | low | 1 | 0 |
nortriptyline | 0 | low | 3 | 0 |
ns 1619 | 0 | low | 3 | 0 |
n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | 0 | low | 12 | 0 |
ofloxacin | 0 | medium | 2 | 2 |
olomoucine | 0 | low | 1 | 0 |
olprinone | 0 | low | 8 | 0 |
omeprazole | 0 | medium | 15 | 2 |
ondansetron | 0 | low | 1 | 0 |
oxidopamine | 0 | low | 3 | 0 |
oxiracetam | 0 | low | 2 | 0 |
oxybutynin | 0 | low | 1 | 0 |
palmidrol | 0 | low | 8 | 0 |
pantoprazole | 0 | low | 1 | 0 |
papaverine | 0 | low | 11 | 0 |
pargyline | 0 | low | 4 | 0 |
pd 98059 | 0 | low | 31 | 0 |
pentobarbital | 0 | low | 9 | 0 |
pentoxifylline | 0 | medium | 107 | 3 |
perhexiline | 0 | low | 2 | 0 |
pheniramine | 0 | low | 8 | 0 |
phenobarbital | 0 | medium | 11 | 2 |
phenolsulfonphthalein | 0 | low | 3 | 0 |
4-phenylbutyric acid | 0 | low | 11 | 0 |
oxophenylarsine | 0 | low | 2 | 0 |
phloretin | 0 | low | 1 | 0 |
moxonidine | 0 | low | 2 | 0 |
pifithrin | 0 | low | 12 | 0 |
pinacidil | 0 | low | 12 | 0 |
pindolol | 0 | low | 1 | 0 |
pioglitazone | 0 | medium | 39 | 2 |
piperazine | 0 | low | 1 | 0 |
piracetam | 0 | low | 8 | 0 |
piretanide | 0 | low | 1 | 0 |
piribedil | 0 | low | 2 | 0 |
potassium chloride | 0 | medium | 86 | 3 |
4-aminobenzoic acid | 0 | low | 3 | 0 |
ag 1879 | 0 | low | 3 | 0 |
ono 1078 | 0 | low | 3 | 0 |
prazosin | 0 | low | 10 | 0 |
proadifen | 0 | low | 1 | 0 |
probenecid | 0 | low | 4 | 0 |
probucol | 0 | low | 5 | 0 |
procainamide | 0 | low | 1 | 0 |
procaine | 0 | medium | 46 | 3 |
procarbazine | 0 | low | 1 | 0 |
procaterol | 0 | low | 6 | 0 |
promazine | 0 | low | 1 | 0 |
promethazine | 0 | low | 2 | 0 |
propafenone | 0 | low | 1 | 0 |
propentofylline | 0 | low | 3 | 0 |
propidium | 0 | low | 9 | 0 |
propranolol | 0 | low | 15 | 0 |
propyl gallate | 0 | low | 4 | 0 |
protoporphyrin ix | 0 | low | 3 | 0 |
pyrilamine | 0 | low | 2 | 0 |
pyrimethamine | 0 | medium | 2 | 2 |
opc 12759 | 0 | low | 7 | 0 |
riluzole | 0 | medium | 6 | 1 |
ro 31-8220 | 0 | low | 1 | 0 |
4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone | 0 | low | 1 | 0 |
rofecoxib | 0 | low | 7 | 0 |
rolipram | 0 | low | 9 | 0 |
ropinirole | 0 | low | 2 | 0 |
3,4,4a,10b-tetrahydro-4-propyl-2h,5h-(1)benzopyrano(4,3-b)-1,4-oxazin-9-ol | 0 | low | 1 | 0 |
s-methylisothiopseudouronium | 0 | low | 6 | 0 |
saccharin | 0 | low | 1 | 0 |
sanguinarine | 0 | low | 1 | 0 |
sarpogrelate | 0 | low | 1 | 0 |
sb 239063 | 0 | low | 4 | 0 |
sb 202190 | 0 | low | 2 | 0 |
sulfadiazine | 0 | medium | 1 | 1 |
linsidomine | 0 | low | 14 | 0 |
sk&f 86002 | 0 | low | 1 | 0 |
sodium fluoride | 0 | medium | 2 | 2 |
iodoacetic acid | 0 | low | 3 | 0 |
fenofibrate | 0 | low | 1 | 0 |
stearic acid | 0 | low | 1 | 0 |
vorinostat | 0 | low | 1 | 0 |
sulfaphenazole | 0 | low | 3 | 0 |
sulfasalazine | 0 | low | 5 | 0 |
sulfisoxazole | 0 | low | 1 | 0 |
sulfobromophthalein | 0 | low | 5 | 0 |
sulforaphane | 0 | low | 18 | 0 |
sumatriptan | 0 | low | 4 | 0 |
suramin | 0 | low | 3 | 0 |
1,4-bis(2-(3,5-dichloropyridyloxy))benzene | 0 | low | 1 | 0 |
temozolomide | 0 | medium | 2 | 2 |
terbutaline | 0 | low | 1 | 0 |
terfenadine | 0 | low | 1 | 0 |
tetracaine | 0 | low | 3 | 0 |
tetraethylammonium | 0 | low | 4 | 0 |
krypton | 0 | low | 1 | 0 |
thalidomide | 0 | low | 8 | 0 |
theobromine | 0 | low | 4 | 0 |
2,4-thiazolidinedione | 0 | low | 1 | 0 |
ticlopidine | 0 | medium | 9 | 2 |
tiopronin | 0 | low | 7 | 0 |
tolbutamide | 0 | low | 2 | 0 |
tolmetin | 0 | low | 1 | 0 |
n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine | 0 | low | 4 | 0 |
tranexamic acid | 0 | low | 2 | 0 |
trapidil | 0 | low | 7 | 0 |
triclosan | 0 | medium | 2 | 1 |
trifluoperazine | 0 | low | 9 | 0 |
trigonelline | 0 | low | 1 | 0 |
tripelennamine | 0 | low | 1 | 0 |
troglitazone | 0 | low | 4 | 0 |
troxipide | 0 | low | 1 | 0 |
tyramine | 0 | low | 1 | 0 |
talactoferrin alfa | 0 | low | 1 | 0 |
urapidil | 0 | low | 1 | 0 |
5-methylurapidil | 0 | low | 1 | 0 |
urethane | 0 | low | 1 | 0 |
vigabatrin | 0 | low | 2 | 0 |
wb 4101 | 0 | low | 1 | 0 |
pirinixic acid | 0 | low | 7 | 0 |
8-(4-((2-aminoethyl)aminocarbonylmethyloxy)phenyl)-1,3-dipropylxanthine | 0 | low | 3 | 0 |
xylazine | 0 | low | 6 | 0 |
3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole | 0 | low | 6 | 0 |
ici 204,219 | 0 | low | 2 | 0 |
zinc chloride | 0 | low | 7 | 0 |
zonisamide | 0 | low | 1 | 0 |
mitomycin | 0 | medium | 2 | 1 |
corticosterone | 0 | low | 15 | 0 |
prednisolone | 0 | low | 10 | 0 |
reserpine | 0 | low | 2 | 0 |
phentolamine | 0 | low | 6 | 0 |
sorbitol | 0 | low | 4 | 0 |
alloxan | 0 | low | 1 | 0 |
thymidine | 0 | medium | 4 | 1 |
piperonyl butoxide | 0 | low | 1 | 0 |
hydroxyproline | 0 | low | 14 | 0 |
thyroxine | 0 | low | 10 | 0 |
carbachol | 0 | low | 21 | 0 |
spironolactone | 0 | medium | 13 | 1 |
aldosterone | 0 | medium | 11 | 1 |
penicillamine | 0 | low | 8 | 0 |
estrone | 0 | low | 2 | 0 |
methylprednisolone acetate | 0 | low | 1 | 0 |
dehydroepiandrosterone | 0 | low | 12 | 0 |
pilocarpine | 0 | low | 2 | 0 |
triiodothyronine | 0 | low | 21 | 0 |
isoflurophate | 0 | low | 1 | 0 |
biguanides | 0 | low | 2 | 0 |
carbon tetrachloride | 0 | low | 12 | 0 |
alanine | 0 | low | 24 | 0 |
serine | 0 | low | 28 | 0 |
aspartic acid | 0 | low | 48 | 0 |
glutamine | 0 | medium | 78 | 4 |
lysine | 0 | low | 28 | 0 |
cyanides | 0 | low | 2 | 0 |
physostigmine | 0 | low | 3 | 0 |
sucrose | 0 | low | 8 | 0 |
9,10-dimethyl-1,2-benzanthracene | 0 | low | 1 | 0 |
apomorphine | 0 | low | 1 | 0 |
puromycin aminonucleoside | 0 | low | 3 | 0 |
adenosine diphosphate | 0 | low | 66 | 0 |
uridine | 0 | low | 5 | 0 |
uridine diphosphate | 0 | low | 3 | 0 |
bromodeoxyuridine | 0 | low | 21 | 0 |
galactose | 0 | medium | 12 | 1 |
carbostyril | 0 | medium | 14 | 1 |
phenylephrine | 0 | medium | 36 | 1 |
levodopa | 0 | low | 4 | 0 |
edetic acid | 0 | low | 27 | 0 |
phenylethyl alcohol | 0 | low | 41 | 0 |
tyrosine | 0 | medium | 193 | 4 |
cysteamine | 0 | low | 9 | 0 |
phlorhizin | 0 | low | 2 | 0 |
methoxamine | 0 | low | 1 | 0 |
adenosine monophosphate | 0 | low | 38 | 0 |
n,n-dimethyltryptamine | 0 | low | 2 | 0 |
methylene blue | 0 | medium | 44 | 1 |
leucine | 0 | medium | 22 | 2 |
berlition | 0 | low | 1 | 0 |
methacholine chloride | 0 | low | 5 | 0 |
aniline | 0 | low | 1 | 0 |
2-aminoisobutyric acid | 0 | low | 1 | 0 |
uridine triphosphate | 0 | low | 2 | 0 |
lactose | 0 | low | 1 | 0 |
methionine | 0 | medium | 19 | 2 |
1,2-dipalmitoylphosphatidylcholine | 0 | low | 3 | 0 |
phenylalanine | 0 | low | 10 | 0 |
desoxycorticosterone | 0 | low | 3 | 0 |
colchicine | 0 | medium | 11 | 2 |
cytidine triphosphate | 0 | low | 1 | 0 |
cycloheximide | 0 | low | 16 | 0 |
egtazic acid | 0 | low | 5 | 0 |
chloroform | 0 | low | 2 | 0 |
gliotoxin | 0 | low | 1 | 0 |
sodium citrate, anhydrous | 0 | low | 1 | 0 |
tubercidin | 0 | low | 2 | 0 |
ampicillin | 0 | low | 1 | 0 |
mannitol | 0 | medium | 141 | 10 |
cytarabine | 0 | low | 1 | 0 |
dithionitrobenzoic acid | 0 | low | 3 | 0 |
trifluridine | 0 | medium | 1 | 1 |
ornithine | 0 | low | 20 | 0 |
dinitrofluorobenzene | 0 | low | 1 | 0 |
histidine | 0 | medium | 43 | 4 |
medroxyprogesterone acetate | 0 | low | 1 | 0 |
valine | 0 | low | 7 | 0 |
threonine | 0 | low | 7 | 0 |
chlorquinaldol | 0 | medium | 1 | 1 |
cordycepin | 0 | low | 5 | 0 |
tryptophan | 0 | low | 23 | 0 |
isoleucine | 0 | low | 1 | 0 |
arginine | 0 | medium | 259 | 8 |
ethane | 0 | low | 3 | 0 |
ethylene | 0 | medium | 2 | 1 |
acetylene | 0 | low | 1 | 0 |
methylene chloride | 0 | low | 2 | 0 |
tribromoethanol | 0 | low | 2 | 0 |
tert-butylhydroperoxide | 0 | low | 16 | 0 |
perflutren | 0 | low | 1 | 0 |
triamcinolone acetonide | 0 | low | 3 | 0 |
phencyclidine | 0 | medium | 6 | 4 |
tromethamine | 0 | low | 14 | 0 |
3-mercaptopropionic acid | 0 | low | 1 | 0 |
pentaerythritol tetranitrate | 0 | medium | 2 | 2 |
linalool | 0 | low | 2 | 0 |
isoprene | 0 | low | 1 | 0 |
acrylic acid | 0 | medium | 2 | 2 |
dichloroacetic acid | 0 | low | 7 | 0 |
pantothenic acid | 0 | low | 11 | 0 |
bisphenol a | 0 | medium | 6 | 2 |
cumene hydroperoxide | 0 | low | 2 | 0 |
alpha-pinene | 0 | low | 3 | 0 |
taurocholic acid | 0 | low | 13 | 0 |
rhodamine b | 0 | medium | 2 | 2 |
visnagin | 0 | low | 3 | 0 |
methylprednisolone | 0 | medium | 58 | 8 |
rotenone | 0 | low | 14 | 0 |
skimmianine | 0 | low | 1 | 0 |
brompheniramine | 0 | low | 2 | 0 |
fluorene | 0 | low | 1 | 0 |
isosorbide dinitrate | 0 | medium | 4 | 1 |
phthalide | 0 | low | 1 | 0 |
n-vinyl-2-pyrrolidinone | 0 | medium | 2 | 2 |
quinoxalines | 0 | medium | 36 | 3 |
isatin | 0 | low | 1 | 0 |
2-naphthylamine | 0 | low | 1 | 0 |
3,3'-diaminobenzidine | 0 | low | 1 | 0 |
tolonium chloride | 0 | low | 2 | 0 |
phenidone | 0 | low | 2 | 0 |
xanthenes | 0 | low | 8 | 0 |
veratric acid | 0 | low | 1 | 0 |
methyleugenol | 0 | low | 3 | 0 |
propylparaben | 0 | low | 1 | 0 |
2-methyl-4-chlorophenoxyacetic acid | 0 | low | 1 | 0 |
benzothiazole | 0 | low | 1 | 0 |
4-butyrolactone | 0 | low | 9 | 0 |
lactobionic acid | 0 | medium | 4 | 1 |
phosphoribosyl pyrophosphate | 0 | low | 2 | 0 |
furaldehyde | 0 | low | 2 | 0 |
pyrrolidonecarboxylic acid | 0 | low | 2 | 0 |
3-aminobenzoic acid | 0 | low | 1 | 0 |
trehalose | 0 | low | 9 | 0 |
carvone | 0 | low | 1 | 0 |
4-bromophenacyl bromide | 0 | low | 1 | 0 |
2-diethylaminoethanol | 0 | low | 1 | 0 |
ethylbenzene | 0 | medium | 2 | 2 |
quinuclidines | 0 | low | 12 | 0 |
boric acid | 0 | low | 6 | 0 |
anisyl alcohol | 0 | low | 1 | 0 |
ethyl bromoacetate | 0 | medium | 2 | 2 |
caprolactam | 0 | medium | 1 | 1 |
acrolein | 0 | low | 11 | 0 |
glyoxal | 0 | low | 1 | 0 |
2-methylpentane | 0 | low | 6 | 0 |
vinyl acetate | 0 | low | 1 | 0 |
methyl malonate | 0 | low | 1 | 0 |
pentane | 0 | low | 4 | 0 |
pyrroles | 0 | medium | 50 | 3 |
thiophenes | 0 | medium | 41 | 1 |
isopropyl myristate | 0 | medium | 1 | 1 |
n-hexane | 0 | low | 2 | 0 |
heptanol | 0 | low | 1 | 0 |
methyl palmitate | 0 | low | 2 | 0 |
phenformin | 0 | low | 1 | 0 |
framycetin | 0 | medium | 5 | 2 |
benzoin | 0 | low | 1 | 0 |
vanillic acid | 0 | low | 5 | 0 |
triethylamine | 0 | low | 1 | 0 |
pyrazolanthrone | 0 | low | 21 | 0 |
iodoantipyrine | 0 | low | 7 | 0 |
meglumine | 0 | medium | 5 | 1 |
cinchophen | 0 | low | 1 | 0 |
1-naphthylamine | 0 | low | 2 | 0 |
2-naphthol | 0 | medium | 7 | 2 |
shikimic acid | 0 | medium | 3 | 1 |
4-nitrosodimethylaniline | 0 | low | 1 | 0 |
protocatechualdehyde | 0 | low | 4 | 0 |
citronellol | 0 | medium | 2 | 2 |
ethyl acetate | 0 | low | 5 | 0 |
hexanoic acid | 0 | low | 1 | 0 |
n-lauroylethanolamine | 0 | low | 1 | 0 |
n-heptane | 0 | low | 1 | 0 |
sodium cyanide | 0 | low | 5 | 0 |
pregnenolone | 0 | low | 1 | 0 |
yohimbine | 0 | low | 9 | 0 |
2-chloroadenosine | 0 | low | 3 | 0 |
1,2-dihydro-2,2,4-trimethylquinoline | 0 | low | 1 | 0 |
ditiocarb | 0 | low | 8 | 0 |
1,2-dihydroxybenzene-3,5-disulfonic acid disodium salt | 0 | low | 3 | 0 |
potassium cyanide | 0 | medium | 6 | 2 |
cycloguanil | 0 | low | 1 | 0 |
catechin | 0 | low | 55 | 0 |
thiamine pyrophosphate | 0 | low | 2 | 0 |
perylene | 0 | low | 1 | 0 |
quinazolines | 0 | low | 13 | 0 |
acridines | 0 | low | 13 | 0 |
indazoles | 0 | medium | 33 | 2 |
benzoxazoles | 0 | medium | 4 | 1 |
adamantane | 0 | low | 16 | 0 |
cyclopentane | 0 | medium | 12 | 2 |
isoxazoles | 0 | medium | 23 | 2 |
oxazoles | 0 | low | 4 | 0 |
thiazoles | 0 | medium | 65 | 4 |
pyrimidine | 0 | low | 1 | 0 |
pyrazines | 0 | medium | 76 | 1 |
nitroblue tetrazolium | 0 | low | 20 | 0 |
triphenyltetrazolium | 0 | low | 53 | 0 |
calcium gluconate | 0 | low | 1 | 0 |
ephedrine | 0 | low | 3 | 0 |
hydrazine | 0 | medium | 14 | 2 |
perfluorodecalin | 0 | low | 2 | 0 |
perfluorotributylamine | 0 | low | 4 | 0 |
evans blue | 0 | low | 54 | 0 |
monocrotaline | 0 | low | 2 | 0 |
aminophylline | 0 | low | 3 | 0 |
azacitidine | 0 | low | 2 | 0 |
triflusal | 0 | low | 2 | 0 |
diazomethane | 0 | low | 2 | 0 |
galantamine | 0 | low | 1 | 0 |
nandrolone decanoate | 0 | low | 1 | 0 |
aminoimidazole carboxamide | 0 | medium | 22 | 1 |
citrulline | 0 | medium | 16 | 2 |
betamethasone | 0 | low | 3 | 0 |
cyanamide | 0 | medium | 1 | 1 |
perflubron | 0 | low | 4 | 0 |
cyproterone acetate | 0 | low | 1 | 0 |
nandrolone | 0 | low | 2 | 0 |
2-aminopurine | 0 | low | 1 | 0 |
hydantoins | 0 | medium | 3 | 2 |
fluorobenzenes | 0 | medium | 17 | 3 |
homocystine | 0 | low | 1 | 0 |
carbonyl sulfide | 0 | low | 1 | 0 |
dextropropoxyphene | 0 | medium | 1 | 1 |
chlorfenvinphos | 0 | low | 1 | 0 |
methylguanidine | 0 | low | 10 | 0 |
limestone | 0 | low | 1 | 0 |
chenodeoxycholic acid | 0 | low | 4 | 0 |
rhein | 0 | low | 4 | 0 |
indirubin | 0 | low | 1 | 0 |
plumbagin | 0 | low | 1 | 0 |
cepharanthine | 0 | low | 4 | 0 |
chrysophanic acid | 0 | low | 6 | 0 |
imperatorin | 0 | low | 1 | 0 |
emetine | 0 | low | 1 | 0 |
osthol | 0 | low | 10 | 0 |
reticulin | 0 | low | 2 | 0 |
cytisine | 0 | low | 1 | 0 |
bicuculline | 0 | low | 5 | 0 |
kainic acid | 0 | low | 12 | 0 |
thymoquinone | 0 | low | 21 | 0 |
diphenoquinone | 0 | low | 1 | 0 |
isomaltose | 0 | low | 1 | 0 |
carvacrol | 0 | low | 7 | 0 |
4-hydroxyphenylethanol | 0 | low | 4 | 0 |
caprolactone | 0 | low | 1 | 0 |
phorone | 0 | low | 2 | 0 |
alpha-aminopyridine | 0 | medium | 13 | 2 |
thiazolidines | 0 | low | 9 | 0 |
iberin | 0 | low | 1 | 0 |
hexacosanoic acid | 0 | medium | 1 | 1 |
oleanolic acid | 0 | low | 18 | 0 |
myrtenol | 0 | low | 1 | 0 |
hematoxylin | 0 | low | 17 | 0 |
podophyllotoxin | 0 | low | 1 | 0 |
hesperidin | 0 | medium | 22 | 2 |
medroxyprogesterone | 0 | low | 1 | 0 |
dihydrotestosterone | 0 | low | 4 | 0 |
luminol | 0 | medium | 13 | 1 |
physcione | 0 | low | 1 | 0 |
flavone | 0 | low | 1 | 0 |
gluconic acid | 0 | low | 3 | 0 |
copper gluconate | 0 | low | 10 | 0 |
azomycin | 0 | low | 8 | 0 |
syringic acid | 0 | low | 4 | 0 |
herniarin | 0 | low | 1 | 0 |
chlormethiazole | 0 | low | 1 | 0 |
perillyl alcohol | 0 | low | 1 | 0 |
methamphetamine | 0 | low | 3 | 0 |
aminoacetonitrile | 0 | low | 1 | 0 |
muscone | 0 | medium | 3 | 1 |
malondialdehyde | 0 | medium | 1,673 | 55 |
trinitrobenzenesulfonic acid | 0 | low | 1 | 0 |
eosine yellowish-(ys) | 0 | low | 17 | 0 |
resazurin | 0 | low | 2 | 0 |
paeonol | 0 | low | 3 | 0 |
lithium carbonate | 0 | low | 2 | 0 |
lignoceric acid | 0 | low | 2 | 0 |
glycerylphosphorylcholine | 0 | low | 3 | 0 |
3-hydroxyflavone | 0 | medium | 25 | 2 |
diphenylamine | 0 | medium | 2 | 2 |
allyl sulfide | 0 | low | 5 | 0 |
megestrol acetate | 0 | low | 2 | 0 |
phenylglyoxylic acid | 0 | low | 1 | 0 |
ethyl pyruvate | 0 | low | 32 | 0 |
c.i. 42510 | 0 | low | 2 | 0 |
erythromycin | 0 | low | 5 | 0 |
dehydroepiandrosterone sulfate | 0 | low | 2 | 0 |
chromonar | 0 | low | 3 | 0 |
docosanol | 0 | low | 1 | 0 |
tetracyanoethylene | 0 | low | 1 | 0 |
2-piperidone | 0 | low | 1 | 0 |
perfluoropentane | 0 | low | 1 | 0 |
levonorgestrel | 0 | medium | 2 | 2 |
tempidon | 0 | low | 1 | 0 |
ethyl gallate | 0 | low | 2 | 0 |
hexafluoroisopropanol | 0 | medium | 3 | 3 |
cyclopentenone | 0 | low | 1 | 0 |
2-cyclohexen-1-one | 0 | low | 2 | 0 |
deoxycytidine | 0 | medium | 1 | 1 |
cytidine diphosphate choline | 0 | medium | 9 | 1 |
nicotinamide mononucleotide | 0 | low | 4 | 0 |
tetramethylpyrazine | 0 | medium | 54 | 1 |
carmine | 0 | medium | 1 | 1 |
calcium peroxide | 0 | medium | 2 | 2 |
durapatite | 0 | low | 2 | 0 |
potassium hydroxide | 0 | low | 1 | 0 |
sodium hydroxide | 0 | low | 2 | 0 |
manganese dioxide | 0 | medium | 3 | 2 |
zinc oxide | 0 | medium | 5 | 3 |
vancomycin | 0 | low | 2 | 0 |
glycyrrhizic acid | 0 | low | 23 | 0 |
d-alpha tocopherol | 0 | medium | 212 | 10 |
tocopherols | 0 | low | 3 | 0 |
pregnenolone carbonitrile | 0 | low | 1 | 0 |
1,2-epoxyhexane | 0 | medium | 1 | 1 |
selenomethionine | 0 | low | 1 | 0 |
azaperone | 0 | low | 1 | 0 |
diphenyldiselenide | 0 | low | 1 | 0 |
paraquat | 0 | low | 4 | 0 |
s,n,n'-tripropylthiocarbamate | 0 | low | 1 | 0 |
2-tert-butylhydroquinone | 0 | low | 2 | 0 |
beta-hydroxymyristic acid | 0 | low | 1 | 0 |
dronabinol | 0 | low | 2 | 0 |
methionine sulfoximine | 0 | low | 5 | 0 |
amiloride | 0 | medium | 21 | 1 |
diallyl trisulfide | 0 | low | 4 | 0 |
perillaldehyde | 0 | low | 2 | 0 |
azetidyl-2-carboxylic acid | 0 | low | 2 | 0 |
diallyl disulfide | 0 | low | 1 | 0 |
fluorescein | 0 | low | 19 | 0 |
2-methylthiazoline | 0 | low | 1 | 0 |
methylprednisolone hemisuccinate | 0 | low | 2 | 0 |
fucose | 0 | low | 4 | 0 |
sulfur hexafluoride | 0 | low | 2 | 0 |
acadesine | 0 | medium | 12 | 1 |
thymine glycol | 0 | low | 1 | 0 |
2,2-bis(bromomethyl)-1,3-propanediol | 0 | low | 1 | 0 |
fluorescein-5-isothiocyanate | 0 | low | 31 | 0 |
sabinene | 0 | low | 6 | 0 |
mannose | 0 | low | 12 | 0 |
dithiothreitol | 0 | medium | 12 | 3 |
palmatine | 0 | low | 1 | 0 |
carbonates | 0 | low | 1 | 0 |
dideoxyadenosine | 0 | low | 1 | 0 |
5-methoxyindole-2-carboxylic acid | 0 | low | 2 | 0 |
fructosamine | 0 | low | 1 | 0 |
trimetazidine | 0 | medium | 64 | 2 |
buthionine sulfoximine | 0 | low | 9 | 0 |
vidarabine | 0 | low | 1 | 0 |
diadenosine tetraphosphate | 0 | low | 1 | 0 |
iodinated glycerol | 0 | low | 6 | 0 |
olsalazine | 0 | low | 1 | 0 |
n-methylaspartate | 0 | low | 35 | 0 |
enbucrilate | 0 | low | 1 | 0 |
3-deazaadenosine | 0 | low | 1 | 0 |
helenalin | 0 | low | 1 | 0 |
tert-nitrosobutane | 0 | low | 1 | 0 |
hepes | 0 | low | 2 | 0 |
iridium | 0 | medium | 3 | 1 |
lanthanum | 0 | low | 2 | 0 |
manganese | 0 | medium | 17 | 2 |
mercury | 0 | medium | 3 | 2 |
molybdenum | 0 | medium | 6 | 2 |
neon | 0 | low | 1 | 0 |
platinum | 0 | low | 4 | 0 |
rhenium | 0 | low | 3 | 0 |
rhodium | 0 | low | 1 | 0 |
ruthenium | 0 | medium | 4 | 2 |
silver | 0 | medium | 7 | 6 |
technetium | 0 | medium | 15 | 2 |
thulium | 0 | medium | 1 | 1 |
titanium | 0 | medium | 8 | 5 |
tungsten | 0 | low | 6 | 0 |
argon | 0 | low | 6 | 0 |
cadmium | 0 | low | 3 | 0 |
cerium | 0 | medium | 11 | 2 |
chromium | 0 | low | 1 | 0 |
europium | 0 | medium | 2 | 1 |
gadolinium | 0 | low | 67 | 0 |
gold | 0 | medium | 11 | 3 |
helium | 0 | medium | 8 | 1 |
uranium | 0 | medium | 1 | 1 |
xenon | 0 | medium | 16 | 1 |
magnesium sulfate | 0 | low | 22 | 0 |
mercuric chloride | 0 | low | 1 | 0 |
acetylglucosamine | 0 | low | 7 | 0 |
galactosamine | 0 | medium | 5 | 2 |
phosphoric acid, trisodium salt | 0 | low | 2 | 0 |
sodium nitrate | 0 | low | 1 | 0 |
hypochlorous acid | 0 | low | 7 | 0 |
camptothecin | 0 | medium | 2 | 2 |
ferric chloride | 0 | low | 2 | 0 |
ferrous sulfate | 0 | low | 2 | 0 |
monoethylglycinexylidide | 0 | medium | 3 | 1 |
zinc sulfate | 0 | medium | 7 | 2 |
calcium phosphate, dibasic, anhydrous | 0 | low | 1 | 0 |
calcium phosphate, monobasic, anhydrous | 0 | low | 1 | 0 |
tricalcium phosphate | 0 | medium | 4 | 2 |
tungstate | 0 | low | 1 | 0 |
silver nitrate | 0 | low | 1 | 0 |
sodium thiosulfate | 0 | low | 5 | 0 |
deuterium | 0 | low | 1 | 0 |
fluorine | 0 | low | 3 | 0 |
deuterium oxide | 0 | low | 3 | 0 |
calcium pyrophosphate | 0 | low | 2 | 0 |
thallium chloride | 0 | low | 1 | 0 |
galactose | 0 | medium | 2 | 1 |
sizofiran | 0 | low | 1 | 0 |
ozone | 0 | medium | 47 | 3 |
radon | 0 | low | 2 | 0 |
ammonium ferric sulfate | 0 | low | 1 | 0 |
sodium selenite | 0 | low | 15 | 0 |
cadmium chloride | 0 | low | 2 | 0 |
magnesium chlorate | 0 | low | 1 | 0 |
barium chloride | 0 | low | 1 | 0 |
trolamine salicylate | 0 | low | 11 | 0 |
clodronic acid | 0 | low | 27 | 0 |
ammonium chloride | 0 | low | 3 | 0 |
titanium dioxide | 0 | medium | 4 | 2 |
sodium tungstate(vi) | 0 | low | 3 | 0 |
mopidamol | 0 | low | 1 | 0 |
diacerein | 0 | low | 2 | 0 |
salen | 0 | low | 1 | 0 |
tiletamine hydrochloride | 0 | low | 4 | 0 |
selegiline | 0 | low | 5 | 0 |
1-methyladenosine | 0 | low | 1 | 0 |
cromolyn sodium | 0 | low | 25 | 0 |
isosorbide-5-mononitrate | 0 | medium | 1 | 1 |
tetradecanoylphorbol acetate | 0 | low | 38 | 0 |
sodium bisulfide | 0 | low | 31 | 0 |
fluorides | 0 | low | 1 | 0 |
clonixin | 0 | low | 1 | 0 |
cresyl violet | 0 | low | 2 | 0 |
calcium dobesilate | 0 | low | 6 | 0 |
phosphotyrosine | 0 | low | 6 | 0 |
bromocriptine | 0 | low | 3 | 0 |
zingerone | 0 | low | 1 | 0 |
phenyl acetate | 0 | medium | 36 | 2 |
cetylpyridinium chloride anhydrous | 0 | low | 1 | 0 |
myrcene | 0 | low | 2 | 0 |
ursodeoxycholic acid | 0 | low | 9 | 0 |
pregnanolone | 0 | low | 1 | 0 |
butylated hydroxytoluene | 0 | low | 1 | 0 |
isothiuronium | 0 | low | 6 | 0 |
metipranolol | 0 | low | 1 | 0 |
4-methoxyamphetamine | 0 | medium | 56 | 3 |
8-bromo cyclic adenosine monophosphate | 0 | low | 4 | 0 |
transferrin | 0 | low | 14 | 0 |
tridemorph | 0 | low | 1 | 0 |
alkenes | 0 | low | 13 | 0 |
calcium oxalate | 0 | low | 1 | 0 |
glutamic acid | 0 | low | 186 | 0 |
glucaric acid | 0 | low | 3 | 0 |
cefazolin | 0 | low | 1 | 0 |
sodium azide | 0 | low | 8 | 0 |
azides | 0 | low | 3 | 0 |
adenosine diphosphate ribose | 0 | low | 1 | 0 |
amoxicillin | 0 | low | 1 | 0 |
timolol | 0 | low | 2 | 0 |
tramadol | 0 | medium | 7 | 2 |
nicergoline | 0 | low | 1 | 0 |
gallium citrate | 0 | medium | 2 | 2 |
enterobactin | 0 | low | 1 | 0 |
moricizine | 0 | low | 1 | 0 |
2-aminotetralin | 0 | low | 1 | 0 |
s-adenosylmethionine | 0 | low | 1 | 0 |
paclitaxel | 0 | medium | 4 | 1 |
alinidine | 0 | low | 1 | 0 |
etoposide | 0 | low | 2 | 0 |
substance p | 0 | medium | 12 | 1 |
dobutamine | 0 | low | 12 | 0 |
phorbol 12,13-dibutyrate | 0 | low | 1 | 0 |
bezafibrate | 0 | low | 1 | 0 |
flunixin meglumine | 0 | low | 1 | 0 |
1-methyl-4-phenylpyridinium | 0 | low | 1 | 0 |
lonidamine | 0 | low | 1 | 0 |
ng-nitroarginine methyl ester | 0 | medium | 267 | 1 |
pirfenidone | 0 | low | 8 | 0 |
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid | 0 | low | 24 | 0 |
lodoxamide ethyl | 0 | low | 1 | 0 |
3,3',5,5'-tetramethylbenzidine | 0 | low | 2 | 0 |
sufentanil | 0 | low | 8 | 0 |
epirubicin | 0 | low | 1 | 0 |
desflurane | 0 | medium | 21 | 4 |
enkephalin, methionine | 0 | low | 2 | 0 |
propiconazole | 0 | low | 2 | 0 |
nitroacetic acid | 0 | low | 1 | 0 |
paroxetine | 0 | low | 1 | 0 |
captopril | 0 | medium | 31 | 2 |
cefoperazone | 0 | low | 1 | 0 |
oltipraz | 0 | low | 2 | 0 |
nicorandil | 0 | medium | 28 | 4 |
bw-755c | 0 | low | 2 | 0 |
pergolide | 0 | low | 1 | 0 |
colforsin | 0 | low | 14 | 0 |
nedocromil | 0 | low | 1 | 0 |
pimonidazole | 0 | low | 8 | 0 |
pefloxacin | 0 | low | 1 | 0 |
daurisoline | 0 | low | 1 | 0 |
fomesafen | 0 | low | 11 | 0 |
dazoxiben | 0 | low | 1 | 0 |
lovastatin | 0 | low | 4 | 0 |
flupirtine | 0 | low | 1 | 0 |
dazmegrel | 0 | low | 5 | 0 |
enoximone | 0 | low | 1 | 0 |
simvastatin | 0 | medium | 56 | 2 |
balsalazide | 0 | low | 1 | 0 |
pravastatin | 0 | medium | 13 | 1 |
amflutizole | 0 | low | 1 | 0 |
raloxifene hydrochloride | 0 | low | 3 | 0 |
cicletanine | 0 | low | 2 | 0 |
anipamil | 0 | low | 1 | 0 |
mifepristone | 0 | low | 5 | 0 |
piroximone | 0 | low | 1 | 0 |
itraconazole | 0 | medium | 2 | 2 |
gusperimus | 0 | low | 1 | 0 |
dopexamine | 0 | medium | 6 | 2 |
salmeterol xinafoate | 0 | medium | 3 | 2 |
ranolazine | 0 | low | 5 | 0 |
fura-2 | 0 | low | 10 | 0 |
zileuton | 0 | low | 3 | 0 |
clopidogrel | 0 | medium | 15 | 2 |
tiagabine | 0 | low | 1 | 0 |
mibefradil | 0 | low | 2 | 0 |
bimakalim | 0 | low | 2 | 0 |
gemcitabine | 0 | medium | 1 | 1 |
technetium tc 99m mertiatide | 0 | low | 2 | 0 |
aripiprazole | 0 | low | 1 | 0 |
sipatrigine | 0 | low | 2 | 0 |
remifentanil | 0 | medium | 24 | 1 |
atorvastatin | 0 | medium | 47 | 3 |
lamivudine | 0 | medium | 2 | 2 |
duloxetine hydrochloride | 0 | low | 2 | 0 |
irinotecan | 0 | low | 1 | 0 |
aptiganel | 0 | low | 3 | 0 |
valsartan | 0 | low | 8 | 0 |
draflazine | 0 | low | 1 | 0 |
3-iodobenzylguanidine | 0 | low | 1 | 0 |
simendan | 0 | low | 14 | 0 |
emtricitabine | 0 | medium | 3 | 2 |
tirofiban | 0 | low | 8 | 0 |
adenosine | 0 | medium | 465 | 14 |
safranal | 0 | low | 1 | 0 |
3-n-butylphthalide | 0 | low | 27 | 0 |
gadolinium chloride | 0 | low | 50 | 0 |
gallium nitrate | 0 | low | 1 | 0 |
vanadates | 0 | low | 4 | 0 |
acridine orange | 0 | low | 9 | 0 |
vanillyl alcohol | 0 | low | 2 | 0 |
caloreen | 0 | low | 1 | 0 |
tenocyclidine | 0 | low | 1 | 0 |
halofuginone | 0 | low | 3 | 0 |
efavirenz | 0 | medium | 3 | 2 |
nelfinavir | 0 | low | 1 | 0 |
u 37883a | 0 | low | 3 | 0 |
rolofylline | 0 | low | 2 | 0 |
glucose, (beta-d)-isomer | 0 | medium | 109 | 2 |
anisodamine | 0 | low | 9 | 0 |
mevastatin | 0 | low | 1 | 0 |
2',7'-dichlorofluorescein | 0 | low | 3 | 0 |
ursolic acid | 0 | low | 3 | 0 |
3-aminoisobutyric acid | 0 | low | 1 | 0 |
thiazolyl blue | 0 | low | 13 | 0 |
3-methylhistidine | 0 | low | 1 | 0 |
betulinic acid | 0 | low | 6 | 0 |
arctigenin | 0 | low | 2 | 0 |
baicalin | 0 | medium | 37 | 1 |
plerixafor | 0 | low | 3 | 0 |
allicin | 0 | low | 10 | 0 |
5-methylcytosine | 0 | low | 3 | 0 |
thionine | 0 | low | 1 | 0 |
epigallocatechin gallate | 0 | low | 30 | 0 |
n-acetylaspartic acid | 0 | low | 9 | 0 |
deoxyuridine triphosphate | 0 | low | 3 | 0 |
fluorexon | 0 | low | 1 | 0 |
gallocatechol | 0 | low | 1 | 0 |
xanthotoxol | 0 | low | 1 | 0 |
2,2'-dipyridyl disulfide | 0 | low | 1 | 0 |
25-hydroxycholesterol | 0 | low | 2 | 0 |
10,10'-dimethyl-9,9'-biacridinium | 0 | low | 11 | 0 |
aica ribonucleotide | 0 | low | 10 | 0 |
salvin | 0 | low | 4 | 0 |
1,2-distearoyllecithin | 0 | low | 1 | 0 |
aconitic anhydride | 0 | low | 1 | 0 |
5-bromo-4-chloro-3-indolyl beta-galactoside | 0 | low | 2 | 0 |
1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose | 0 | low | 2 | 0 |
2-oxothiazolidine-4-carboxylic acid | 0 | low | 1 | 0 |
pyrrolidine dithiocarbamate | 0 | low | 28 | 0 |
peroxynitric acid | 0 | low | 35 | 0 |
glutathione disulfide | 0 | low | 63 | 0 |
4-nitrobenzylthioinosine | 0 | low | 2 | 0 |
iopamidol | 0 | low | 1 | 0 |
cephalosporin c | 0 | low | 4 | 0 |
erdosteine | 0 | low | 13 | 0 |
zatebradine | 0 | low | 1 | 0 |
dicarbine | 0 | low | 12 | 0 |
lathosterol | 0 | low | 1 | 0 |
rutecarpine | 0 | low | 2 | 0 |
atrinositol | 0 | low | 1 | 0 |
oxaceprol | 0 | low | 2 | 0 |
tedisamil | 0 | low | 2 | 0 |
lercanidipine | 0 | low | 1 | 0 |
web 2086 | 0 | low | 9 | 0 |
bepafant | 0 | low | 6 | 0 |
rp 59227 | 0 | low | 1 | 0 |
azelnidipine | 0 | low | 3 | 0 |
raxofelast | 0 | low | 3 | 0 |
setipafant | 0 | low | 1 | 0 |
siratiazem | 0 | low | 1 | 0 |
lubeluzole | 0 | low | 2 | 0 |
telmisartan | 0 | low | 13 | 0 |
nicanartine | 0 | low | 1 | 0 |
inogatran | 0 | low | 1 | 0 |
methacycline | 0 | low | 2 | 0 |
bergenin | 0 | low | 1 | 0 |
2-methoxyestradiol | 0 | low | 3 | 0 |
naphthalimides | 0 | low | 2 | 0 |
alpha-naphthyl isocyanate | 0 | low | 1 | 0 |
3-hydroxy-4'-nitro-2-naphthanilide chloroacetate | 0 | low | 1 | 0 |
1,7-phenanthroline | 0 | low | 5 | 0 |
benzo-1,2,3-thiadiazole | 0 | low | 1 | 0 |
triazoles | 0 | medium | 48 | 1 |
pinocembrin | 0 | low | 8 | 0 |
tangeretin | 0 | low | 2 | 0 |
sesamol | 0 | low | 1 | 0 |
fluorodeoxyglucose f18 | 0 | medium | 15 | 4 |
sertraline | 0 | low | 1 | 0 |
selfotel | 0 | low | 2 | 0 |
zoledronic acid | 0 | low | 5 | 0 |
cloricromen | 0 | low | 3 | 0 |
dimethyl itaconate | 0 | low | 1 | 0 |
5-hydroxymethylcytosine | 0 | low | 3 | 0 |
nefiracetam | 0 | low | 1 | 0 |
cromakalim | 0 | low | 10 | 0 |
emopamil | 0 | low | 1 | 0 |
nicaraven | 0 | low | 6 | 0 |
erythromycin propionate-n-acetylcysteinate | 0 | low | 1 | 0 |
atipamezole | 0 | low | 4 | 0 |
dapoxetine | 0 | medium | 1 | 1 |
masoprocol | 0 | low | 7 | 0 |
antebate | 0 | low | 1 | 0 |
voriconazole | 0 | medium | 1 | 1 |
nipradilol | 0 | low | 1 | 0 |
efaroxan | 0 | low | 2 | 0 |
terlipressin | 0 | medium | 1 | 1 |
hesperetin | 0 | low | 4 | 0 |
4-o-methyl-12-o-tetradecanoylphorbol 13-acetate | 0 | low | 1 | 0 |
magnolol | 0 | low | 12 | 0 |
honokiol | 0 | low | 8 | 0 |
sesamin | 0 | low | 1 | 0 |
coptisine | 0 | low | 1 | 0 |
nobiletin | 0 | low | 9 | 0 |
leupeptin | 0 | low | 2 | 0 |
picropodophyllin | 0 | low | 1 | 0 |
n-(2-hydroxyethyl)nicotinamide | 0 | low | 1 | 0 |
chimyl alcohol | 0 | low | 1 | 0 |
tetrandrine | 0 | low | 10 | 0 |
3-deazaneplanocin | 0 | low | 2 | 0 |
dehydrocostus lactone | 0 | low | 1 | 0 |
nodakenin | 0 | low | 1 | 0 |
bes | 0 | low | 1 | 0 |
calpeptin | 0 | low | 3 | 0 |
dauricine | 0 | low | 3 | 0 |
brusatol | 0 | low | 6 | 0 |
cornin iridoid | 0 | low | 2 | 0 |
panaxadiol | 0 | low | 1 | 0 |
corilagin | 0 | low | 3 | 0 |
bilobalide | 0 | low | 6 | 0 |
panaxatriol | 0 | low | 1 | 0 |
arjunolic acid | 0 | low | 1 | 0 |
maslinic acid | 0 | low | 2 | 0 |
gallein | 0 | low | 1 | 0 |
ceric oxide | 0 | medium | 10 | 2 |
methylene green | 0 | low | 1 | 0 |
6-carboxyfluorescein | 0 | low | 3 | 0 |
enpiperate | 0 | low | 1 | 0 |
ethyl protocatechuate | 0 | low | 2 | 0 |
2',7'-dichlorodihydrofluorescein diacetate | 0 | low | 1 | 0 |
1-benzylimidazole | 0 | low | 2 | 0 |
rivastigmine | 0 | low | 1 | 0 |
rosiglitazone | 0 | medium | 25 | 1 |
fc 75 | 0 | low | 1 | 0 |
n-hydroxysuccinimide | 0 | low | 1 | 0 |
hydroxyguanidine | 0 | low | 2 | 0 |
carvacryl acetate | 0 | low | 1 | 0 |
bexarotene | 0 | low | 1 | 0 |
s20098 | 0 | low | 1 | 0 |
3,4-dihydroxyphenylethanol | 0 | low | 5 | 0 |
propagermanium | 0 | low | 3 | 0 |
4-phenylbutylamine | 0 | low | 2 | 0 |
3,4,5-trihydroxybenzaldehyde | 0 | low | 1 | 0 |
biocytin | 0 | low | 1 | 0 |
d-aspartic acid | 0 | low | 1 | 0 |
albendazole sulfoxide | 0 | low | 1 | 0 |
ketorolac tromethamine | 0 | low | 1 | 0 |
clarithromycin | 0 | low | 1 | 0 |
coenzyme a | 0 | low | 2 | 0 |
loganin | 0 | low | 1 | 0 |
gentiopicroside | 0 | low | 1 | 0 |
mebeverine | 0 | low | 1 | 0 |
nicotine | 0 | medium | 19 | 3 |
fibrinogen | 0 | medium | 37 | 3 |
tandospirone | 0 | low | 1 | 0 |
7-ketocholesterol | 0 | low | 1 | 0 |
cholest-4-en-3-one | 0 | low | 1 | 0 |
3,4-dihydroxyphenylglycol | 0 | low | 3 | 0 |
homocysteine | 0 | medium | 17 | 1 |
4-hydroxyphenylglycine | 0 | low | 2 | 0 |
adenosine 5'-methylenediphosphate | 0 | low | 2 | 0 |
chalcone epoxide | 0 | low | 1 | 0 |
levobupivacaine | 0 | medium | 1 | 1 |
zofenopril | 0 | low | 5 | 0 |
mci 9038 | 0 | low | 4 | 0 |
lopinavir | 0 | medium | 1 | 1 |
gamma-tocopherol | 0 | low | 2 | 0 |
indole-3-lactic acid | 0 | low | 1 | 0 |
arginine methyl ester | 0 | low | 1 | 0 |
firefly luciferin | 0 | low | 2 | 0 |
droxidopa | 0 | low | 1 | 0 |
glycidyl nitrate | 0 | low | 1 | 0 |
chloromethylstyrene | 0 | low | 1 | 0 |
pyrimidine dimers | 0 | low | 1 | 0 |
6-paradol | 0 | low | 1 | 0 |
pyrroline | 0 | low | 1 | 0 |
glucuronic acid | 0 | low | 1 | 0 |
osajin | 0 | low | 1 | 0 |
4-(phenylthio)butanoic acid | 0 | low | 1 | 0 |
stepharine | 0 | low | 1 | 0 |
2-acetylcyclopentanone | 0 | low | 1 | 0 |
2,5-dihydroxypyridine | 0 | medium | 2 | 2 |
diosgenin | 0 | low | 13 | 0 |
2,2,5,7,8-pentamethyl-1-hydroxychroman | 0 | low | 2 | 0 |
isosteviol | 0 | low | 2 | 0 |
3,7-dimethyl-1-propargylxanthine | 0 | low | 1 | 0 |
thaliporphine | 0 | low | 1 | 0 |
syringaresinol | 0 | low | 1 | 0 |
n-methyladenosine | 0 | medium | 3 | 1 |
cobalt | 0 | low | 24 | 0 |
p-methoxy-n-methylphenethylamine | 0 | low | 16 | 0 |
fulvestrant | 0 | low | 9 | 0 |
hydrogen sulfite | 0 | low | 1 | 0 |
1-amino-1,3-dicarboxycyclopentane | 0 | low | 1 | 0 |
chlorates | 0 | low | 1 | 0 |
desethylamiodarone | 0 | low | 1 | 0 |
enkephalin, d-penicillamine (2,5)- | 0 | low | 1 | 0 |
u 73122 | 0 | low | 2 | 0 |
arginyl-glycyl-aspartic acid | 0 | low | 5 | 0 |
vitamin b 6 | 0 | low | 1 | 0 |
cremophor el | 0 | low | 1 | 0 |
sr141716 | 0 | low | 4 | 0 |
s-nitrosoglutathione | 0 | low | 15 | 0 |
bosentan anhydrous | 0 | medium | 25 | 1 |
u 74006f | 0 | medium | 31 | 1 |
diacetyldichlorofluorescein | 0 | low | 4 | 0 |
u 74389f | 0 | medium | 51 | 3 |
1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1h-imidazole | 0 | low | 2 | 0 |
chlorethylclonidine | 0 | low | 3 | 0 |
fluo-3 | 0 | low | 2 | 0 |
1,n(6)-ethenoadenine | 0 | medium | 1 | 1 |
paxilline | 0 | low | 6 | 0 |
prolinedithiocarbamate | 0 | low | 9 | 0 |
fructose 2,6-diphosphate | 0 | low | 2 | 0 |
artesunic acid | 0 | low | 5 | 0 |
dihydrorhodamine 123 | 0 | low | 12 | 0 |
cyanates | 0 | low | 1 | 0 |
bradykinin, des-arg(9)- | 0 | low | 1 | 0 |
methyllycaconitine | 0 | low | 3 | 0 |
indobufen | 0 | low | 1 | 0 |
thiamethoxam | 0 | medium | 1 | 1 |
fluorocitrate | 0 | low | 1 | 0 |
s-ethyl glutathione | 0 | low | 2 | 0 |
u 78517f | 0 | low | 4 | 0 |
cv 3988 | 0 | low | 2 | 0 |
sivelestat | 0 | medium | 31 | 1 |
propionylcarnitine | 0 | low | 7 | 0 |
cv 6209 | 0 | low | 5 | 0 |
gr 127935 | 0 | low | 1 | 0 |
perindopril | 0 | low | 2 | 0 |
fr 139317 | 0 | low | 2 | 0 |
geniposide | 0 | low | 16 | 0 |
procyanidin | 0 | low | 24 | 0 |
dihydrokainate | 0 | low | 4 | 0 |
dityrosine | 0 | low | 1 | 0 |
epicatechin gallate | 0 | low | 3 | 0 |
deguelin | 0 | low | 1 | 0 |
u 74500a | 0 | low | 10 | 0 |
fingolimod hydrochloride | 0 | medium | 41 | 1 |
dihydrocapsaicin | 0 | low | 4 | 0 |
n(g)-iminoethylornithine | 0 | low | 11 | 0 |
triptolide | 0 | low | 8 | 0 |
quinaprilat | 0 | low | 3 | 0 |
1h-indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2- (carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1s,2r,3s)- | 0 | low | 5 | 0 |
cobaltiprotoporphyrin | 0 | low | 23 | 0 |
sri 63-441 | 0 | low | 1 | 0 |
cafestol | 0 | low | 1 | 0 |
asiaticoside | 0 | low | 4 | 0 |
proanthocyanidin | 0 | low | 6 | 0 |
parthenolide | 0 | low | 1 | 0 |
tesmilifene | 0 | low | 2 | 0 |
schizandrin b | 0 | low | 5 | 0 |
tamibarotene | 0 | low | 1 | 0 |
kt 5823 | 0 | low | 4 | 0 |
1-hexadecyl-2-acetyl-glycero-3-phosphocholine | 0 | medium | 102 | 1 |
sr 140333 | 0 | low | 1 | 0 |
bifendate | 0 | low | 1 | 0 |
deoxyglucose | 0 | low | 13 | 0 |
tadalafil | 0 | low | 22 | 0 |
ta 0910 | 0 | low | 1 | 0 |
3',4'-dichlorobenzamil | 0 | low | 3 | 0 |
homoorientin | 0 | medium | 2 | 2 |
selenomethylselenocysteine | 0 | low | 1 | 0 |
higenamine | 0 | low | 3 | 0 |
oxymatrine | 0 | low | 2 | 0 |
n-(1-methyl-2-phenylethyl)adenosine | 0 | low | 1 | 0 |
t 61 | 0 | low | 1 | 0 |
thromboxanes | 0 | low | 13 | 0 |
landiolol | 0 | low | 4 | 0 |
tanshinone | 0 | low | 22 | 0 |
sc 41930 | 0 | low | 3 | 0 |
bn 50739 | 0 | low | 1 | 0 |
geraniin | 0 | low | 1 | 0 |
gastrodin | 0 | low | 10 | 0 |
way 100135 | 0 | low | 1 | 0 |
phenylalanyl-prolyl-arginine-chloromethyl ketone | 0 | low | 2 | 0 |
3,5-dibromo-4-nitrosobenzenesulfonate | 0 | low | 1 | 0 |
ginkgolide a | 0 | low | 1 | 0 |
sc 58125 | 0 | low | 2 | 0 |
stachydrine | 0 | low | 1 | 0 |
taraxasterol | 0 | low | 1 | 0 |
marimastat | 0 | low | 1 | 0 |
nitroaspirin | 0 | medium | 3 | 1 |
asiatic acid | 0 | low | 3 | 0 |
cynaropicrin | 0 | low | 1 | 0 |
lithospermate b | 0 | low | 5 | 0 |
1-o-hexyl-2,3,5-trimethylhydroquinone | 0 | low | 1 | 0 |
dioscin | 0 | low | 7 | 0 |
astilbin | 0 | low | 4 | 0 |
ginsenoside rh2 | 0 | low | 1 | 0 |
n-gamma-glutamylcysteine ethyl ester | 0 | low | 1 | 0 |
iodofiltic acid | 0 | low | 4 | 0 |
n-(9h-(2,7-dimethylfluoren-9-ylmethoxy)carbonyl)leucine | 0 | low | 4 | 0 |
n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride | 0 | low | 1 | 0 |
caprylates | 0 | low | 2 | 0 |
tris(2-carboxyethyl)phosphine | 0 | medium | 2 | 2 |
n-nitrosomorpholinoaminoacetonitrile | 0 | low | 1 | 0 |
k 76 carboxylic acid | 0 | low | 2 | 0 |
3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid | 0 | low | 1 | 0 |
pramipexole | 0 | low | 2 | 0 |
parecoxib | 0 | low | 11 | 0 |
tetranitrotetrazolium blue | 0 | low | 1 | 0 |
brl 44408 | 0 | low | 1 | 0 |
a 63162 | 0 | low | 2 | 0 |
sb 204070a | 0 | low | 1 | 0 |
ezogabine | 0 | low | 2 | 0 |
perftoran | 0 | low | 1 | 0 |
l 658758 | 0 | low | 3 | 0 |
6,6'-methylenebis(2,2-dimethyl-4-methanesulfonic acid-1,2-dihydroquinoline) | 0 | low | 4 | 0 |
bw a868c | 0 | low | 1 | 0 |
ly 255283 | 0 | low | 1 | 0 |
pd 81723 | 0 | low | 3 | 0 |
s-nitroso-n-acetylcysteine | 0 | low | 6 | 0 |
formylmethionyl-leucyl-phenylalanine methyl ester | 0 | low | 1 | 0 |
l 655240 | 0 | low | 1 | 0 |
rc 3095 | 0 | low | 3 | 0 |
dx 9065a | 0 | low | 3 | 0 |
pd 142893 | 0 | low | 1 | 0 |
gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate | 0 | low | 3 | 0 |
l 659989 | 0 | low | 2 | 0 |
tryptophan methyl ester | 0 | low | 3 | 0 |
tyrosyl-arginyl-phenylalanyl-lysinamide | 0 | low | 1 | 0 |
kallidin, des-arg(10)- | 0 | low | 1 | 0 |
butyryl-coenzyme a | 0 | low | 1 | 0 |
5-chloromethylfluorescein diacetate | 0 | low | 1 | 0 |
emoxypine succinate | 0 | low | 2 | 0 |
a 68930 | 0 | low | 1 | 0 |
efaproxiral | 0 | low | 1 | 0 |
astragaloside a | 0 | low | 34 | 0 |
celastrol | 0 | low | 9 | 0 |
procyanidin b2 | 0 | low | 1 | 0 |
peroxynitrous acid | 0 | medium | 70 | 1 |
fullerene c60 | 0 | low | 9 | 0 |
imatinib mesylate | 0 | medium | 5 | 1 |
mk 0663 | 0 | low | 4 | 0 |
gefitinib | 0 | medium | 1 | 1 |
rhod-2 | 0 | low | 1 | 0 |
anisodine | 0 | low | 1 | 0 |
n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine | 0 | low | 6 | 0 |
2-mercaptomethyl-3-guanidinoethylthiopropionic acid | 0 | low | 1 | 0 |
angiotensin ii, des-phe(8)- | 0 | low | 11 | 0 |
2-chloro-n(6)cyclopentyladenosine | 0 | low | 14 | 0 |
heliox | 0 | low | 2 | 0 |
angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- | 0 | low | 1 | 0 |
n,n-dimethylarginine | 0 | low | 15 | 0 |
hoe 694 | 0 | low | 4 | 0 |
cyclic adp-ribose | 0 | low | 2 | 0 |
bis(sulfosuccinimidyl)suberate | 0 | low | 1 | 0 |
3-(2,2,2-trimethylhydrazine)propionate | 0 | low | 5 | 0 |
interleukin-1beta (163-171) | 0 | low | 5 | 0 |
tak 044 | 0 | low | 13 | 0 |
bq 610 | 0 | low | 7 | 0 |
indo-1 pentaacetoxymethyl ester | 0 | low | 1 | 0 |
4-(alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl)-n,n-diethylbenzamide | 0 | low | 1 | 0 |
3,3'-dithiobis(sulfosuccinimidyl propionate) | 0 | low | 1 | 0 |
alanylglutamine | 0 | medium | 13 | 1 |
gamma-glutamylcysteine | 0 | low | 2 | 0 |
zd 7288 | 0 | low | 1 | 0 |
e 64 | 0 | low | 2 | 0 |
tetrahydrocurcumin | 0 | low | 3 | 0 |
ra 642 | 0 | low | 1 | 0 |
skullcapflavone ii | 0 | low | 1 | 0 |
2',6'-dimethyltyrosine | 0 | low | 1 | 0 |
cp 66713 | 0 | low | 1 | 0 |
phosphocyclocreatine | 0 | low | 1 | 0 |
8-oxo-dado | 0 | low | 1 | 0 |
lipoyl-4-aminobenzoic acid | 0 | low | 1 | 0 |
n-succinimidyl-5-iodo-3-pyridinecarboxylic acid | 0 | low | 1 | 0 |
2-ethyl-1-hydroxy-2,5,5-trimethyl-3-oxazolidine | 0 | low | 1 | 0 |
t-butyloxycarbonyl-methionyl-leucyl-phenylalanine | 0 | low | 2 | 0 |
butyloxycarbonyl-phenylalanyl-leucyl-phenylalanyl-leucyl-phenylalanine | 0 | low | 1 | 0 |
ectoine | 0 | low | 2 | 0 |
4-iodophenyl-9-methylpentadecanoic acid | 0 | low | 2 | 0 |
pre 084 | 0 | low | 3 | 0 |
l 012 | 0 | low | 1 | 0 |
methotrexate | 0 | low | 2 | 0 |
sb 211475 | 0 | low | 2 | 0 |
mar 99 | 0 | low | 2 | 0 |
jtp 2942 | 0 | low | 1 | 0 |
ly 293558 | 0 | low | 1 | 0 |
clausenamide | 0 | low | 3 | 0 |
ym 16638 | 0 | low | 1 | 0 |
salvinorin a | 0 | low | 2 | 0 |
dihydroethidium | 0 | low | 8 | 0 |
cyanidin | 0 | low | 2 | 0 |
2-iminobiotin | 0 | low | 1 | 0 |
tamsulosin | 0 | low | 1 | 0 |
sipi 549 | 0 | low | 1 | 0 |
rufinamide | 0 | low | 1 | 0 |
planinin | 0 | low | 1 | 0 |
olmesartan medoxomil | 0 | low | 1 | 0 |
e 5880 | 0 | low | 3 | 0 |
dexpanthenol | 0 | low | 10 | 0 |
mdl 73404 | 0 | low | 1 | 0 |
cornuside | 0 | low | 1 | 0 |
safinamide | 0 | low | 2 | 0 |
2h-1,4-benzoxazine, 3,4-dihydro-2,2-dimethyl-6-nitro-4-(2-pyridinyl)-, n-oxide | 0 | low | 1 | 0 |
ro 43-5054 | 0 | low | 1 | 0 |
cgp 52432 | 0 | low | 3 | 0 |
t 593 | 0 | low | 2 | 0 |
ilomastat | 0 | low | 2 | 0 |
t 588 | 0 | low | 2 | 0 |
5-(2,3,5-trichlorophenyl)pyrimidine-2,4-diamine ethane sulfonate | 0 | low | 1 | 0 |
omega-n-methylarginine | 0 | medium | 29 | 1 |
ivabradine | 0 | low | 1 | 0 |
ws 79089b | 0 | low | 1 | 0 |
n(4)-octadecyl-1-arabinofuranosylcytosine | 0 | low | 1 | 0 |
febuxostat | 0 | low | 5 | 0 |
carbapenems | 0 | medium | 2 | 2 |
calcium borate | 0 | medium | 1 | 1 |
fc 80 | 0 | low | 1 | 0 |
xylose | 0 | low | 1 | 0 |
cv 159 | 0 | low | 3 | 0 |
beta-lactams | 0 | medium | 2 | 2 |
m 8218 | 0 | low | 11 | 0 |
tempol | 0 | low | 2 | 0 |
7,8-dimethoxycoumarin | 0 | low | 1 | 0 |
sinensetin | 0 | low | 1 | 0 |
proline | 0 | medium | 20 | 2 |
cucurbitaceae | 0 | low | 1 | 0 |
3,3',4'-trihydroxyflavone | 0 | low | 4 | 0 |
dipfluzine | 0 | low | 2 | 0 |
2-(1-octynyl)adenosine | 0 | low | 3 | 0 |
docetaxel anhydrous | 0 | medium | 2 | 1 |
ym 872 | 0 | low | 2 | 0 |
peptide elongation factor 2 | 0 | low | 1 | 0 |
levofloxacin | 0 | low | 1 | 0 |
ezetimibe | 0 | low | 2 | 0 |
5-methoxytryptophan | 0 | low | 1 | 0 |
cox 189 | 0 | low | 1 | 0 |
cilomilast | 0 | low | 1 | 0 |
conivaptan | 0 | low | 1 | 0 |
cariporide | 0 | low | 28 | 0 |
tezosentan | 0 | low | 7 | 0 |
vatalanib | 0 | low | 1 | 0 |
evodiamine | 0 | low | 1 | 0 |
3,17-diacetoxyestra-1,3,5(10)-trien-2-carboxylic acid | 0 | low | 1 | 0 |
tellimagrandin ii | 0 | low | 1 | 0 |
mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin | 0 | low | 15 | 0 |
rostafuroxin | 0 | low | 1 | 0 |
cvt 124 | 0 | low | 1 | 0 |
clevidipine | 0 | low | 1 | 0 |
ruboxistaurin | 0 | low | 2 | 0 |
bazedoxifene | 0 | low | 1 | 0 |
rp 73401 | 0 | low | 1 | 0 |
phorbols | 0 | low | 1 | 0 |
kolaviron | 0 | low | 3 | 0 |
tomentosin | 0 | low | 1 | 0 |
schizandrin a | 0 | low | 1 | 0 |
varespladib | 0 | low | 1 | 0 |
atractylenolide iii | 0 | low | 1 | 0 |
cinacalcet | 0 | low | 1 | 0 |
hydroxyl radical | 0 | medium | 106 | 3 |
lubiprostone | 0 | low | 1 | 0 |
2-methoxystypandrone | 0 | low | 1 | 0 |
olmesartan | 0 | low | 1 | 0 |
curculigoside | 0 | low | 1 | 0 |
rhodioloside | 0 | low | 25 | 0 |
malvidin | 0 | low | 1 | 0 |
atrasentan | 0 | low | 4 | 0 |
singlet oxygen | 0 | medium | 3 | 2 |
peroxymonosulfate | 0 | medium | 2 | 2 |
fidarestat | 0 | low | 3 | 0 |
ukrain | 0 | low | 3 | 0 |
apovincaminic acid | 0 | low | 1 | 0 |
cryptotanshinone | 0 | low | 4 | 0 |
fenton's reagent | 0 | low | 1 | 0 |
dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination | 0 | low | 3 | 0 |
cyc 202 | 0 | low | 6 | 0 |
3,5-dimethoxy-4'-hydroxystilbene | 0 | low | 2 | 0 |
saccharopine | 0 | low | 1 | 0 |
3,5-diiodothyropropionic acid | 0 | low | 1 | 0 |
liensinine | 0 | low | 1 | 0 |
prostaglandins b | 0 | low | 2 | 0 |
leonurine | 0 | low | 2 | 0 |
ampelopsin | 0 | low | 3 | 0 |
dithiothreitol tetraacetate | 0 | low | 1 | 0 |
acyloin | 0 | low | 2 | 0 |
8-o-acetyl shanzhiside methyl ester | 0 | low | 1 | 0 |
platycodin d | 0 | low | 2 | 0 |
2-ethyl-2,5,5-trimethyl-3-oxazolidinoxyl | 0 | low | 1 | 0 |
schizandrer a | 0 | low | 2 | 0 |
bw a522 | 0 | low | 1 | 0 |
1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino)propane | 0 | low | 2 | 0 |
bactenecin | 0 | low | 1 | 0 |
fk 3311 | 0 | low | 7 | 0 |
sialyl-le(a) oligosaccharide | 0 | low | 1 | 0 |
abanoquil | 0 | low | 1 | 0 |
4-trifluoromethylsalicylic acid | 0 | low | 1 | 0 |
hydromethylthionine | 0 | low | 1 | 0 |
calcium pyrophosphate | 0 | low | 1 | 0 |
technetium tc 99m pentetate | 0 | medium | 8 | 1 |
boswellic acid | 0 | low | 1 | 0 |
symmetric dimethylarginine | 0 | low | 4 | 0 |
cinnamophilin | 0 | low | 3 | 0 |
varenicline | 0 | low | 1 | 0 |
methyl protodioscin | 0 | low | 1 | 0 |
biotin | 0 | low | 8 | 0 |
angiotensin ii | 0 | medium | 84 | 2 |
pinoresinol diglucoside | 0 | low | 1 | 0 |
atropine | 0 | medium | 10 | 1 |
yomogin | 0 | low | 1 | 0 |
oleanolic acid 3-o-monoglucuronide | 0 | low | 1 | 0 |
sb 203580 | 0 | low | 28 | 0 |
sb 216763 | 0 | low | 7 | 0 |
zm 241385 | 0 | low | 11 | 0 |
erlotinib hydrochloride | 0 | medium | 2 | 1 |
lu 135252 | 0 | low | 2 | 0 |
organophosphonates | 0 | medium | 7 | 2 |
ly 293111 | 0 | low | 1 | 0 |
ly 231617 | 0 | low | 2 | 0 |
limonin | 0 | low | 1 | 0 |
aceglutamide | 0 | low | 1 | 0 |
schaftoside | 0 | low | 1 | 0 |
tak 779 | 0 | low | 2 | 0 |
melagatran | 0 | low | 2 | 0 |
a 2545 | 0 | low | 1 | 0 |
scutellarin | 0 | low | 23 | 0 |
propargylglycine | 0 | low | 4 | 0 |
alpha-fluoromethylhistidine | 0 | low | 3 | 0 |
isospaglumic acid | 0 | low | 1 | 0 |
bd 1047 | 0 | low | 1 | 0 |
loureirin b | 0 | low | 1 | 0 |
phenserine | 0 | low | 1 | 0 |
cavidine | 0 | low | 1 | 0 |
mdl 74270 | 0 | low | 2 | 0 |
dronedarone | 0 | low | 2 | 0 |
ramelteon | 0 | low | 1 | 0 |
deferasirox | 0 | low | 1 | 0 |
cp 424391 | 0 | low | 1 | 0 |
dabigatran | 0 | low | 2 | 0 |
sorafenib | 0 | low | 4 | 0 |
lenalidomide | 0 | medium | 2 | 2 |
regadenoson | 0 | medium | 1 | 1 |
lacosamide | 0 | low | 1 | 0 |
cholic acid | 0 | low | 2 | 0 |
brazilin | 0 | low | 1 | 0 |
deoxycholic acid | 0 | low | 1 | 0 |
cortisone | 0 | low | 1 | 0 |
3-nitrotyrosine | 0 | medium | 143 | 2 |
5-hydroxymethylfurfural | 0 | low | 2 | 0 |
sodium sulfide | 0 | low | 5 | 0 |
lanosterol | 0 | low | 1 | 0 |
anisomycin | 0 | low | 3 | 0 |
benzofurans | 0 | medium | 70 | 2 |
cyclovirobuxine d | 0 | low | 2 | 0 |
withaferin a | 0 | low | 1 | 0 |
noscapine | 0 | low | 3 | 0 |
acivicin | 0 | low | 1 | 0 |
wortmannin | 0 | low | 30 | 0 |
withanolides | 0 | low | 2 | 0 |
medicarpin | 0 | low | 1 | 0 |
phyllanthin | 0 | low | 1 | 0 |
lobetyolin | 0 | low | 1 | 0 |
taurochenodeoxycholic acid | 0 | medium | 18 | 1 |
bortezomib | 0 | medium | 13 | 2 |
ritonavir | 0 | medium | 1 | 1 |
acetogenins | 0 | low | 1 | 0 |
mrs 1191 | 0 | low | 2 | 0 |
bardoxolone methyl | 0 | low | 5 | 0 |
dihydropyridines | 0 | low | 19 | 0 |
permanganate | 0 | medium | 1 | 1 |
leupeptins | 0 | low | 12 | 0 |
carboplatin | 0 | medium | 1 | 1 |
lithium chloride | 0 | low | 12 | 0 |
5'-methylthioadenosine | 0 | low | 1 | 0 |
glycogen | 0 | medium | 49 | 2 |
n-acetylneuraminic acid | 0 | medium | 3 | 1 |
fibrin | 0 | low | 38 | 0 |
bradykinin | 0 | medium | 66 | 3 |
canavanine | 0 | low | 1 | 0 |
hexacyanoferrate iii | 0 | low | 1 | 0 |
glucosamine | 0 | low | 9 | 0 |
carnosine | 0 | low | 22 | 0 |
mevalonic acid | 0 | medium | 6 | 1 |
ribose 1-phosphate | 0 | low | 1 | 0 |
raffinose | 0 | medium | 234 | 8 |
naringenin | 0 | low | 3 | 0 |
epiglucan | 0 | low | 8 | 0 |
oxytocin | 0 | low | 12 | 0 |
pantetheine | 0 | low | 1 | 0 |
dithioerythritol | 0 | low | 1 | 0 |
theanine | 0 | low | 8 | 0 |
3,4-dihydroxyphenyllactic acid | 0 | low | 7 | 0 |
inositol 1,4,5-trisphosphate | 0 | low | 2 | 0 |
ouabain | 0 | low | 12 | 0 |
allose | 0 | low | 15 | 0 |
puromycin | 0 | low | 2 | 0 |
taxifolin | 0 | low | 3 | 0 |
isomaltulose | 0 | low | 1 | 0 |
tosylphenylalanyl chloromethyl ketone | 0 | low | 1 | 0 |
tartaric acid | 0 | low | 1 | 0 |
pentostatin | 0 | low | 2 | 0 |
nicotinamide-beta-riboside | 0 | low | 3 | 0 |
nitroarginine | 0 | low | 34 | 0 |
adenosine 5'-o-(3-thiotriphosphate) | 0 | low | 2 | 0 |
dehydroascorbic acid | 0 | low | 11 | 0 |
arbutin | 0 | low | 3 | 0 |
psicose, (d)-isomer | 0 | low | 1 | 0 |
strychnine | 0 | low | 2 | 0 |
quinidine | 0 | low | 1 | 0 |
monensin | 0 | low | 1 | 0 |
digitoxin | 0 | low | 1 | 0 |
pentazocine | 0 | low | 1 | 0 |
rocuronium | 0 | low | 1 | 0 |
hyperforin | 0 | low | 1 | 0 |
phalloidine | 0 | low | 5 | 0 |
indican | 0 | low | 6 | 0 |
ryanodine | 0 | low | 6 | 0 |
furostanol i | 0 | low | 2 | 0 |
ginsenoside re | 0 | low | 2 | 0 |
ginsenoside rg1 | 0 | low | 26 | 0 |
notoginsenoside r1 | 0 | low | 12 | 0 |
carnosol | 0 | low | 5 | 0 |
stevioside | 0 | low | 1 | 0 |
decursin | 0 | low | 1 | 0 |
micheliolide | 0 | low | 1 | 0 |
patchouli alcohol | 0 | low | 1 | 0 |
genipin | 0 | low | 5 | 0 |
naringin | 0 | low | 15 | 0 |
swertiamarin | 0 | low | 2 | 0 |
gingerol | 0 | low | 2 | 0 |
cyclopamine | 0 | low | 3 | 0 |
lignans | 0 | low | 47 | 0 |
acetylleucyl-leucyl-norleucinal | 0 | low | 1 | 0 |
bq 485 | 0 | low | 5 | 0 |
bq 123 | 0 | low | 13 | 0 |
n-formylmethionine leucyl-phenylalanine | 0 | low | 12 | 0 |
diprenorphine | 0 | low | 1 | 0 |
sodium arsenite | 0 | low | 5 | 0 |
actinonin | 0 | low | 1 | 0 |
eplerenone | 0 | medium | 2 | 1 |
vinpocetine | 0 | low | 11 | 0 |
ao 128 | 0 | low | 1 | 0 |
betadex | 0 | low | 1 | 0 |
maleic acid | 0 | low | 2 | 0 |
acetyl coenzyme a | 0 | low | 2 | 0 |
trichostatin a | 0 | low | 9 | 0 |
tretinoin | 0 | medium | 14 | 1 |
arachidonic acid | 0 | low | 58 | 0 |
fumaric acid | 0 | low | 1 | 0 |
farnesol | 0 | low | 1 | 0 |
phosphoramidon | 0 | low | 4 | 0 |
resveratrol | 0 | low | 138 | 0 |
retinol | 0 | low | 21 | 0 |
latrunculin a | 0 | low | 2 | 0 |
palmitoleic acid | 0 | low | 1 | 0 |
oleic acid | 0 | low | 8 | 0 |
ferulic acid | 0 | medium | 20 | 1 |
pectins | 0 | low | 1 | 0 |
cerivastatin | 0 | low | 2 | 0 |
cocaine | 0 | low | 4 | 0 |
eicosapentaenoic acid | 0 | low | 10 | 0 |
thapsigargin | 0 | low | 7 | 0 |
cgs 27023a | 0 | low | 1 | 0 |
mycophenolic acid | 0 | low | 34 | 0 |
dihydrorhodamine 6g | 0 | low | 1 | 0 |
mupirocin | 0 | low | 1 | 0 |
clindamycin | 0 | low | 1 | 0 |
gw 6471 | 0 | low | 1 | 0 |
lycopene | 0 | low | 20 | 0 |
zithromax | 0 | low | 2 | 0 |
geranylgeranyl pyrophosphate | 0 | low | 1 | 0 |
apstatin | 0 | low | 1 | 0 |
obeticholic acid | 0 | low | 4 | 0 |
stigmatellin | 0 | low | 1 | 0 |
t0901317 | 0 | low | 1 | 0 |
y 27632 | 0 | low | 18 | 0 |
adenosine-5'-(n-ethylcarboxamide) | 0 | low | 4 | 0 |
prostaglandin d2 | 0 | low | 13 | 0 |
eptifibatide | 0 | low | 2 | 0 |
dexamethasone sodium phosphate | 0 | low | 1 | 0 |
roflumilast | 0 | low | 5 | 0 |
h 89 | 0 | low | 9 | 0 |
imidazolidines | 0 | low | 5 | 0 |
acid fuchsin | 0 | low | 1 | 0 |
decitabine | 0 | low | 2 | 0 |
pantethine | 0 | low | 1 | 0 |
texas red | 0 | low | 1 | 0 |
iridoids | 0 | medium | 33 | 2 |
kt 5720 | 0 | low | 2 | 0 |
laminaran | 0 | low | 1 | 0 |
dactinomycin | 0 | low | 7 | 0 |
gamma-sitosterol | 0 | low | 2 | 0 |
melphalan | 0 | low | 1 | 0 |
enkephalin, leucine | 0 | low | 6 | 0 |
benzyloxycarbonylleucyl-leucyl-leucine aldehyde | 0 | low | 9 | 0 |
tenofovir | 0 | medium | 3 | 2 |
schizandrin | 0 | low | 2 | 0 |
micafungin | 0 | low | 1 | 0 |
shikonin | 0 | low | 2 | 0 |
23-hydroxytormentic acid | 0 | low | 1 | 0 |
riboflavin | 0 | low | 7 | 0 |
lisofylline | 0 | low | 2 | 0 |
likviriton | 0 | low | 1 | 0 |
m40401 | 0 | low | 4 | 0 |
2,3-bis(bromomethyl)quinoxaline-1,4-dioxide | 0 | medium | 1 | 1 |
potassium permanganate | 0 | low | 1 | 0 |
sodium bicarbonate | 0 | low | 12 | 0 |
sodium acetate, anhydrous | 0 | low | 1 | 0 |
triacetoneamine-n-oxyl | 0 | low | 2 | 0 |
3-carbamoyl-2,2,5,5-tetramethyl-1-pyrrolidinyl-n-oxyl | 0 | low | 2 | 0 |
jp-1302 | 0 | low | 2 | 0 |
bromochloroacetic acid | 0 | low | 5 | 0 |
carbenoxolone sodium | 0 | low | 6 | 0 |
alpha-asarone | 0 | low | 3 | 0 |
cinnamaldehyde | 0 | low | 3 | 0 |
trans-4-coumaric acid | 0 | low | 1 | 0 |
anethole | 0 | low | 2 | 0 |
geraniol | 0 | medium | 6 | 2 |
dimethyl fumarate | 0 | low | 10 | 0 |
glycosides | 0 | low | 28 | 0 |
chalcone | 0 | low | 26 | 0 |
sinapinic acid | 0 | low | 1 | 0 |
isomethyleugenol | 0 | medium | 8 | 1 |
piplartine | 0 | low | 2 | 0 |
citral | 0 | low | 1 | 0 |
retinaldehyde | 0 | low | 1 | 0 |
piperine | 0 | low | 3 | 0 |
stilbenes | 0 | low | 133 | 0 |
isoliquiritigenin | 0 | low | 2 | 0 |
phenyl-n-tert-butylnitrone | 0 | low | 29 | 0 |
xanthohumol | 0 | low | 4 | 0 |
picibanil | 0 | low | 1 | 0 |
cardamonin | 0 | low | 3 | 0 |
xanthoangelol | 0 | low | 1 | 0 |
citraconic acid | 0 | low | 2 | 0 |
flavin-adenine dinucleotide | 0 | low | 7 | 0 |
cannabidiol | 0 | low | 10 | 0 |
malonyl coenzyme a | 0 | low | 2 | 0 |
buprenorphine | 0 | low | 3 | 0 |
lypressin | 0 | low | 1 | 0 |
arginine vasopressin | 0 | low | 4 | 0 |
sea 0400 | 0 | low | 7 | 0 |
pyrophosphate | 0 | low | 4 | 0 |
gw9662 | 0 | low | 11 | 0 |
s 1033 | 0 | low | 1 | 0 |
dihydrosphingosine 1-phosphate | 0 | low | 2 | 0 |
acetyl-aspartyl-glutamyl-valyl-aspartal | 0 | low | 2 | 0 |
bucillamine | 0 | low | 3 | 0 |
canrenoic acid | 0 | low | 1 | 0 |
benidipine hydrochloride | 0 | low | 1 | 0 |
benidipine | 0 | low | 2 | 0 |
sodium metabisulfite | 0 | medium | 1 | 1 |
xe 991, anthracenone | 0 | low | 1 | 0 |
tram 34 | 0 | low | 2 | 0 |
prednisolone hemisuccinate | 0 | low | 1 | 0 |
propylthiouracil | 0 | low | 2 | 0 |
r 59949 | 0 | low | 1 | 0 |
n(6)-cyclopentyladenosine | 0 | low | 5 | 0 |
sesquiterpenes | 0 | low | 21 | 0 |
etomidate | 0 | medium | 8 | 1 |
sb 366791 | 0 | low | 3 | 0 |
3,3',4,5'-tetrahydroxystilbene | 0 | low | 6 | 0 |
alpha-methyltryptophan, (l)-isomer | 0 | low | 1 | 0 |
1-methyltryptophan | 0 | low | 1 | 0 |
thioinosine | 0 | low | 2 | 0 |
caffeic acid | 0 | low | 12 | 0 |
cid755673 | 0 | low | 1 | 0 |
n-(1,3-benzodioxol-5-ylmethyl)-2,6-dichlorobenzamide | 0 | low | 8 | 0 |
cotinine | 0 | low | 3 | 0 |
flunarizine | 0 | low | 6 | 0 |
tetrahydropalmatine | 0 | low | 6 | 0 |
curcumin | 0 | medium | 127 | 4 |
ucf 101 | 0 | low | 4 | 0 |
rhodanine | 0 | low | 2 | 0 |
5-(4-ethylbenzylidene)-2-thioxothiazolidin-4-one | 0 | low | 1 | 0 |
thiohydantoins | 0 | medium | 2 | 2 |
3-(1-azepanylsulfonyl)-n-(3-bromphenyl)benzamide | 0 | low | 1 | 0 |
methimazole | 0 | low | 6 | 0 |
urb 597 | 0 | low | 2 | 0 |
cinnarizine | 0 | low | 2 | 0 |
sulindac | 0 | low | 1 | 0 |
capsaicin | 0 | low | 43 | 0 |
epalrestat | 0 | low | 2 | 0 |
aurapten | 0 | low | 1 | 0 |
farnesiferol b | 0 | low | 1 | 0 |
chlorogenic acid | 0 | medium | 12 | 2 |
neotetrazolium | 0 | low | 2 | 0 |
thiobarbituric acid | 0 | medium | 25 | 1 |
1,3-dimethylthiourea | 0 | low | 29 | 0 |
thiourea | 0 | medium | 57 | 2 |
safranine t | 0 | low | 1 | 0 |
indigo carmine | 0 | medium | 2 | 1 |
D-fructopyranose | 0 | low | 15 | 0 |
thioacetamide | 0 | low | 4 | 0 |
unithiol | 0 | low | 1 | 0 |
tempo | 0 | low | 4 | 0 |
ferric ferrocyanide | 0 | low | 3 | 0 |
succimer | 0 | low | 3 | 0 |
digoxin | 0 | low | 4 | 0 |
n-hydroxy-n'-(4-butyl-2-methylphenyl)formamidine | 0 | low | 6 | 0 |
bml 241 | 0 | low | 1 | 0 |
capsazepine | 0 | low | 9 | 0 |
fumonisin b1 | 0 | low | 1 | 0 |
1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole | 0 | low | 3 | 0 |
2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide | 0 | low | 2 | 0 |
tamoxifen | 0 | low | 6 | 0 |
tocopherylquinone | 0 | low | 1 | 0 |
nadp | 0 | medium | 46 | 2 |
1,1-diphenyl-2-picrylhydrazyl | 0 | medium | 12 | 1 |
hc-067047 | 0 | low | 1 | 0 |
stattic | 0 | low | 3 | 0 |
2-nitro-5-(phenylsulfonyl)phenyl 4-chlorobenzoate | 0 | low | 1 | 0 |
krn 7000 | 0 | low | 4 | 0 |
sirtinol | 0 | low | 4 | 0 |
methyl-thiohydantoin-tryptophan | 0 | low | 31 | 0 |
zeranol | 0 | low | 2 | 0 |
valinomycin | 0 | low | 1 | 0 |
thiopental | 0 | medium | 15 | 3 |
estrone sulfate | 0 | low | 1 | 0 |
ranitidine | 0 | low | 8 | 0 |
maraviroc | 0 | low | 1 | 0 |
u 0126 | 0 | low | 25 | 0 |
tetomilast | 0 | low | 2 | 0 |
6-methyl-2-(phenylethynyl)pyridine | 0 | low | 2 | 0 |
lithium | 0 | low | 10 | 0 |
cobaltous chloride | 0 | low | 20 | 0 |
nitrogen dioxide | 0 | medium | 3 | 2 |
dermatan sulfate | 0 | low | 2 | 0 |
orlistat | 0 | low | 3 | 0 |
idoxifene | 0 | low | 2 | 0 |
quinine | 0 | low | 1 | 0 |
aprikalim | 0 | low | 2 | 0 |
n-benzyloxycarbonyl-valyl-phenylalanine methyl ester | 0 | low | 2 | 0 |
kaurenoic acid | 0 | low | 1 | 0 |
1,2-bis(2-aminophenoxy)ethane n,n,n',n'-tetraacetic acid acetoxymethyl ester | 0 | low | 1 | 0 |
indium oxine | 0 | low | 1 | 0 |
thymidine glycol | 0 | medium | 2 | 1 |
2,2-dimethyl-5-hydroxy-1-pyrrolidinyloxy | 0 | low | 1 | 0 |
mdl 72527 | 0 | low | 1 | 0 |
rtki cpd | 0 | low | 2 | 0 |
2,4-dinitrofluorobenzene sulfonic acid | 0 | low | 1 | 0 |
dimethyl(2-hydroxy-5-nitrobenzyl)sulfonium | 0 | low | 1 | 0 |
n-tert-butyl-alpha-(4-nitrophenyl)nitrone | 0 | low | 1 | 0 |
gea 3162 | 0 | low | 1 | 0 |
4-phenyl-1-(4-phenylbutyl)piperidine | 0 | low | 2 | 0 |
8-bromoguanosino-3',5'-cyclic monophosphorothioate | 0 | low | 1 | 0 |
2-chloro-n(6)-(3-iodobenzyl)adenosine-5'-n-methyluronamide | 0 | low | 4 | 0 |
thioperamide | 0 | low | 4 | 0 |
arg-(3-hyp-5-thi-7-tic-9-oic)-9-desarg-bradykinin | 0 | low | 1 | 0 |
cystine | 0 | medium | 6 | 2 |
u-50488 | 0 | low | 7 | 0 |
sch 23390 | 0 | low | 1 | 0 |
chaetomellic acid a | 0 | low | 2 | 0 |
clamikalant | 0 | low | 1 | 0 |
dimemorfan | 0 | low | 1 | 0 |
lamifiban | 0 | low | 1 | 0 |
fospropofol | 0 | low | 1 | 0 |
modipafant | 0 | low | 2 | 0 |
rasagiline | 0 | low | 2 | 0 |
safingol | 0 | low | 2 | 0 |
dasatinib | 0 | low | 1 | 0 |
ha 1100 | 0 | low | 2 | 0 |
oxalylglycine | 0 | low | 6 | 0 |
pelargonidin-3-glucoside | 0 | low | 1 | 0 |
glycyl-prolyl-glutamic acid | 0 | low | 1 | 0 |
2-(2-benzofuranyl)-2-imidazoline | 0 | low | 1 | 0 |
peptide t amide | 0 | low | 1 | 0 |
phosphoglyceroyl-atp | 0 | low | 1 | 0 |
dipalmitoylphosphatidylserine | 0 | low | 1 | 0 |
sc 52608 | 0 | low | 1 | 0 |
deuterohemin | 0 | low | 3 | 0 |
cytellin | 0 | low | 4 | 0 |
ginsenosides | 0 | low | 78 | 0 |
2-(4-(2-carboxyethyl)phenethylamino)-5'-n-ethylcarboxamidoadenosine | 0 | low | 13 | 0 |
2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline | 0 | low | 4 | 0 |
ovalbumin | 0 | low | 2 | 0 |
sw033291 | 0 | low | 1 | 0 |
gw 7647 | 0 | low | 1 | 0 |
sodium dodecyl sulfate | 0 | low | 1 | 0 |
blister | 0 | low | 3 | 0 |
crocin | 0 | low | 13 | 0 |
galactomannan | 0 | low | 1 | 0 |
ncs 382 | 0 | low | 1 | 0 |
mtt formazan | 0 | low | 4 | 0 |
2-chloro-5-hydroxyphenylglycine | 0 | low | 1 | 0 |
l 663536 | 0 | low | 10 | 0 |
6-cyano-7-nitroquinoxaline-2,3-dione | 0 | low | 3 | 0 |
2,4-dinitrophenylhydrazine | 0 | low | 1 | 0 |
6-hydrazinopyridine-3-carboxylic acid | 0 | low | 1 | 0 |
zinc protoporphyrin ix | 0 | low | 40 | 0 |
3-(2,4-dichloro-5-methoxyphenyl)-2-sulfanyl-4(3h)-quinazolinone | 0 | low | 11 | 0 |
sb 225002 | 0 | low | 1 | 0 |
fg 9041 | 0 | low | 5 | 0 |
alpha-chymotrypsin | 0 | low | 3 | 0 |
alpinetin | 0 | low | 1 | 0 |
ferrostatin-1 | 0 | low | 9 | 0 |
sew2871 | 0 | low | 6 | 0 |
tetramethylrhodamine isothiocyanate | 0 | low | 1 | 0 |
4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione | 0 | low | 12 | 0 |
naphthoquinones | 0 | low | 10 | 0 |
2',3'-dialdehyde atp | 0 | low | 1 | 0 |
jhw 015 | 0 | low | 1 | 0 |
am 630 | 0 | low | 2 | 0 |
sc 560 | 0 | low | 5 | 0 |
osteoprotegerin | 0 | low | 2 | 0 |
cathepsin g | 0 | low | 2 | 0 |
1-cyclohexyl-3-dodecylurea | 0 | low | 1 | 0 |
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1h-imidazol-2-yl)benzamide | 0 | low | 1 | 0 |
rhodamine 123 | 0 | low | 12 | 0 |
myelin basic protein | 0 | low | 7 | 0 |
ex 527 | 0 | low | 4 | 0 |
tetrathiomolybdate | 0 | low | 1 | 0 |
diethyl maleate | 0 | low | 6 | 0 |
ginkgetin | 0 | low | 1 | 0 |
fraxin | 0 | low | 2 | 0 |
fraxetin | 0 | low | 1 | 0 |
eupatilin | 0 | low | 4 | 0 |
ku 55933 | 0 | low | 1 | 0 |
sphingosine | 0 | low | 84 | 0 |
quercetin | 0 | low | 82 | 0 |
ubiquinone q2 | 0 | low | 1 | 0 |
bilirubin | 0 | medium | 86 | 6 |
dinoprostone | 0 | medium | 100 | 1 |
dinoprost | 0 | medium | 32 | 1 |
biochanin a | 0 | low | 2 | 0 |
formononetin | 0 | medium | 4 | 1 |
prostaglandin b1 | 0 | low | 1 | 0 |
arachidonyltrifluoromethane | 0 | low | 2 | 0 |
vitexin | 0 | low | 5 | 0 |
apigenin | 0 | low | 29 | 0 |
luteolin | 0 | medium | 22 | 2 |
7,3'-dihydroxy-4'-methoxyisoflavone | 0 | low | 11 | 0 |
linoleic acid | 0 | low | 8 | 0 |
calcitriol | 0 | low | 11 | 0 |
quercitrin | 0 | low | 2 | 0 |
scopoletin | 0 | low | 1 | 0 |
vitamin k semiquinone radical | 0 | low | 2 | 0 |
beta carotene | 0 | medium | 11 | 1 |
11-cis-retinal | 0 | low | 4 | 0 |
leukotriene b4 | 0 | medium | 49 | 1 |
leukotriene c4 | 0 | low | 17 | 0 |
thromboxane a2 | 0 | low | 41 | 0 |
hymecromone | 0 | low | 1 | 0 |
daphnetin | 0 | low | 2 | 0 |
8,11,14-eicosatrienoic acid | 0 | medium | 15 | 1 |
luteolin-7-glucoside | 0 | low | 1 | 0 |
alprostadil | 0 | medium | 98 | 5 |
5-hydroxy-6,8,11,14-eicosatetraenoic acid | 0 | medium | 1 | 1 |
vitamin d 2 | 0 | low | 5 | 0 |
stigmasterol | 0 | low | 3 | 0 |
cholecalciferol | 0 | medium | 9 | 1 |
rutin | 0 | medium | 22 | 3 |
kaempferol | 0 | low | 4 | 0 |
leukotriene d4 | 0 | low | 1 | 0 |
15-ketoprostaglandin f2alpha | 0 | low | 1 | 0 |
6-ketoprostaglandin f1 alpha | 0 | medium | 57 | 1 |
6-ketoprostaglandin e1 | 0 | low | 1 | 0 |
lipoxin a4 | 0 | low | 14 | 0 |
alpha-linolenic acid | 0 | low | 4 | 0 |
prostaglandin f1 | 0 | low | 5 | 0 |
genistein | 0 | low | 26 | 0 |
eprosartan | 0 | low | 3 | 0 |
montelukast | 0 | low | 17 | 0 |
entacapone | 0 | low | 3 | 0 |
paricalcitol | 0 | low | 5 | 0 |
petroselinic acid | 0 | low | 1 | 0 |
butein | 0 | low | 1 | 0 |
astaxanthine | 0 | low | 22 | 0 |
fucoxanthin | 0 | low | 2 | 0 |
lutein | 0 | low | 10 | 0 |
esculetin | 0 | low | 2 | 0 |
esculin | 0 | low | 1 | 0 |
7-hydroxycoumarin | 0 | low | 1 | 0 |
humulene | 0 | medium | 2 | 2 |
oleuropein | 0 | medium | 9 | 2 |
garcinol | 0 | low | 1 | 0 |
baicalein | 0 | medium | 19 | 4 |
chrysin | 0 | low | 9 | 0 |
diosmetin | 0 | low | 4 | 0 |
diosmin | 0 | medium | 21 | 1 |
fisetin | 0 | low | 5 | 0 |
galangin | 0 | low | 3 | 0 |
gossypin | 0 | low | 1 | 0 |
hispidulin | 0 | low | 2 | 0 |
hyperoside | 0 | low | 6 | 0 |
mangiferin | 0 | low | 6 | 0 |
mangostin | 0 | low | 4 | 0 |
morin | 0 | low | 5 | 0 |
morusin | 0 | medium | 2 | 2 |
myricetin | 0 | low | 5 | 0 |
myricitrin | 0 | low | 1 | 0 |
orientin | 0 | low | 2 | 0 |
scutellarein | 0 | low | 4 | 0 |
tricin | 0 | low | 2 | 0 |
wogonin | 0 | low | 1 | 0 |
daidzein | 0 | low | 5 | 0 |
trans-2,3',4,5'-tetrahydroxystilbene | 0 | low | 1 | 0 |
pterostilbene | 0 | low | 11 | 0 |
echinacoside | 0 | low | 3 | 0 |
forsythiaside | 0 | low | 1 | 0 |
caffeic acid phenethyl ester | 0 | low | 33 | 0 |
rosmarinic acid | 0 | medium | 11 | 2 |
salvianolic acid a | 0 | low | 27 | 0 |
shogaol | 0 | low | 2 | 0 |
acteoside | 0 | low | 6 | 0 |
4'-methoxy-3',5,7-trihydroxyisoflavone | 0 | low | 1 | 0 |
rottlerin | 0 | low | 6 | 0 |
ellagic acid | 0 | low | 9 | 0 |
coenzyme q10 | 0 | medium | 40 | 1 |
anandamide | 0 | low | 12 | 0 |
astragalin | 0 | low | 3 | 0 |
cilnidipine | 0 | low | 1 | 0 |
plaunotol | 0 | low | 1 | 0 |
geranylgeranylacetone | 0 | low | 13 | 0 |
sofalcone | 0 | low | 1 | 0 |
travoprost | 0 | low | 1 | 0 |
tranilast | 0 | low | 1 | 0 |
4-acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic acid | 0 | low | 2 | 0 |
8-epi-prostaglandin f2alpha | 0 | medium | 24 | 1 |
glyceryl 2-arachidonate | 0 | low | 4 | 0 |
n,n-dimethylsphingenine | 0 | low | 3 | 0 |
menatetrenone | 0 | low | 1 | 0 |
misoprostol | 0 | low | 7 | 0 |
dothiepin hydrochloride | 0 | low | 1 | 0 |
ozagrel | 0 | low | 16 | 0 |
fondaparinux | 0 | low | 5 | 0 |
pibutidine hydrochloride | 0 | low | 1 | 0 |
pitavastatin | 0 | low | 3 | 0 |
15-keto-13,14-dihydroprostaglandin f2alpha | 0 | low | 2 | 0 |
16,16-dimethylprostaglandin e2 | 0 | low | 1 | 0 |
2,3-dinor-6-ketoprostaglandin f1alpha | 0 | low | 1 | 0 |
thromboxane b2 | 0 | medium | 87 | 4 |
2,3-dinor-thromboxane b2 | 0 | low | 1 | 0 |
thromboxane b3 | 0 | low | 1 | 0 |
14,15-dihydroxyeicosatrienoic acid | 0 | low | 1 | 0 |
20-hydroxy-5,8,11,14-eicosatetraenoic acid | 0 | low | 19 | 0 |
arachidonic acid 5-hydroperoxide | 0 | low | 1 | 0 |
8,9-epoxyeicosatrienoic acid | 0 | low | 1 | 0 |
2-nonenal, (trans)-isomer | 0 | low | 1 | 0 |
4-hydroxy-2-nonenal | 0 | low | 56 | 0 |
linoleoyl ethanolamide | 0 | low | 1 | 0 |
n-oleoylethanolamine | 0 | low | 3 | 0 |
ubiquinone 8 | 0 | medium | 2 | 2 |
menaquinone 6 | 0 | medium | 2 | 1 |
sphingosine 1-phosphate | 0 | low | 48 | 0 |
diminazene aceturate | 0 | low | 4 | 0 |
dorzolamide | 0 | low | 1 | 0 |
levetiracetam | 0 | low | 2 | 0 |
nalmefene | 0 | low | 2 | 0 |
naloxone | 0 | low | 25 | 0 |
oxycodone | 0 | low | 3 | 0 |
vitamin k 1 | 0 | low | 1 | 0 |
sirolimus | 0 | medium | 105 | 1 |
topiramate | 0 | low | 3 | 0 |
menaquinone 7 | 0 | medium | 1 | 1 |
alvocidib | 0 | low | 1 | 0 |
17-(dimethylaminoethylamino)-17-demethoxygeldanamycin | 0 | low | 2 | 0 |
morphine | 0 | low | 39 | 0 |
lysophosphatidylglycerol | 0 | low | 1 | 0 |
ar-r 17779 | 0 | low | 2 | 0 |
3-(2,4-dimethoxybenzylidene)anabaseine | 0 | low | 2 | 0 |
a 192621 | 0 | low | 2 | 0 |
adp beta s | 0 | low | 1 | 0 |
arachidonylcyclopropylamide | 0 | low | 1 | 0 |
beta-funaltrexamine | 0 | low | 2 | 0 |
bibp 3226 | 0 | low | 2 | 0 |
bimatoprost | 0 | low | 2 | 0 |
cloprostenol | 0 | low | 1 | 0 |
deamino arginine vasopressin | 0 | low | 2 | 0 |
dexmedetomidine | 0 | medium | 179 | 12 |
ly 344864 | 0 | low | 1 | 0 |
fluticasone | 0 | medium | 2 | 2 |
herbimycin | 0 | low | 3 | 0 |
fr 173657 | 0 | low | 3 | 0 |
kallidin | 0 | low | 1 | 0 |
iloprost | 0 | low | 58 | 0 |
l 365260 | 0 | low | 1 | 0 |
15-deoxy-delta(12,14)-prostaglandin j2 | 0 | low | 3 | 0 |
latanoprost | 0 | low | 2 | 0 |
ono-di-004 | 0 | low | 1 | 0 |
ly 320135 | 0 | low | 1 | 0 |
ly 334370 | 0 | low | 1 | 0 |
lysophosphatidic acid | 0 | low | 6 | 0 |
lysophosphatidylcholines | 0 | low | 5 | 0 |
mdl 100907 | 0 | low | 2 | 0 |
n-(n-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester | 0 | low | 6 | 0 |
nateglinide | 0 | low | 1 | 0 |
ono 3708 | 0 | low | 6 | 0 |
pd 123319 | 0 | low | 7 | 0 |
sq 30741 | 0 | low | 2 | 0 |
sq 29548 | 0 | low | 4 | 0 |
kn 93 | 0 | low | 2 | 0 |
kn 62 | 0 | low | 2 | 0 |
s 145 | 0 | low | 1 | 0 |
biliverdine | 0 | low | 24 | 0 |
syringin | 0 | low | 3 | 0 |
linarin | 0 | low | 3 | 0 |
ethyl caffeate | 0 | low | 1 | 0 |
hexahydrocurcumin | 0 | low | 2 | 0 |
calycosin-7-o-beta-d-glucopyranoside | 0 | low | 1 | 0 |
andrographolide | 0 | low | 4 | 0 |
isorhapontigenin | 0 | low | 3 | 0 |
kaempferol-3-o-rutinoside | 0 | low | 2 | 0 |
icaritin | 0 | low | 3 | 0 |
icariin | 0 | low | 8 | 0 |
licochalcone a | 0 | low | 1 | 0 |
ligustilide | 0 | low | 7 | 0 |
3'-methoxypuerarin | 0 | low | 1 | 0 |
5,7-dihydroxy-4',6-dimethoxyflavone | 0 | low | 1 | 0 |
tilianin | 0 | low | 1 | 0 |
caryophyllene | 0 | low | 10 | 0 |
1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3h-cyclopenta(c)quinolin-8-yl)ethanone | 0 | low | 1 | 0 |
malealdehyde | 0 | low | 1 | 0 |
fluvoxamine | 0 | low | 2 | 0 |
casein kinase ii | 0 | low | 9 | 0 |
ag 556 | 0 | low | 2 | 0 |
ag-490 | 0 | low | 22 | 0 |
su 11248 | 0 | low | 4 | 0 |
ergothioneine | 0 | low | 4 | 0 |
lead | 0 | medium | 5 | 2 |
12-hydroxy-5,8,10,14-eicosatetraenoic acid | 0 | medium | 9 | 2 |
15-hydroxy-5,8,11,13-eicosatetraenoic acid | 0 | medium | 1 | 1 |
6,7-dihydroxyflavone | 0 | low | 3 | 0 |
8-(3-chlorostyryl)caffeine | 0 | low | 3 | 0 |
4-amylcinnamoylanthranilic acid | 0 | low | 2 | 0 |
bay 11-7082 | 0 | low | 7 | 0 |
bay 11-7085 | 0 | low | 2 | 0 |
5,5',6,6'-tetrachloro-1,1',3,3'-tetraethylbenzimidazolocarbocyanine | 0 | low | 2 | 0 |
diamide | 0 | low | 2 | 0 |
15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid | 0 | low | 7 | 0 |
antimony | 0 | low | 1 | 0 |
barium | 0 | low | 1 | 0 |
strontium | 0 | medium | 2 | 2 |
bismuth | 0 | medium | 4 | 4 |
thallium | 0 | low | 1 | 0 |
arsenic | 0 | medium | 4 | 1 |
naltrexone | 0 | low | 16 | 0 |
dextromethorphan | 0 | low | 6 | 0 |
dextrorphan | 0 | low | 1 | 0 |
gallium | 0 | medium | 4 | 2 |
butorphanol | 0 | low | 1 | 0 |
lisinopril | 0 | low | 3 | 0 |
ramipril | 0 | low | 6 | 0 |
batimastat | 0 | low | 1 | 0 |
indinavir sulfate | 0 | low | 1 | 0 |
sulfur | 0 | medium | 6 | 2 |
geldanamycin | 0 | low | 4 | 0 |
musk | 0 | low | 4 | 0 |
costunolide | 0 | low | 1 | 0 |
plastoquinone | 0 | low | 5 | 0 |
puerarin | 0 | low | 28 | 0 |
bedaquiline | 0 | low | 1 | 0 |
sanglifehrin a | 0 | low | 2 | 0 |
enalapril | 0 | low | 14 | 0 |
ternatin (flavonoid) | 0 | low | 1 | 0 |
sinomenine | 0 | low | 5 | 0 |
ecdysterone | 0 | low | 4 | 0 |
deoxyribose | 0 | low | 2 | 0 |
fumarates | 0 | low | 14 | 0 |
phycocyanobilin | 0 | low | 1 | 0 |
cysteine | 0 | medium | 41 | 2 |
indium | 0 | low | 1 | 0 |
phosphorus | 0 | medium | 20 | 3 |
boron | 0 | medium | 3 | 2 |
enalaprilat anhydrous | 0 | low | 4 | 0 |
2,2'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid | 0 | low | 1 | 0 |
ramiprilat | 0 | low | 4 | 0 |
nitecapone | 0 | low | 1 | 0 |
imidapril | 0 | low | 1 | 0 |
2,3-dehydrosilybin | 0 | low | 1 | 0 |
bakuchiol | 0 | low | 1 | 0 |
panaxynol | 0 | low | 1 | 0 |
poricoic acid a | 0 | low | 1 | 0 |
pepstatin | 0 | low | 2 | 0 |
cefepime | 0 | medium | 1 | 1 |
norbinaltorphimine | 0 | low | 5 | 0 |
monodehydroascorbate | 0 | low | 2 | 0 |
pachymic acid | 0 | low | 2 | 0 |
ici 118551 | 0 | low | 3 | 0 |
enkephalin, ala(2)-mephe(4)-gly(5)- | 0 | low | 2 | 0 |
licostinel | 0 | low | 1 | 0 |
6-(1h-imidazol-1-yl)-7-nitro-2,3(1h,4h)-quinoxalinedione | 0 | low | 1 | 0 |
troxerutin | 0 | low | 2 | 0 |
pregabalin | 0 | medium | 7 | 1 |
biphalin | 0 | low | 1 | 0 |
3,8-dihydroxy-6h-dibenzo(b,d)pyran-6-one | 0 | low | 2 | 0 |
baohuoside i | 0 | low | 6 | 0 |
oxyhyponitrite | 0 | low | 2 | 0 |
aliskiren | 0 | low | 7 | 0 |
n-acetylsphingosine | 0 | low | 1 | 0 |
triolein | 0 | low | 2 | 0 |
docosapentaenoic acid | 0 | low | 1 | 0 |
naltrindole | 0 | low | 5 | 0 |
guanabenz | 0 | low | 1 | 0 |
resiniferatoxin | 0 | low | 2 | 0 |
3,3'-dioctadecylindocarbocyanine | 0 | low | 1 | 0 |
carbocyanines | 0 | low | 10 | 0 |
salubrinal | 0 | low | 3 | 0 |
3-(3-pyridinyl)-1-(4-pyridinyl)-2-propen-1-one | 0 | low | 1 | 0 |
cefotaxime | 0 | low | 1 | 0 |
semapimod | 0 | low | 4 | 0 |
4-(4-dihexadecylaminostyryl)-n-methylpyridium | 0 | low | 1 | 0 |
1,2-dielaidoylphosphatidylethanolamine | 0 | low | 1 | 0 |
ammonium sulfate | 0 | low | 1 | 0 |
bisabolol | 0 | low | 2 | 0 |
4,4'-diisothiocyanostilbene-2,2'-disulfonic acid | 0 | low | 5 | 0 |
proguanil | 0 | low | 1 | 0 |
am-356 | 0 | low | 1 | 0 |
ma-1 | 0 | medium | 1 | 1 |
monorden | 0 | low | 2 | 0 |
coomassie brilliant blue | 0 | low | 2 | 0 |
ono 1301 | 0 | low | 2 | 0 |
tetrodotoxin | 0 | low | 11 | 0 |
germanium | 0 | low | 3 | 0 |
selenium | 0 | medium | 37 | 1 |
selenocysteine | 0 | low | 2 | 0 |
tellurium | 0 | low | 1 | 0 |
oxalates | 0 | low | 1 | 0 |
pyroantimonate | 0 | low | 1 | 0 |
(3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid | 0 | low | 3 | 0 |
maxacalcitol | 0 | low | 1 | 0 |
fk 409 | 0 | low | 19 | 0 |
mevalonolactone | 0 | low | 1 | 0 |
raubasine | 0 | low | 1 | 0 |
dizocilpine maleate | 0 | medium | 50 | 2 |
antimycin a | 0 | low | 13 | 0 |
caldaret | 0 | low | 1 | 0 |
eniporide | 0 | low | 3 | 0 |
zoniporide | 0 | low | 3 | 0 |
bongkrekic acid | 0 | low | 1 | 0 |
cilastatin | 0 | low | 1 | 0 |
dithiadene | 0 | low | 1 | 0 |
latrunculin b | 0 | low | 1 | 0 |
bafilomycin a1 | 0 | low | 1 | 0 |
germacrone | 0 | low | 2 | 0 |
carboprostacyclin | 0 | low | 1 | 0 |
1-oleoyl-2-acetylglycerol | 0 | low | 1 | 0 |
15-hydroperoxy-5,8,11,13-eicosatetraenoic acid | 0 | low | 1 | 0 |
myxothiazol | 0 | low | 2 | 0 |
plastochromanol 8 | 0 | low | 2 | 0 |
ono 4057 | 0 | low | 2 | 0 |
op 2507 | 0 | low | 5 | 0 |
limaprost | 0 | low | 1 | 0 |
2-(4-amylcinnamoyl)amino-4-chlorobenzoic acid | 0 | low | 1 | 0 |
thermozymocidin | 0 | low | 1 | 0 |
2,3,5,4'-tetrahydroxystilbene 2-o-glucopyranoside | 0 | low | 4 | 0 |
tautomycetin | 0 | low | 1 | 0 |
tmk 688 | 0 | low | 1 | 0 |
n,n,n-trimethylsphingosine | 0 | low | 3 | 0 |
aj 3941 | 0 | low | 1 | 0 |
1,1'-(4,4,7,7-tetramethyl-4,7-diazaundecamethylene)bis-4-(3-methyl-2,3-dihydro(benzo-1,3-thiazole)-2-methylidene)quinolinium | 0 | low | 1 | 0 |
disufenton sodium | 0 | low | 2 | 0 |
eicosa-5,11,14-trienoic acid | 0 | low | 1 | 0 |
op 41483-alpha-cyclodextrin | 0 | low | 1 | 0 |
everolimus | 0 | low | 11 | 0 |
fk 352 | 0 | low | 1 | 0 |
isoliquiritin apioside | 0 | low | 1 | 0 |
hydroxysafflor yellow a | 0 | low | 22 | 0 |
u 75302 | 0 | low | 2 | 0 |
b 1287 | 0 | low | 1 | 0 |
asialo gm1 ganglioside | 0 | low | 1 | 0 |
zy 17617b | 0 | low | 1 | 0 |
axitinib | 0 | medium | 1 | 1 |
ovatodiolide | 0 | low | 1 | 0 |
salvianolic acid B | 0 | low | 27 | 0 |
i(3)so3-galactosylceramide | 0 | low | 7 | 0 |
l 744832 | 0 | low | 1 | 0 |
trilobatin | 0 | low | 1 | 0 |
technetium tc 99m pyrophosphate | 0 | low | 8 | 0 |
engeletin | 0 | low | 2 | 0 |
glucuronyl glucosamine glycan sulfate | 0 | low | 2 | 0 |
brazilein | 0 | low | 2 | 0 |
(melle-4)cyclosporin | 0 | low | 8 | 0 |
beta-escin | 0 | low | 7 | 0 |
cyclosporin h | 0 | low | 1 | 0 |
tanespimycin | 0 | low | 1 | 0 |
verlukast | 0 | low | 3 | 0 |
gw 1929 | 0 | low | 3 | 0 |
isbogrel | 0 | low | 2 | 0 |
beta-escin | 0 | low | 102 | 0 |
glucoraphanin | 0 | low | 1 | 0 |
s-nitroso-n-acetylpenicillamine | 0 | low | 2 | 0 |
nitrofurantoin | 0 | low | 1 | 0 |
ro 25-6981 | 0 | low | 1 | 0 |
lactacystin | 0 | low | 3 | 0 |
ca 074 methyl ester | 0 | low | 1 | 0 |
echinocystic acid | 0 | low | 1 | 0 |
gadolinium dtpa | 0 | medium | 15 | 1 |
morphinans | 0 | low | 6 | 0 |
snj-1945 | 0 | low | 1 | 0 |
sq-23377 | 0 | low | 4 | 0 |
eritoran | 0 | low | 3 | 0 |
fostriecin | 0 | low | 1 | 0 |
fk 866 | 0 | low | 2 | 0 |
enkephalin, leucine-2-alanine | 0 | low | 16 | 0 |
enkephalin-leu, ala(2)-arg(6)- | 0 | low | 1 | 0 |
beraprost | 0 | low | 3 | 0 |
vapiprost | 0 | low | 2 | 0 |
hexarelin | 0 | low | 2 | 0 |
pki 166 | 0 | low | 1 | 0 |
bn 80933 | 0 | low | 1 | 0 |
lu 208075 | 0 | low | 7 | 0 |
jwh-133 | 0 | low | 5 | 0 |
omtriptolide | 0 | low | 1 | 0 |
vildagliptin | 0 | low | 7 | 0 |
pep005 | 0 | low | 1 | 0 |
corosolic acid | 0 | low | 1 | 0 |
rebaudioside a | 0 | low | 2 | 0 |
isoborneol | 0 | low | 15 | 0 |
staurosporine | 0 | low | 1 | 0 |
shu 508 | 0 | low | 1 | 0 |
hypericum | 0 | low | 6 | 0 |
phosphocreatine | 0 | medium | 73 | 1 |
sl 327 | 0 | low | 1 | 0 |
formazans | 0 | low | 6 | 0 |
guanoxabenz | 0 | low | 1 | 0 |
s 1743 | 0 | low | 2 | 0 |
triacsin c | 0 | low | 1 | 0 |
s-nitrosocysteine | 0 | low | 1 | 0 |
s-allylcysteine | 0 | low | 7 | 0 |
3-((2-methyl-1,3-thiazol-4-yl)ethynyl)piperidine | 0 | low | 1 | 0 |
bo 653 | 0 | low | 1 | 0 |
ns 7 | 0 | low | 1 | 0 |
gw 501516 | 0 | low | 2 | 0 |
lexipafant | 0 | low | 5 | 0 |
atl 146e | 0 | low | 17 | 0 |
bay 58-2667 | 0 | low | 2 | 0 |
acth (4-7), pro-gly-pro- | 0 | low | 2 | 0 |
bimosiamose | 0 | low | 1 | 0 |
sacubitril | 0 | low | 1 | 0 |
ts-011 | 0 | low | 1 | 0 |
sappanone a | 0 | low | 1 | 0 |
1-(2,4-dichlorobenzyl)indazole-3-carbohydrazide | 0 | low | 2 | 0 |
bicyclol | 0 | low | 3 | 0 |
kb r7943 | 0 | low | 15 | 0 |
rosavin | 0 | low | 1 | 0 |
arl 17477 | 0 | low | 2 | 0 |
seryl-leucyl-isoleucyl-glycyl--arginyl-leucinamide | 0 | low | 1 | 0 |
jasplakinolide | 0 | low | 1 | 0 |
davunetide | 0 | low | 1 | 0 |
sincalide | 0 | low | 3 | 0 |
pd 150606 | 0 | low | 2 | 0 |
etomoxir | 0 | low | 2 | 0 |
licochalcone c | 0 | low | 1 | 0 |
n(6)-cyclohexyladenosine | 0 | low | 1 | 0 |
ursodoxicoltaurine | 0 | medium | 19 | 1 |
ginsenoside m1 | 0 | low | 1 | 0 |
bms201038 | 0 | low | 1 | 0 |
cangrelor | 0 | low | 1 | 0 |
knk 437 | 0 | low | 1 | 0 |
gc 1 compound | 0 | low | 1 | 0 |
mocetinostat | 0 | medium | 1,048 | 16 |
sc 236 | 0 | low | 2 | 0 |
alloin | 0 | low | 1 | 0 |
cp 105696 | 0 | low | 2 | 0 |
remimazolam | 0 | low | 1 | 0 |
sabiporide | 0 | low | 2 | 0 |
fimasartan | 0 | low | 1 | 0 |
ticagrelor | 0 | medium | 8 | 2 |
rivaroxaban | 0 | low | 1 | 0 |
lipid a | 0 | medium | 8 | 2 |
gpi 6150 | 0 | low | 1 | 0 |
dehydroxymethylepoxyquinomicin | 0 | low | 2 | 0 |
n-((1s,trans)-2-hydroxycyclopentyl)adenosine | 0 | low | 1 | 0 |
sja 6017 | 0 | low | 2 | 0 |
xestospongin a | 0 | low | 1 | 0 |
gw 4064 | 0 | low | 1 | 0 |
shu 9119 | 0 | low | 1 | 0 |
ginsenoside rb1 | 0 | low | 22 | 0 |
g(m2) ganglioside | 0 | low | 1 | 0 |
cholest-5-en-3-one | 0 | low | 1 | 0 |
ornithine alpha-ketoglutarate | 0 | low | 3 | 0 |
thiocolchicoside | 0 | medium | 2 | 2 |
mitoquinol | 0 | low | 1 | 0 |
ginsenoside rg3 | 0 | low | 3 | 0 |
sorbitan monooleate | 0 | medium | 1 | 1 |
tocotrienols | 0 | low | 1 | 0 |
ssr180575 | 0 | low | 1 | 0 |
rucaparib | 0 | medium | 2 | 2 |
vulm 1457 | 0 | low | 2 | 0 |
gw0742 | 0 | low | 2 | 0 |
ono 8713 | 0 | low | 1 | 0 |
jte 607 | 0 | low | 1 | 0 |
rotigaptide | 0 | medium | 1 | 1 |
pasireotide | 0 | low | 1 | 0 |
s 5682 | 0 | low | 3 | 0 |
bpc 157 | 0 | low | 3 | 0 |
zeolites | 0 | medium | 3 | 1 |
pitolisant | 0 | medium | 1 | 1 |
3,4-dihydro-5-(4-(1-piperidinyl)butoxy)-1(2h)-isoquinolinone | 0 | low | 1 | 0 |
tetramethylrhodamine | 0 | low | 1 | 0 |
1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine dihydrochloride | 0 | low | 1 | 0 |
acetyl-prolyl-histidyl-seryl-cysteinyl-asparaginamide | 0 | low | 1 | 0 |
ubiquinol | 0 | low | 5 | 0 |
g(m1) ganglioside | 0 | low | 12 | 0 |
vortioxetine | 0 | low | 1 | 0 |
lipoxin a4 methyl ester | 0 | low | 1 | 0 |
aluminum oxide | 0 | medium | 2 | 2 |
rs 102895 | 0 | low | 1 | 0 |
cgp 20712a | 0 | low | 2 | 0 |
n-(1-methylethyl)-1,1,2-trimethylpropylamine | 0 | low | 1 | 0 |
methionine sulfoxide | 0 | low | 2 | 0 |
vorapaxar | 0 | low | 3 | 0 |
ly-2157299 | 0 | low | 1 | 0 |
givinostat hydrochloride | 0 | low | 1 | 0 |
linagliptin | 0 | low | 2 | 0 |
cystathionine | 0 | low | 2 | 0 |
as 601245 | 0 | low | 2 | 0 |
pazopanib | 0 | low | 1 | 0 |
tribulus | 0 | low | 3 | 0 |
phenobarbital sodium | 0 | low | 2 | 0 |
am 1241 | 0 | low | 3 | 0 |
1-(2-(1-adamantyl)ethyl)-1-pentyl-3-(3-(4-pyridyl)propyl)urea | 0 | low | 1 | 0 |
act 058362 | 0 | low | 1 | 0 |
dimethylarginine | 0 | low | 5 | 0 |
m 40403 | 0 | low | 4 | 0 |
artenimol | 0 | medium | 3 | 2 |
homocarnosine | 0 | low | 1 | 0 |
decanoylcarnitine | 0 | low | 1 | 0 |
nodosin | 0 | low | 2 | 0 |
dibudipine | 0 | low | 1 | 0 |
trans-sodium crocetinate | 0 | low | 3 | 0 |
sotrastaurin | 0 | low | 2 | 0 |
alpha-synuclein | 0 | low | 4 | 0 |
8-nitroxanthine | 0 | low | 1 | 0 |
macelignan | 0 | low | 1 | 0 |
mebudipine | 0 | low | 2 | 0 |
erinacine a | 0 | low | 1 | 0 |
tg100-115 | 0 | low | 1 | 0 |
cc 401 | 0 | low | 1 | 0 |
4-hna | 0 | low | 1 | 0 |
oxadiazoles | 0 | medium | 18 | 2 |
sch 442416 | 0 | low | 1 | 0 |
aloperine | 0 | low | 1 | 0 |
nigranoic acid | 0 | low | 1 | 0 |
ribose | 0 | low | 2 | 0 |
urb602 | 0 | low | 2 | 0 |
acebutolol | 0 | medium | 3 | 1 |
8-oxo-2'-deoxyadenosine | 0 | low | 1 | 0 |
lactulose | 0 | medium | 5 | 2 |
gilvocarcin v | 0 | low | 1 | 0 |
regorafenib | 0 | medium | 1 | 1 |
lodoxamide tromethamine | 0 | low | 1 | 0 |
calpain inhibitor iii | 0 | low | 3 | 0 |
2-amino-4-(3,4-(methylenedioxy)benzylamino)-6-(3-methoxyphenyl)pyrimidine | 0 | low | 1 | 0 |
erastin | 0 | low | 3 | 0 |
px 478 | 0 | low | 1 | 0 |
brimonidine tartrate | 0 | low | 5 | 0 |
pnu-282987 | 0 | low | 3 | 0 |
3-cyano-n-(1,3-diphenyl-1h-pyrazol-5-yl)benzamide | 0 | low | 1 | 0 |
fg-4592 | 0 | low | 3 | 0 |
bay 63-2521 | 0 | low | 2 | 0 |
triglycerides | 0 | low | 1 | 0 |
np 031112 | 0 | low | 1 | 0 |
resolvin d2 | 0 | low | 2 | 0 |
mitoquinone | 0 | low | 12 | 0 |
ks370g | 0 | low | 1 | 0 |
vx 765 | 0 | low | 3 | 0 |
bms 747158-02 | 0 | low | 1 | 0 |
technetium tc 99m disofenin | 0 | low | 1 | 0 |
technetium tc 99m mebrofenin | 0 | low | 2 | 0 |
9-(benzoyloxy)-2-(3-furanyl)dodecahydro-6a,10b-dimethyl-4,10-dioxo-2h-naphtho(2,1-c)pyran-7-carboxylic acid methyl ester | 0 | low | 1 | 0 |
nutlin-3a | 0 | low | 1 | 0 |
ym 244769 | 0 | low | 1 | 0 |
alogliptin | 0 | low | 1 | 0 |
alisporivir | 0 | low | 1 | 0 |
bimosiamose disodium | 0 | low | 4 | 0 |
dorsomorphin | 0 | low | 2 | 0 |
hu 308 | 0 | low | 2 | 0 |
carfilzomib | 0 | medium | 2 | 2 |
sitagliptin phosphate | 0 | low | 13 | 0 |
col-144 | 0 | low | 1 | 0 |
veratridine | 0 | low | 2 | 0 |
atl 313 | 0 | low | 7 | 0 |
zstk474 | 0 | low | 1 | 0 |
fostamatinib | 0 | low | 3 | 0 |
ginsenoside rd | 0 | low | 4 | 0 |
lyoniresinol | 0 | low | 1 | 0 |
bay 60-6583 | 0 | low | 2 | 0 |
physalin b | 0 | low | 1 | 0 |
gpi 15427 | 0 | low | 1 | 0 |
losartan potassium | 0 | medium | 227 | 6 |
d-arg-dmt-lys-phe-nh2 | 0 | medium | 10 | 1 |
alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc | 0 | low | 13 | 0 |
empagliflozin | 0 | medium | 9 | 2 |
palmitoylcarnitine | 0 | low | 3 | 0 |
technetium tc 99m exametazime | 0 | low | 3 | 0 |
at 13387 | 0 | low | 1 | 0 |
agn 192403 | 0 | low | 1 | 0 |
calcimycin | 0 | low | 13 | 0 |
dihydroouabain | 0 | low | 1 | 0 |
dextrothyroxine | 0 | low | 1 | 0 |
ferryl iron | 0 | low | 1 | 0 |
sepharose | 0 | low | 1 | 0 |
indocyanine green | 0 | medium | 20 | 1 |
scopolamine hydrobromide | 0 | low | 3 | 0 |
dactolisib | 0 | low | 1 | 0 |
pituitrin | 0 | low | 9 | 0 |
virginiamycin | 0 | low | 1 | 0 |
n4-(2,2-dimethyl-3-oxo-4h-pyrid(1,4)oxazin-6-yl)-5-fluoro-n2-(3,4,5-trimethoxyphenyl)-2,4-pyrimidinediamine | 0 | low | 1 | 0 |
pyrostatin a | 0 | low | 1 | 0 |
n-monoacetylcystine | 0 | low | 1 | 0 |
5-ethoxycarbonyl-5-methyl-1-pyrroline n-oxide | 0 | low | 1 | 0 |
phytosterols | 0 | low | 1 | 0 |
trametenolic acid b | 0 | low | 1 | 0 |
enerbol | 0 | low | 2 | 0 |
nomilin | 0 | low | 1 | 0 |
tenuigenin | 0 | low | 1 | 0 |
taurodehydrocholate | 0 | low | 1 | 0 |
clove | 0 | low | 1 | 0 |
ginsenoside rb3 | 0 | low | 3 | 0 |
acid phosphatase | 0 | low | 13 | 0 |
aminoethyl-isothiourea | 0 | low | 2 | 0 |
ataprost | 0 | low | 7 | 0 |
ammonium citrate | 0 | low | 1 | 0 |
chikusetsu saponin iva | 0 | low | 1 | 0 |
(3z,6alpha,7alpha)-isomer of 3-butylidene-4,5,6,7-tetrahydro-6,7-dihydroxy-1(3h)-isobenzofuranone | 0 | low | 1 | 0 |
salvianolic acid c | 0 | low | 1 | 0 |
boeravinone b | 0 | low | 1 | 0 |
alisol b monoacetate | 0 | low | 1 | 0 |
glaucocalyxin b | 0 | low | 1 | 0 |
butaprost | 0 | low | 1 | 0 |
britannin | 0 | low | 1 | 0 |
lyoniside | 0 | low | 2 | 0 |
norisoboldine | 0 | low | 1 | 0 |
2',7'-dichlorodihydrofluorescein | 0 | low | 2 | 0 |
oregonin | 0 | low | 1 | 0 |
icatibant | 0 | medium | 22 | 1 |
jaw | 0 | low | 1 | 0 |
ankaflavin | 0 | low | 1 | 0 |
hmr 1098 | 0 | low | 2 | 0 |
cyanidin-3-o-beta-glucopyranoside | 0 | low | 8 | 0 |
nad | 0 | medium | 81 | 2 |
rrx-001 | 0 | low | 1 | 0 |
tin mesoporphyrin | 0 | low | 1 | 0 |
serofendic acid | 0 | low | 2 | 0 |
protectin d1 | 0 | low | 8 | 0 |
cytochrome c-t | 0 | low | 188 | 0 |
17,18-epoxy-5,8,11,14-eicosatetraenoic acid | 0 | low | 2 | 0 |
gw 4869 | 0 | low | 2 | 0 |
bisaramil | 0 | low | 1 | 0 |
cosyntropin | 0 | low | 1 | 0 |
cholecystokinin | 0 | low | 4 | 0 |
ceruletide | 0 | low | 5 | 0 |
motilin | 0 | low | 1 | 0 |
atrial natriuretic factor | 0 | medium | 48 | 3 |
cys(11)-cys(15)-endothelin-1 (11-21) | 0 | low | 1 | 0 |
xenin 25 | 0 | low | 1 | 0 |
hes1 protein, human | 0 | low | 1 | 0 |
cs1 peptide | 0 | low | 1 | 0 |
desferrioxamine b-succinyl-phenylalanine(1)-octreotide | 0 | low | 1 | 0 |
peptide i | 0 | low | 1 | 0 |
humanin | 0 | low | 7 | 0 |
nociceptin | 0 | low | 4 | 0 |
glucagon-like peptide 1 (7-36)amide | 0 | low | 1 | 0 |
gastrins | 0 | low | 7 | 0 |
glucagon | 0 | medium | 12 | 1 |
beta-endorphin | 0 | low | 1 | 0 |
thymosin beta(4) | 0 | low | 2 | 0 |
neuropeptide y | 0 | low | 9 | 0 |
conotoxin gv | 0 | low | 1 | 0 |
anaritide | 0 | low | 1 | 0 |
s6c sarafotoxin | 0 | low | 4 | 0 |
angiotensinogen | 0 | low | 6 | 0 |
astressin | 0 | low | 2 | 0 |
irl 1620 | 0 | low | 3 | 0 |
glucagon-like peptide 1 (7-36) | 0 | low | 1 | 0 |
cyn 154806 | 0 | low | 1 | 0 |
tannins | 0 | low | 5 | 0 |
oligonucleotides | 0 | low | 15 | 0 |
liraglutide | 0 | low | 8 | 0 |
ziconotide | 0 | low | 2 | 0 |
glucagon-like peptide 1 | 0 | medium | 21 | 1 |
incretins | 0 | low | 5 | 0 |
msh, 4-nle-7-phe-alpha- | 0 | low | 3 | 0 |
c-peptide | 0 | low | 4 | 0 |
natriuretic peptide, c-type | 0 | low | 2 | 0 |
exendin (9-39) | 0 | low | 1 | 0 |
pr 39 | 0 | low | 1 | 0 |
ristocetin | 0 | low | 1 | 0 |
cellulose | 0 | medium | 5 | 5 |
sodium borate | 0 | low | 1 | 0 |
endothelin-1 | 0 | medium | 195 | 1 |
phosphatidylcholines | 0 | low | 31 | 0 |
4-aminobenzoyl-glycyl-prolyl-leucyl-alanine hydroxamic acid | 0 | low | 1 | 0 |
atractyloside | 0 | low | 6 | 0 |
gap 134 | 0 | low | 3 | 0 |
1-(3,4-dihydroxyphenyl)-2-thiocyanate-ethanone | 0 | low | 1 | 0 |
azd 1480 | 0 | low | 1 | 0 |
chlorophyll a | 0 | low | 1 | 0 |
vendex | 0 | low | 1 | 0 |
3-(3-(4-((pyridin-2-yloxy)methyl)benzyl)isoxazol-5-yl)pyridin-2-amine | 0 | medium | 2 | 2 |
pevonedistat | 0 | low | 1 | 0 |
dihydroceramide | 0 | low | 2 | 0 |
nsc 23766 | 0 | low | 3 | 0 |
didymin | 0 | low | 1 | 0 |
adenosine kinase | 0 | low | 5 | 0 |
boc-d-fmk | 0 | low | 1 | 0 |
hoe 33342 | 0 | low | 2 | 0 |
sodium salicylate | 0 | low | 3 | 0 |
sphingosine kinase | 0 | low | 30 | 0 |
ubiquinone | 0 | medium | 72 | 3 |
pinoresinol | 0 | low | 1 | 0 |
s-nitrosopenicillamine | 0 | low | 1 | 0 |
calpain | 0 | medium | 93 | 1 |
lucifer yellow | 0 | low | 1 | 0 |
ginsenoside rh3 | 0 | low | 1 | 0 |
sapogenins | 0 | low | 1 | 0 |
ginsenoside rg2 | 0 | low | 1 | 0 |
scalaradial | 0 | low | 2 | 0 |
chitosan | 0 | medium | 11 | 1 |
1,2-bis(2-amino-5,6-difluorophenoxy)ethane-n,n,n',n'-tetraacetic acid | 0 | low | 1 | 0 |
nnc 55-0396 | 0 | low | 1 | 0 |
technetium tc 99m sestamibi | 0 | low | 6 | 0 |
15-deoxyprostaglandin j2 | 0 | low | 6 | 0 |
s-nitro-n-acetylpenicillamine | 0 | low | 7 | 0 |
mesna | 0 | low | 7 | 0 |
sodium oxybate | 0 | medium | 4 | 1 |
azuletil sodium | 0 | low | 1 | 0 |
bucladesine | 0 | low | 12 | 0 |
sodium bisulfite | 0 | low | 2 | 0 |
sodium lactate | 0 | low | 1 | 0 |
sodium nitrite | 0 | medium | 13 | 1 |
tanshinone ii a sodium sulfonate | 0 | low | 4 | 0 |
holothurin a | 0 | low | 1 | 0 |
ro13-9904 | 0 | low | 4 | 0 |
sodium pertechnetate tc 99m | 0 | low | 3 | 0 |
cortisol succinate, sodium salt | 0 | low | 1 | 0 |
chiniofon | 0 | low | 1 | 0 |
bof 4272 | 0 | low | 2 | 0 |
olaparib | 0 | low | 1 | 0 |
gelsemine | 0 | low | 2 | 0 |
forsythoside b | 0 | low | 1 | 0 |
srt1720 | 0 | low | 5 | 0 |
liriodendrin | 0 | low | 1 | 0 |
cx 4945 | 0 | low | 1 | 0 |
s-adenosylmethionine | 0 | low | 13 | 0 |
picrotoxin | 0 | low | 1 | 0 |
st2825 | 0 | low | 1 | 0 |
canagliflozin | 0 | low | 2 | 0 |
pci 32765 | 0 | low | 2 | 0 |
madecassoside | 0 | low | 2 | 0 |
ponatinib | 0 | low | 2 | 0 |
meglumine cyclic adenylate | 0 | low | 3 | 0 |
crx-526 | 0 | low | 1 | 0 |
oxymatrine | 0 | low | 12 | 0 |
sch772984 | 0 | low | 1 | 0 |
albiflorin | 0 | low | 2 | 0 |
sb 290157 | 0 | low | 2 | 0 |
niraparib | 0 | medium | 2 | 2 |
navitoclax | 0 | low | 1 | 0 |
jzl 184 | 0 | low | 1 | 0 |
egg white | 0 | low | 1 | 0 |
n-(adamantan-1-yl)-4-oxo-1-pentyl-6-phenyl-1,4-dihydroquinoline-3-carboxamide | 0 | low | 1 | 0 |
4,4-difluoro-4-bora-3a,4a-diaza-s-indacene | 0 | low | 1 | 0 |
cardiovascular agents | 0 | medium | 52 | 1 |
neurotensin | 0 | low | 3 | 0 |
fibrinopeptide a | 0 | medium | 2 | 1 |
apelin-13 peptide | 0 | low | 11 | 0 |
a 68828 | 0 | low | 1 | 0 |
compstatin | 0 | low | 1 | 0 |
srt2104 | 0 | low | 1 | 0 |
mannans | 0 | medium | 5 | 2 |
3,4-oxoisopropylideneshikimic acid | 0 | low | 1 | 0 |
emixustat | 0 | low | 2 | 0 |
8-iso-prostaglandin a2 | 0 | low | 1 | 0 |
11,12-epoxy-5,8,14-eicosatrienoic acid | 0 | low | 4 | 0 |
2-chlorohexadecanal | 0 | low | 1 | 0 |
plx4032 | 0 | medium | 3 | 2 |
triiodothyronine, reverse | 0 | low | 2 | 0 |
glycolipids | 0 | medium | 17 | 1 |
necrox-7 | 0 | low | 2 | 0 |
alamandine | 0 | low | 2 | 0 |
piperidines | 0 | medium | 109 | 4 |
resolvin d1 | 0 | low | 10 | 0 |
cyanidin 3-galactoside | 0 | low | 1 | 0 |
bryostatin 1 | 0 | low | 2 | 0 |
thymosin | 0 | low | 5 | 0 |
7,8-dihydroxyflavanone | 0 | low | 1 | 0 |
interleukin-8 | 0 | medium | 129 | 11 |
antibiotic cv-1 | 0 | low | 2 | 0 |
dabrafenib | 0 | low | 2 | 0 |
sd 1029 | 0 | low | 1 | 0 |
gypenoside XVII | 0 | low | 2 | 0 |
punicalagin | 0 | low | 1 | 0 |
5-(4-amino-1-propan-2-yl-3-pyrazolo[3,4-d]pyrimidinyl)-1,3-benzoxazol-2-amine | 0 | medium | 1 | 1 |
int-777 | 0 | low | 1 | 0 |
exenatide | 0 | medium | 19 | 2 |
gsk0660 | 0 | low | 1 | 0 |
galloylpaeoniflorin | 0 | low | 1 | 0 |
gypenoside ix | 0 | low | 1 | 0 |
chymostatin | 0 | low | 1 | 0 |
fructose-1,6-diphosphate | 0 | low | 14 | 0 |
gyy 4137 | 0 | low | 7 | 0 |
physalin f | 0 | low | 1 | 0 |
pf-4708671 | 0 | low | 1 | 0 |
isoquercitrin | 0 | low | 4 | 0 |
dimethylaminomicheliolide | 0 | low | 1 | 0 |
3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-(6-(4-(4-ethylpiperazin-1-yl)-phenylamino)pyrimidin-4-yl)-1-methylurea | 0 | low | 1 | 0 |
vasoactive intestinal peptide | 0 | low | 18 | 0 |
natriuretic peptide, brain | 0 | medium | 19 | 4 |
acy-1215 | 0 | low | 1 | 0 |
heme | 0 | medium | 34 | 2 |
leukotoxin | 0 | low | 1 | 0 |
anemarsaponin b | 0 | low | 1 | 0 |
methylophiopogonanone a | 0 | low | 1 | 0 |
heparitin sulfate | 0 | medium | 16 | 2 |
ascorbic acid | 0 | medium | 156 | 10 |
tetracycline | 0 | medium | 8 | 2 |
minocycline | 0 | low | 39 | 0 |
salicylates | 0 | low | 12 | 0 |
piroxicam | 0 | low | 5 | 0 |
acenocoumarol | 0 | low | 2 | 0 |
mobic | 0 | medium | 9 | 1 |
laquinimod | 0 | low | 1 | 0 |
warfarin | 0 | low | 31 | 0 |
metastat | 0 | low | 1 | 0 |
antimycin | 0 | low | 1 | 0 |
2-o-octadecylascorbic acid | 0 | low | 1 | 0 |
teriflunomide | 0 | medium | 3 | 2 |
mna 715 | 0 | low | 1 | 0 |
s 0139 | 0 | low | 1 | 0 |
lornoxicam | 0 | low | 2 | 0 |
ascorbic acid 2-o-glucoside | 0 | low | 1 | 0 |
6-deoxy-6-fluoroascorbic acid | 0 | low | 1 | 0 |
potassium ascorbyl tocopheryl phosphate | 0 | low | 11 | 0 |
oc 5186 | 0 | low | 1 | 0 |
byl719 | 0 | medium | 2 | 2 |
rgfp966 | 0 | low | 1 | 0 |
n,n'-bis(pyridoxal-5-phosphate)ethylenediamine-n,n'-diacetic acid | 0 | low | 1 | 0 |
omega-agatoxin iva | 0 | low | 1 | 0 |
snx 230 | 0 | low | 1 | 0 |
epidermal growth factor | 0 | medium | 51 | 1 |
gastrin-releasing peptide | 0 | low | 4 | 0 |
calca protein, human | 0 | medium | 6 | 1 |
kaolinite | 0 | low | 1 | 0 |
plasmalyte a | 0 | low | 1 | 0 |
charybdotoxin | 0 | low | 1 | 0 |
bismuth oxybromide | 0 | medium | 2 | 2 |
transforming growth factor beta | 0 | low | 104 | 0 |
phytoestrogens | 0 | medium | 10 | 2 |
semaglutide | 0 | low | 3 | 0 |
epz004777 | 0 | low | 1 | 0 |
astressin-2b | 0 | low | 1 | 0 |
okadaic acid | 0 | low | 3 | 0 |
tcv 309 | 0 | low | 12 | 0 |
sr9009 | 0 | low | 1 | 0 |
pg 545 | 0 | low | 1 | 0 |
sybr green i | 0 | low | 2 | 0 |
gkt137831 | 0 | low | 1 | 0 |
bay 85-3934 | 0 | low | 1 | 0 |
bay 94-8862 | 0 | low | 2 | 0 |
pf-543 | 0 | low | 4 | 0 |
benzalazine | 0 | low | 1 | 0 |
ly3000328 | 0 | low | 1 | 0 |
tan 67 | 0 | low | 3 | 0 |
3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester | 0 | low | 1 | 0 |
platycoside e | 0 | low | 1 | 0 |
bgp 15 | 0 | low | 2 | 0 |
ML355 | 0 | medium | 2 | 1 |
kiss1 protein, human | 0 | low | 6 | 0 |
chebulic acid | 0 | low | 2 | 0 |
araldite | 0 | low | 1 | 0 |
pravastatin | 0 | low | 1 | 0 |
platonin | 0 | low | 3 | 0 |
maitotoxin | 0 | low | 1 | 0 |
3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide | 0 | low | 2 | 0 |
pf-06463922 | 0 | low | 1 | 0 |
rta 408 | 0 | low | 1 | 0 |
as 1842856 | 0 | low | 1 | 0 |
bc-1215 | 0 | low | 1 | 0 |
cobra cardiotoxin proteins | 0 | low | 1 | 0 |
xjb-5-131 | 0 | low | 1 | 0 |
imm-h004 | 0 | low | 3 | 0 |
hirudin | 0 | medium | 4 | 2 |
glutaminase | 0 | low | 9 | 0 |
ginsenoside rg5 | 0 | low | 1 | 0 |
cyclin d1 | 0 | low | 31 | 0 |
ganoderic acid | 0 | low | 1 | 0 |
caseins | 0 | low | 2 | 0 |
bafilomycin b1 | 0 | low | 1 | 0 |
alisol a 24-acetate | 0 | low | 1 | 0 |
technetium tc 99m sulfur colloid | 0 | low | 1 | 0 |
mitotracker green fm | 0 | low | 1 | 0 |
ap20187 | 0 | low | 1 | 0 |
oligomycins | 0 | low | 5 | 0 |
duramycin | 0 | low | 2 | 0 |
g(m3) ganglioside | 0 | low | 1 | 0 |
benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone | 0 | low | 12 | 0 |
s-nitroglutathione | 0 | low | 1 | 0 |
kr 31378 | 0 | low | 5 | 0 |
hydroxytyrosyl acetate | 0 | low | 1 | 0 |
gsk3235025 | 0 | low | 1 | 0 |
lewis x antigen | 0 | low | 5 | 0 |
glucagon-like peptide 2 | 0 | low | 7 | 0 |
calpastatin | 0 | low | 9 | 0 |
angiotensin i | 0 | low | 18 | 0 |
gsk1278863 | 0 | low | 1 | 0 |
ferric oxide, saccharated | 0 | low | 1 | 0 |
gadoxetic acid disodium | 0 | low | 3 | 0 |
cibinetide | 0 | low | 4 | 0 |
hyaluronoglucosaminidase | 0 | low | 2 | 0 |
adrenomedullin | 0 | medium | 36 | 1 |
epoetin alfa | 0 | medium | 16 | 2 |
lithospermic acid | 0 | low | 1 | 0 |
harpagide | 0 | low | 1 | 0 |
diospyros | 0 | low | 1 | 0 |
nephrin | 0 | low | 1 | 0 |
ginkgolide k | 0 | low | 4 | 0 |
carboxyatractyloside | 0 | low | 1 | 0 |
ginkgolide b | 0 | medium | 31 | 1 |
neferine | 0 | low | 1 | 0 |
oridonin | 0 | low | 4 | 0 |
morroniside | 0 | low | 1 | 0 |
sanggenone c | 0 | low | 1 | 0 |
peoniflorin | 0 | low | 15 | 0 |
vitamin b 12 | 0 | low | 10 | 0 |
bb 1101 | 0 | low | 1 | 0 |
aconitine | 0 | low | 4 | 0 |
ecallantide | 0 | low | 1 | 0 |
oxyntomodulin | 0 | low | 6 | 0 |
transforming growth factor alpha | 0 | low | 4 | 0 |
cyclosporine | 0 | medium | 179 | 3 |
flavin mononucleotide | 0 | low | 9 | 0 |
silybin | 0 | low | 15 | 0 |
triciribine | 0 | low | 2 | 0 |
cytochalasin d | 0 | low | 7 | 0 |
peptide yy | 0 | low | 1 | 0 |
lactoferrin | 0 | medium | 9 | 2 |
peptide t | 0 | low | 1 | 0 |
digitonin | 0 | low | 2 | 0 |
catalpol | 0 | medium | 7 | 1 |
oxysophocarpine | 0 | low | 1 | 0 |
edetic acid | 0 | low | 1 | 0 |
neohesperidin | 0 | low | 1 | 0 |
poncirin | 0 | low | 1 | 0 |
orabase | 0 | low | 3 | 0 |
technetium tc 99m medronate | 0 | low | 2 | 0 |
technetium tc-99m tetrofosmin | 0 | low | 2 | 0 |
apyrase | 0 | low | 24 | 0 |
thromboplastin | 0 | low | 37 | 0 |
muramidase | 0 | low | 6 | 0 |
kutkin | 0 | low | 2 | 0 |
senkyunolide i | 0 | low | 4 | 0 |
liriodendrin, 1r-(1alpha,3abeta,4beta,6aalpha)-isomer | 0 | low | 1 | 0 |
chondroitin sulfates | 0 | low | 4 | 0 |
angiogenin | 0 | low | 3 | 0 |
protopanaxatriol | 0 | low | 1 | 0 |
technetium tc 99m dimercaptosuccinic acid | 0 | low | 3 | 0 |
1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one | 0 | low | 2 | 0 |
akt-i-1,2 compound | 0 | low | 1 | 0 |
nu 1025 | 0 | low | 1 | 0 |
levoleucovorin | 0 | low | 1 | 0 |
cyclic gmp | 0 | medium | 100 | 1 |
sepiapterin | 0 | low | 4 | 0 |
deoxyguanosine | 0 | low | 42 | 0 |
guanosine monophosphate | 0 | low | 2 | 0 |
guanosine triphosphate | 0 | low | 8 | 0 |
guanine | 0 | low | 6 | 0 |
guanosine | 0 | low | 9 | 0 |
hypoxanthine | 0 | medium | 46 | 1 |
inosinic acid | 0 | low | 4 | 0 |
inosine | 0 | low | 13 | 0 |
inosine diphosphate | 0 | low | 6 | 0 |
sapropterin | 0 | medium | 27 | 2 |
folic acid | 0 | low | 23 | 0 |
3-methyladenine | 0 | low | 44 | 0 |
isoxanthopterin | 0 | low | 1 | 0 |
neopterin | 0 | low | 4 | 0 |
rifampin | 0 | low | 1 | 0 |
clozapine | 0 | low | 2 | 0 |
ganciclovir | 0 | low | 2 | 0 |
oxypurinol | 0 | low | 24 | 0 |
zaprinast | 0 | low | 4 | 0 |
2-methyl-6-(4-methoxyphenyl)-3,7-dihydroimidazo(1,2-alpha)pyrazin-3-one | 0 | low | 2 | 0 |
rsva405 | 0 | low | 1 | 0 |
allopurinol | 0 | medium | 704 | 14 |
2,2'-(hydroxynitrosohydrazono)bis-ethanamine | 0 | low | 2 | 0 |
celestine blue | 0 | low | 1 | 0 |
xanthopterin | 0 | low | 1 | 0 |
8-hydroxyguanosine | 0 | low | 4 | 0 |
4-hydroxyquinazoline | 0 | low | 1 | 0 |
2-amino-4-hydroxy-6-formylpteridine | 0 | low | 1 | 0 |
tirapazamine | 0 | low | 1 | 0 |
sildenafil citrate | 0 | medium | 43 | 2 |
da 8159 | 0 | low | 4 | 0 |
etifoxine | 0 | low | 1 | 0 |
vardenafil dihydrochloride | 0 | low | 11 | 0 |
tetrahydroneopterin | 0 | medium | 3 | 1 |
5(4'-hydroxybenzylidenoimino)-3-methylisothiazolo(5,4-d)pyrimidine-(7h)-4,6-dione | 0 | low | 1 | 0 |
8-bromocyclic gmp | 0 | low | 9 | 0 |
8-hydroxyguanine | 0 | low | 3 | 0 |
hesperadin | 0 | low | 1 | 0 |
trypan blue | 0 | low | 14 | 0 |
8-hydroxy-2'-deoxyguanosine | 0 | medium | 46 | 1 |
clozapine n-oxide | 0 | low | 1 | 0 |
coelenterazine | 0 | low | 1 | 0 |
echinochrome a | 0 | low | 1 | 0 |
5-methyltetrahydrofolate | 0 | low | 1 | 0 |
fr 167653 | 0 | low | 31 | 0 |
9-(4-fluoro-3-hydroxymethylbutyl)guanine | 0 | low | 1 | 0 |
phosphocreatinine | 0 | low | 2 | 0 |
cytidylyl-3'-5'-guanosine | 0 | low | 1 | 0 |
alpha-(4-pyridyl-1-oxide)-n-tert-butylnitrone | 0 | low | 2 | 0 |
heme arginate | 0 | medium | 3 | 1 |
amelubant | 0 | low | 1 | 0 |
defibrotide | 0 | low | 10 | 0 |
fenobam | 0 | low | 1 | 0 |
liproxstatin-1 | 0 | low | 6 | 0 |
cyanine dye 3 | 0 | low | 1 | 0 |
alcian blue | 0 | low | 1 | 0 |
8-hydroxy-2'-deoxyguanosine 5'-triphosphate | 0 | low | 1 | 0 |
s 3226 | 0 | low | 1 | 0 |
nitritocobalamin | 0 | low | 1 | 0 |
lipoteichoic acid | 0 | low | 2 | 0 |
eye | 0 | low | 20 | 0 |
swinholide a | 0 | low | 1 | 0 |
potassium magnesium aspartate | 0 | medium | 1 | 1 |
mitotempo | 0 | low | 3 | 0 |
acetylcellulose | 0 | medium | 1 | 1 |
apelin-12 peptide | 0 | low | 1 | 0 |
carbidopa | 0 | low | 1 | 0 |
picroside ii | 0 | low | 8 | 0 |
concanavalin a | 0 | low | 2 | 0 |
technetium tc 99m bicisate | 0 | medium | 2 | 1 |
trypsinogen | 0 | low | 1 | 0 |
metallothionein | 0 | low | 10 | 0 |
cog1410 | 0 | low | 1 | 0 |
phosphorus radioisotopes | 0 | low | 3 | 0 |
acetylpuerarin | 0 | low | 3 | 0 |
rada16-i | 0 | low | 1 | 0 |
leptin | 0 | medium | 38 | 2 |
reamberin | 0 | medium | 2 | 1 |
pkh 26 | 0 | low | 1 | 0 |
pyrimidinones | 0 | low | 7 | 0 |
araban | 0 | low | 1 | 0 |
n-acetylheparin | 0 | low | 1 | 0 |
cyclo(7-aminoheptanoylphenylalanyl-tryptophyl-lysyl-benzylthreonyl) | 0 | low | 1 | 0 |
filipin | 0 | low | 1 | 0 |
phenanthrenes | 0 | low | 33 | 0 |